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SUMMARY 
 
Eph receptor tyrosine kinases (RTKs) and their membrane-bound ephrin ligands have 
essential functions in development and disease. They regulate cell movement and positioning 
in establishing and stabilizing patterns of cellular organization. They have been suggested as 
graded molecular markers that monitor the abundance or density of their binding partners on 
opposing cells and relay this information, eliciting correspondingly graded cellular responses. 
Trans-interactions of Ephs with ephrins generate higher-order clusters that are substantial for 
triggering responses, such as neuronal growth cone collapse. Recently, array-like signaling 
assemblies by Eph ectodomain-driven interactions in cis were suggested to drive a nucleation 
mechanism, which is thought to cause recruitment of a proportion of receptors into a signaling 
cluster. In this respect, studies on clustering of the bacterial chemotaxis system have 
highlighted important features such as a heightened sensitivity, increased responsiveness, and 
other functional implications for receptor clustering in signaling systems. By contrast, 
progress into the mechanism of Eph cluster formation and the functional link to downstream 
signaling has been slow. The results presented in this thesis bridge this gap by investigating 
the function of clustering in Eph-mediated cell responses. 
 
Firstly, I have implemented a versatile system to induce clustering and Eph signaling at a 
receptor- and cell-autonomous level. With the use of small chemical dimerizers, which non-
covalently crosslink between one and three FKBP (FK506 binding protein) domains inserted 
into the EphB2 intracellular domain, the system allows the generation of clusters of defined 
sizes, which physiologically form at cell-contact interfaces. Mechanistically, cluster sizes 
were characterized using blue-native PAGE and homo-FRET imaging. Functionally, I 
demonstrate that receptor activation and kinase-dependent signaling is solely triggered by 
Eph-Eph cis-interactions, suggesting that ephrin trans-interactions may be necessary to trigger 
clustering, but may not be required to form a highly ordered array.  
Secondly, Eph receptor clustering correlates with subsequent signaling events, including 
receptor autophosphorylation, cellular collapse responses and growth cone collapse of 
primary neurons. Surprisingly, the composition of the EphB2 cluster sizes determined the 
strength of the cellular response. This is based on the finding that different oligomer sizes 
have distinct activation states. Furthermore, not only the cluster size distribution, but also the 
quality or stability of clusters influences the cumulative signaling response. Thus, clustering 
appears to convert analog signals in a uniform digital output. In this respect, I suggest 
clustering to be beneficial for a high fidelity of response and robustness of signaling. 
Digitalization through clustering has to be reconverted into an analog signal of kinase activity 
for interpretation by the cell’s signaling network. Here, I hypothesize that clustering may also 
serve as a mechanistic relay for shifting the conformational dynamics of the kinase domain to 
the catalytically-competent, kinase-active state, caused by a clustering-evoked 
macromolecular crowding effect.  
XII 
 
Thirdly, my findings propose clustering to be an instance of higher-order control, which 
allows for integration of multiple determinants in the Eph signaling process. Cells that express 
predimerized EphB2 are more sensitive to ephrins, suggesting that intracellular and 
extracellular clustering determinants synergize to induce downstream cellular effects. 
Furthermore, inhibition of clustering by steric hindrance abrogates Eph kinase-dependent 
signaling responses and turns repulsion between cells into adhesion, suggesting that clustering 
is a key regulator in determining if kinase-dependent or kinase-independent signaling 
dominates cellular outcomes. 
Finally, RTK signaling is, by no small means, also influenced by movement and processing. I 
addressed this issue with respect to Eph clustering using TIRF microscopy. Here I 
substantiate that clustering leads to the formation of static spatial signaling entities, which 
preferentially accumulate at the lateral cell edge.  
Overall, my study contributes substantially to the understanding of Eph clustering and its 
importance for signaling. It may be of broad interest for the whole field of Eph/ephrin 
research ranging from developmental neurobiology to cancer.  
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INTRODUCTION 
1. INTRODUCTION 
 
One of the tremendous challenges an animal cell, as an integrated unit of a multicellular 
organism, has to face every millisecond (during development or adulthood) is to establish, 
send and process information. It took 2.5 billion years for unicellular life forms to evolve to 
multicellular organisms. The lag of time may reflect the difficulty for inventing machinery 
which would allow cells to collaborate and coordinate their behavior and labor constantly. 
Even present-day unicellular organisms like bacteria or yeast possess simple strategies of cell-
cell communication and information processing. Although these cells largely live 
independently, they can communicate and influence one another’s behavior by responding to 
chemical signals, i.e. quorum sensing to measure their population density in suspension [1,2]. 
In highly complex multicellular organisms such as vertebrates, communication between cells 
is needed to temporally and spatially control signals for processes like developmental pattern 
formation, organogenesis or homeostasis in adult organisms [2].  
Secreted extracellular signaling molecules are used to bridge information processing between 
single cells. Some of these operate over long distances e.g. as hormones in the blood stream 
(endocrine system); others signal only to immediate neighbors by releasing signals into the 
extracellular space (paracrine signaling) or in a contact-dependent manner. In the nervous 
system, neurons send their signals through their axons, covering sometimes long distances in 
the body. Electrical or chemical signals are transduced through synapses (synaptic signaling) 
to the postsynaptic region of the target cell [2,3]. 
In general, reception of the signals depends on receptor proteins, usually located at the cell 
surface, which bind the signal molecule and relay the information to the inside of the cell. 
Immediate cell responses can vary significantly - from a rearrangement of the cytoskeleton to 
altering the cell metabolism, the function of single proteins or the gene expression pattern. 
The three largest classes of cell-surface receptor proteins are ion-channel-coupled, G-Protein-
coupled (GPCRs), and enzyme-coupled receptors each activating intracellular events through 
different mechanisms [2]. 
Ion-channel-coupled receptors or transmitter-gated ion channels are regulated by the binding 
of their ligands. The ligand binding changes the open-or-closed state equilibrium, influencing 
the ion permeability of the plasma membrane and thus the excitability of the neuron (e.g. 
glutamate regulation of ionotropic glutamate receptors, AMPA-receptors (AMPA - α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid) [4-6]. GPCRs possess seven transmembrane 
helices that span the membrane. When a ligand e.g. neurotransmitter or hormone binds, the 
induced conformational change in the receptor leads to activation of a trimeric G-protein 
(GTP-binding protein). Trimeric G-proteins have 3 subunits α, β and γ, and upon the 
exchange of GDP with GTP the α-subunit dissociates from the β and γ subunits, and both G-
GTP and G can start different signaling cascades [7,8]. Enzyme-coupled receptors function 
directly as enzymes or associate directly with enzymes that they activate. They are usually 
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single-pass transmembrane proteins with an extracellular ligand binding site and a 
cytoplasmic catalytic or enzyme binding site. The majority of the enzyme-coupled receptors 
are protein kinases that act through phosphorylation of intracellular signaling proteins [2]. The 
most prominent and diverse class is comprised by RTKs. It consists of 20 heterogeneous 
families each having important functions in cell signaling [9]. Eph receptors (from 
erythropoietin-producing hepatocellular carcinoma cell, the cell line from which their cDNAs 
were first isolated) together with their ligands, the ephrins (Eph receptor interacting protein) 
represent the biggest family with very unique features among the RTKs [9]. These receptors 
shall be of particular interest in this study. 
 
1.1 Cell signaling by receptor tyrosine kinases 
 
RTKs play an important role in fundamental cellular processes such as cell cycle, cell 
proliferation and differentiation, cell migration as well as cell metabolism and survival 
[10,11]. They share a conserved domain architecture with ligand-binding domains in the 
extracellular region, a single transmembrane helix and a cytoplasmic region which contains 
the important catalytic protein tyrosine kinase domain. Apart from this rather uniform domain 
composition they exhibit variations in structural components, which often contain unique 
features for receptor function and signaling, as e.g. the juxtamembrane region, which in some 
receptor families controls kinase activity. Other structural assets like the PSD95/Dlg/ZO1 
(PDZ)-binding motif might also serve as docking site for downstream adaptor proteins. 
Although the overall topology, some paradigms of kinase activation and some key 
components of the downstream signaling pathways are highly conserved in vertebrates, the 
latest structural studies of RTKs have also revealed an unexpected diversity in the 
mechanisms of activation by their ligand [9]. Interestingly, Eph receptors - in comparison to 
other RTK families - are a remarkable example of diversification in activation and signaling. 
 
 
 
Fig. 1.1 Diversification in ligand-induced dimerization and kinase activation strategies among 
receptor tyrosine kinases. 
(A) EGF receptor dimerization is entirely receptor-mediated. EGF binds simultaneously to two 
domains (L1 and L2) within the same receptor molecule and drives conformational rearrangement in 
the extracellular region. This causes the interaction of regions CR1 between neighboring receptors 
[12].TrkB receptor dimerization is entirely ligand-mediated. A nerve growth factor dimer like BDNF 
crosslinks two TrkB  molecules without any direct contact between the two receptors [13,14]. Receptor 
dimers phosphorylate each other in trans (indicated by P). CR1/2, cystein-rich domain; L1/2, ligand 
binding domain; C1/C2: C-terminal domain; l, leucine-rich domain; K, kinase domain; N, N-lobe/kinase 
domain; C, C-lobe/kinase domain. (B) Dimerization of the extracellular regions of RTKs activates the 
intracellular tyrosine kinase domains, which contain a C-lobe (labeled with C), N-lobe (labeled with N) 
and an activation loop (AL, in grey or green for the inactive and active state, respectively). While the 
crystal structures of the activated kinase domains are very similar, structures of inactive kinase 
domains differ substantially among the receptors [15]. In Tie2, for example, the C-terminal tail (in red) 
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interacts with the active site of the kinase domain to stabilize an inactive conformation [16]. By 
contrast, in EGF receptor no such interaction is involved in inhibition of the kinase activity. However, 
for activation of EGF receptor a destabilization of the autoinhibitory cis-interactions is required by a 
direct contact between the C-lobe/kinase domain of one receptor, called the “activator” and the N-
lobe/kinase domain of the neighboring receptor, called “receiver” [17-19]. (B) is adapted from [9]. 
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Different modes of RTK dimerization. While the general mechanism of receptor activation 
was long thought to start out with ligand-induced receptor dimerization of monomeric 
receptors [20], recent studies for e.g. EGFR (epidermal growth factor receptor) and others, 
like the insulin receptor, made clear that a subset of RTKs forms oligomers even in the 
absence of their ligands [21-23]. Today, a more favorable view sees the general mechanism of 
RTK activation as stabilizing a specific relationship between individual receptor molecules in 
an active dimer or oligomer. The thereby provoked self-association of the extracellular region 
is thought to guide the intracellular domains into a dimeric conformation that activates their 
tyrosine kinase domains. One receptor in the dimer/oligomer phosphorylates one or more 
tyrosines on an adjacent RTK, a process called autophosphorylation, and the phosphorylated 
receptor then serves as a site for assembly of intracellular signaling proteins [20].  
Early studies of ligand-induced dimerization of RTK extracellular regions suggested a 
conceptually straightforward mechanism with a bivalent ligand interacting simultaneously 
with two receptor molecules and thereby effectively crosslinking them non-covalently in a 
dimeric complex [24]. Recent structures of more complete extracellular regions of RTKs have 
provided important additional insight into the range of mechanisms used for ligand-induced 
dimerization, which can be categorized in two extremes: (1) dimerization is entirely “receptor 
mediated” and the ligand makes no direct contribution to the dimer interface, e.g EGFR 
[12,23]; (2) dimerization is entirely “ligand mediated” and the two receptors make no direct 
contact, e.g. TrkB (tropomyosin receptor kinase B) (Fig. 1.1A) [25]. Alternatively, 
dimerization can also involve a combination of ligand-mediated and receptor mediated 
components. 
 
Diverse strategies in kinase activation mechanisms. The mechanisms which regulate kinase 
activation have been addressed in detail for several RTKs, including the stem cell factor 
receptor KIT (kinase receptor), FGFR (fibroblast growth factor receptor), the insulin receptor, 
EGFR and the angiopoietin receptor Tie2 and have turned out to be surprisingly diverse [9]. 
In their active conformation all tyrosine kinase domains share a great structural similarity 
[15]. The important structural elements are the “activation loop” and the αC helix in the 
kinase N-lobe, which reveal a specific conformation that is required for catalysis of 
phosphotransfer [26]. In their inactive conformation, by contrast, structural similarity among 
RTKs substantially vanishes, greatly reflecting the diversity in regulatory mechanisms. 
Autoinhibition of each tyrosine kinase domain is accomplished by a specific set of 
intramolecular cis-interactions. Upon ligand engagement and receptor dimerization, the 
release of structural constraints is the key event that triggers RTK activation [10] (Fig. 1.1B).  
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1.2 Eph receptors and ephrin ligands 
 
Eph receptors and ephrin ligands are one of the key player families in contact-dependent cell 
signaling. They are found in a wide variety of cell types in tissues with reciprocal or 
overlapping expression patterns. When Eph receptors and ephrin ligands are expressed in a 
complementary pattern, the activation occurs at the interface of their expression domains 
[27,28]. 
Eph/ephrin interaction mediates cell-to-cell communication that has important roles in the 
establishment of neuronal, vascular and lymphatic networks during embryonic development, 
which involves diverse processes like (neuronal) cell migration, axon guidance, (neo-)angio-
genesis and tissue patterning (e.g. topographic mapping, segmental patterning) [29,30]. 
Furthermore, Ephs/ephrins are implicated in an increasing number of physiological and 
pathological processes in many cell types and different organs of the adult organism 
summarized in Box 1 [28].  
In distinction to other RTKs, Ephs/ephrins possess three unique features with respect to cell-
contact dependence in signaling and mechanism of receptor activation. First, Ephs require 
membrane bound or preclustered ligands for activation [31]. Second, both receptor and ligand 
are membrane-anchored thereby requiring the actual cell-to-cell contact to initiate binding and 
signaling. In consequence, receptor and ligand can transduce signals bi-directionally into both 
the receptor-expressing cell (forward signaling) and the ligand-expressing cell (reverse 
signaling) [28,32,33]. And third, in contrast to other RTKs where dimerization is sufficient, 
multimeric Eph/ephrin complexes are necessary to induce robust Eph phosphorylation and 
biological responses [34].  
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Box 1. Overview of Eph/ephrin functions in physiology and disease. 
Development Neuronal connections 
Ephs/ephrins have well-known roles in axon guidance and 
synaptogenesis. Ephs/ephrins are distributed in gradients or form 
boundaries and thereby influence the trajectories of axonal projections.
[30,35,36] 
Vascular & lymphatic system 
In cardiovascular development, Ephs/ephrins control the angiogenic 
remodeling of blood vessels and lymphatic vessels. They play essential 
roles in endothelial cells as well as in supporting pericytes and vascular 
smooth muscle cells. 
[37-40] 
Physiology  
& 
homeostasis 
Plasticity of neuronal circuits 
Eph/ephrin expression persists in the adult brain where neuronal 
circuits continue to be remodeled in response to environmental 
changes. Ephs/ephrins play a role in paradigms of acivity-dependent 
synaptic-plasticity that influence learning and memory. 
[41-44] 
Immune system 
Ephs/ephrins are expressed in lymphoid organs and lymphocytes. Eph 
receptor function is implicated in development of thymocytes in mature 
T-cells, subsequent differentiation of activated T-cells into effector cells 
in the periphery, modulation of T-cell responses and various other 
processes of immune function including B-lymphocytes.
[45-47] 
Glucose homeostasis 
The β-cells of the pancreas communicate via EphA/ephrinA. EphA 
forward signaling (inhibits insulin secretion) and ephrinA reverse 
signaling (enhances insulin secretion) can be differentially regulated in 
pancreatic cells. 
[48] 
Bone maintenance 
EphB/ephrinB bi-directional signaling between osteoblasts and 
osteoclasts has been shown to be important for the regulation of bone 
homeostasis in the adult. 
[49,50] 
Intestinal homeostasis 
The intestinal epithelium undergoes continuous self- renewal 
throughout life. Newly born epithelial cells migrate while gradually losing 
EphB expression and acquiring ephrinB expression as they move away 
from mesenchymal cells which control Eph expression through Wnt 
secretion and stimulation of the canonical Wnt/β-catenin/Tcf signaling 
pathway. 
[51-53] 
Patho-
physiology  
&  
disease 
Nervous system injury and repair 
Ephs/ephrins are upregulated in expression at sites of nervous system 
injuries. Ephs/ephrins may provide guidance cues enabling the re-
wiring of neuronal projection patterns, but they may also hinder proper 
axon re-growth through repulsive signaling. 
[54-57] 
Alzheimer disease 
A loss of EphB2 and EphA4 has been shown to precede memory 
decline in a murine model of Alzheimer’s disease. Reversing EphB2 
depletion rescues cognitive functions in Alzheimer model.
[58,59] 
Cancer 
Ephs and/or ephrins are present, and often upregulated, in essentially 
all types of cancer cells including pathologies of colorectal, breast and 
skin cancers. The Eph system is also operational in the tumor 
microenvironment through promoting tumor angiogenesis. 
[28,60-63] 
Viral infections 
It was discovered that ephrinB2 and ephrinB3 serve as the cell entry 
receptors for Nipah and Hendra viruses, two emerging 
paramyxoviruses comprising the newly defined Henipavirus genus. 
[64-67] 
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1.2.1 Eph/ephrin domain topology 
 
In mammals, Ephs are subdivided based on sequence similarity and ligand-binding 
characteristics into an A-subclass (EphA1-EphA8, EphA10) and a B-subclass (EphB1-EphB4, 
EphB6) [33,68]. Their ligands, the ephrins, are also subdivided into an A-subclass (ephrinA1-
A5) and B-subclass (ephrinB1-B3) according to their affinities for receptors, sequence 
conservation and the mode of membrane attachment [27,69].  
EphAs bind to ephrinAs whereas EphBs bind to ephrinBs. Exceptions to this rule are EphB2, 
that can also bind to ephrinA5 [70] and EphA4 that can also bind to ephrinBs [33,71]. 
 
 
 
Fig. 1.2 Domain composition of Eph receptors and ephrin ligands. 
Known tyrosine phosphorylation sites are indicated by Y. PDZ, PSD95/Dlg/ZO1 (PDZ)-binding motif; 
TM, transmembrane domain; RBD, receptor-binding domain; GPI, glycosylphosphatidylinositol-anchor; 
LBD, ligand-binding domain; Cys-rich, cystein-rich domain; FNIIIa/b, fibronectin type-III repeat a/b; JM, 
juxtamembrane segment; SAM, sterile-α-motif. 
 
 
Ephs share a common domain organization throughout all subclasses (Fig. 1.2). They are 
characterized by their globular extracellular ligand-binding domain (LBD) followed by the 
cystein-rich (Cys-rich) domain segment and two type-III fibronectin repeats (FNIIIa/b). The 
previously uncharacterized Cys-rich domain is composed of a sushi domain and EGF-like 
domain [72]. A hydrophobic transmembrane (TM) α-helical domain spans the membrane. The 
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intracellular part of the receptor consists of a juxtamembrane (JM)  segment containing two 
conserved tyrosines, the important catalytic kinase domain, the sterile-α-motif (SAM) and the 
PDZ-binding motif [28].  
EphrinAs are tethered to the cell surface by a GPI-anchor (GPI - glycosylphosphatidyl–
inositol), whereas ephrinBs are single pass transmembrane proteins (Fig. 1.2). They possess a 
short and highly conserved cytoplasmic region of ~80 amino acid (aa) residues with five 
conserved tyrosines, phosphorylated upon activation and a PDZ-binding motif. The 
extracellular part of both ephrin subclasses consists of a globular receptor-binding domain 
(RBD) distanced from the membrane by ~40 aa residues. Note, both subclasses lack an 
intrinsic catalytic activity [28]. 
 
1.2.2 Structural basis of Eph receptors and ephrin ligands 
 
Extracellular Eph receptor structural architecture. Over the last couple of years, 
Ephs/ephrins have been studied intensively on a structural basis to better understand their 
molecular mechanisms of action. Their important role in oncogenesis has led to great interest 
in targeting Ephs/ephrins with small peptides or compounds [73], to generate specific anti-
tumor drugs aside from broad-specificity kinase inhibitors binding in the enzyme’s 
ATP/substrate pocket [74]. Indeed, small-molecule signaling inhibitors that bind to the EphA2 
and EphA4 receptors were reported recently [75-77]. 
First structural studies led to detailed knowledge about the LBD of EphB2, which was shown 
to be a compact globular structure with a β-sandwich “jellyroll” folding topology consisting 
of a concave and convex β-sheet (Fig. 1.3A) [78]. Moreover two distinct ephrin-binding 
interfaces of different affinity were identified from a LBD-RBD x-ray crystallographic 
structure  [79]. On one side of the globular LBD structure, the β-strands are connected by a 
loop of varying length, the so-called H-I loop, which packs against the concave β-sheet being 
part of the low-affinity tetramerization interface; on the other side, two other loops (D-E; J-K) 
protrude from the middle of the convex β-sheet, which forms the high-affinity dimerization 
interface. Interestingly, the length of the H-I loop differs significantly between subclasses but 
is conserved within [80]. A chimeric EphB2 LBD with an H-I loop from EphA3 adopted 
specificity for both A and B-subclass receptors prompting the loop to be entitled the “class-
specificity-loop” [78].  
 
Extracellular ephrin ligand structural architecture. The RBD of ephrinB2 shows a 
globular β-barrel structure with a Greek key folding topology [79,81]. Interestingly, in 
crystals of ephrinB2 not complexed with Eph receptors, hydrophobic regions of the RBD 
around a so-called G-I loop get buried in-between ephrin dimers indicating that ephrins 
undergo a significant rearrangement upon Eph binding. The 40 aa residues linker serves as 
disordered spacer to the membrane and does not seem to be involved in ligand-receptor 
binding [79,81]. 
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NMR-studies of the complete cytoplasmic region of ephrinBs revealed a 33 aa residues long 
highly structured C-terminal tail forming a well-packed hairpin structure and a preceding 48 
aa residues long random-coil structure prone to aggregation [82].  
 
1.2.3 Eph/ephrin recognition and subclass specificity 
 
EphBs/ephrinB recognition and subclass specificity. The recognition specificity of 
ephrinB2 and EphB2 is ensured by ligand induced receptor folding (induced fit mechanism). 
While binding, the dimerization interface centers on the long G-H loop of ephrinB2, which 
gets buried in a channel on the surface of EphB2. This process is thermodynamically driven 
by the hydrophobic effect. Loops lining the inside of the channel in EphB2 undergo a 
secondary-structure rearrangement from disordered to structured, thereby building an 
extensive interaction surface that is complementary to the ligand G-H loop. The 
conformational change in EphB2 is strictly localized to the interaction interface and most 
likely does not involve the intracellular part of the receptor [70,80]. The crystal structure from 
EphB2/ephrinB2 also gave insights into the molecular basis for subclass specificity [79]. The 
ligand-receptor high-affinity dimerization interface contains bulky and small polar and 
hydrophobic side chains on either side. In EphBs these residues are positioned in order to find 
an energetically favorable conformational state, whereas in EphAs, the side chains are 
shuffled in position, and therefore would produce an energetically unfavorable conformational 
state upon ephrinB-binding (e.g. polar residues to face hydrophobic ones). The H-I loop 
guarantees the formation of tetramers of receptor belonging to the same subclass. However, it 
is not sure, if a heterogeneous expression of different subclass members would cause 
heterogeneous clusters which contain more than one type of ligand and/or receptor.  
Other structural studies of EphB4/ephrinB2 further suggested a single aa (Leu95) to be 
responsible for defining ligand selectivity of EphBs. This selectivity could be altered via 
protein engineering approaches [83]. On the ligand side, further structural studies of unbound 
ephrinB1 and ephrinA5 underlined the importance of the G-H loop for receptor recognition 
but also pointed out the uniqueness in the molecular mechanism for receptor-ligand 
specificity of each cognate pair [84,85].  
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Fig. 1.3 Eph/ephrin complex formation and cluster architecture. 
(A) Comparison of the structures from the unligated EphA2 (cyan) and EphB2 (magenta) ligand-
binding domain. Secondary structure elements are labeled on the ribbon diagram (arrows). Both the 
EphA2 and EphB2 structure are close to congruence. The main structural differences between EphA2 
and the EphB receptors are the conformations of the D-E, J-K and H-I loops. The H-I loop length is the 
only clear feature that distinguishes the sequences of the A- and B-class molecules (with EphA 
receptors H-I loop four residues shorter in length). In the EphB2/ephrinB2 crystal structure, this H-I 
loop is involved in forming the low-affinity tetramerization interface [79]. The J-K and D-E loops are 
responsible for forming the ligand-binding cleft. Although in the unligated B-class receptors they adopt 
more open conformations [86], in EphA2 they form a compact ligand-binding channel - even in the 
absence of the ligand [87]. The tetramerization and dimerization interface is indicated by stippled lines 
[79]. (B) Conformational changes in A- and B-class Eph receptors upon ephrin binding. Left: 
comparison of the structures of unligated EphB2 (yellow), ephrin-bound EphB2 (green), and a 12-mer 
antagonistic peptide-bound EphB2 (magenta) [87,88]. Right: comparison of the structures of unligated 
(green) and ephrin-A1 bound (blue) EphA2. In contrast to EphA2, EphB2 undergoes significant 
structural rearrangements upon ligand/peptide binding (see arrows). (C) Comparison of the structures 
of the known A- and B-class Eph receptor/ephrin complexes except for EphA4/ephrinB2. EphB2: 
Val27-Arg207; ephrin-B2: Ile31–Gly168; ephrin-A5: Val28–Met165; EphB4: Glu17–Lys196. The 
EphA2/ephrin-A1 heterodimer is architecturally similar to the B-class complexes. (D) Schematic 
presentation of the 1:1 receptor - ligand contact of opposing cells. The circle indicates the cross-
sectional view taken to depict receptor/ligand complex formation in panels (E) - (I). For simplification 
reasons, receptor and ligand are presented in a truncated form (indicated by X) only displaying the 
ectodomains. (E) Initial Eph/ephrin contact produces a high-affinity interaction of the receptor and 
ligand-binding domain. The G-H loop of ephrinB2 gets buried in a channel on the surface of EphB2-
LBD leading to secondary structure rearrangements as shown in (B). (F) Formation of the tetrameric 
EphB2/ephrinB2 complex involving the class-specificity H-I loop and the surrounding surface as 
indicated in (A). This complex is thought to be the minimal functional unit to activate receptors [79]. (G) 
Hypothetical higher-order cluster formation model of Ephs/ephrins based on various structural and 
functional studies. Note, that a third interaction site is proposed between the ligand and receptor which 
belongs to neighboring tetrameric Eph/ephrin complexes [89] and interactions between the Cys-rich 
domains [90]. (H,I) Latest model to propose an extracellular steric seeding mechanism for the 
formation of array-like networks of EphA2 [72]. A switch from a parallel staggered array, produced by 
interactions of the LBD and sushi domain of adjacent unligated EphA2 receptors, to ephrin-bound in-
register arrays, characterized by LBD-LBD/sushi-sushi and FNIIIa-FNIIIa interactions, is proposed. 
The Cys-rich and FNIII domain are highlighted to be required for higher-order cluster formation. Similar 
other results support this model [91]. Ribbon diagrams in (A,B,C) are adapted from [87]. 
 
 
EphAs/ephrinA recognition and subclass specificity. The first study to investigate the 
structural basis of EphAs/ephrinAs was done by Himanen and colleagues presenting the 
crystal structure of an EphA2/ephrinA1 complex [87]. Although these structures are overall 
similar to their B-class counterparts (Fig. 1.3B,C), they reveal important differences that 
define subclass specificity. EphAs/ephrinAs interactions involve smaller rearrangements in 
the interacting partners, better described by a “lock-and-key”- type binding mechanism, in 
contrast to the “induced fit” mechanism defining the B-class molecules (Fig. 1.3B). In 
retrospective, the fact that no small-molecule antagonists have been found for any EphBs so 
far highlights the biological relevance of their different binding modes.  
 
Eph binding promiscuity. Cross-subclass interactions were revealed by the physiologically 
relevant receptor/ligand pair EphB2/ephrinA5 (Fig 1.3C) [70]. EphB2/ephrinA5 complex is a 
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heterodimer architecturally distinct from the tetrameric EphB2/ephrinB2 structure. The 
authors concluded that bi-directional signaling is the result of a combination of Eph/ephrin 
interactions - both intrasubclass and intersubclass. Thus, even interactions that are of lower 
affinity could significantly cause signaling responses depending on the number or density of 
interacting molecules. In this context, the authors also put up for debate that receptor 
activation might not require the precise positioning of nearby Eph receptors. 
EphA4, one of the most studied Eph receptors, shows cross-subclass binding promiscuity. 
Published structures differ considerably from each other and strikingly different explanations 
for the exceptional cross-subclass specificity and affinity were proposed [71,77,92]. One 
report addressing these contradictory findings showed that the receptor has an unprecedented 
ability to adopt two distinct, well-ordered structures even in the unbound state. These results 
suggest that the ligand promiscuity of EphA4 is directly correlated with the structural 
flexibility of the ligand-binding surface of the receptor [93]. 
 
1.2.4 Eph/ephrin complex and higher‐order cluster formation 
 
Eph/ephrin complex formation. The first step in initiating signaling is a 1:1 heterodimer 
formation between Ephs and their cognate ephrin ligands (Fig. 1.3D,E) [94,95]. Subsequently, 
for EphB2/ephrinB2, heterodimers tetramerize into a ring-like structure with a much lower KD 
into 2:2 complexes and eventually form higher-order oligomers (Fig. 1.3F,G) [79,96]. In the 
forward signaling direction, it is suspected that EphB2/ephrinB2 heterotrimers, consisting of 
one ligand in complex with two receptors form the minimal functional unit [80]. In order to 
signal bi-directionally, EphB2/ephrinB2 complexes have to adopt the tetrameric 2:2 
stoichiometry [79].  
 
Eph/ephrin higher-order cluster formation. Studies on EphA3/ephrinA5 using a random 
mutagenesis approach identified three distinct EphA3 surface areas that are essential for 
complex formation [89]. While two of these surfaces correspond to the dimerization and 
tetramerization interfaces of EphB2, the third falls outside the structurally characterized 
interaction domains. Further experimental work confirmed the existence of the third surface to 
be required for oligomerization and full activation of EphA3 [97]. Based on the 
EphB2/ephrinB2 x-ray crystallographic structure, the newly discovered third Eph-ephrin 
interface and the previously described EphA3-EphA3 interaction [79,89,90,97], the formerly 
introduced “tetramerization model” (Fig. 1.3F) was advanced to allow explanation of higher-
order oligomerization into larger 2-dimensional Eph/ephrin signaling clusters (Fig. 1.3G) 
[89].  
Lately, structural biologists have also crystallized the whole ectodomain of Eph receptors to 
get a deeper insight in the molecular basis of Eph/ephrin higher-order oligomerization. 
Homotypic interactions between the LBDs of EphA2 receptors as well as homotypic Cys-rich 
domain and FNIIIa interactions were confirmed and identified to be responsible for the 
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assembly of higher-order clusters [72,90,91]. Interestingly, unliganded EphA2 ectodomains 
form array-like networks with staggered, parallel interactions between the LBD and sushi 
domain which are relevant to the cell-surface signaling, as shown by functional experiments 
(Fig.1.3H) [72].  
Upon ephrinA5 binding, arrays shift to in-register arrays involving LBD-LBD and sushi-sushi 
contact interfaces in addition to the previously described RBD-dependent contact interfaces 
(Fig. 1.3I)  [72,80,87]. A similar ectodomain structure was obtained for the EphA2/ephrinA1 
complexes [91], which also emphasized the receptor-mediated nature of the oligomerization 
process when looking beyond the size of tetrameric complexes.  
Other Eph receptor domains such as the transmembrane segment [98], and the intracellular 
SAM domain [99-102] are also implicated in the constitution, stabilization and maturation of 
Eph signaling arrays but were so far not shown to be functionally relevant. FNIII repeats of 
EphA3 were also reported to interact with the RBD of ephrinA5. Yet, this interaction was 
shown to occur in cis with co-expressed ephrinA5 thereby inhibiting Eph complex formation 
and signaling [103]. 
Taken together, structures of whole ectodomains of EphAs/ephrinAs show an arrangement 
somewhat reminiscent of the tetramerization model observed in the initial EphB2/ephrinB2 
structure (personal communication with E. Seiradake & [72,79,89,91]). However, structures 
of other Eph/ephrin complexes have not revealed explicit tetrameric arrangements 
[70,87,88,93], which may indicate an overgeneralization of the tetramerization model. 
Furthermore, the array-like model for higher-order cluster formation seems more consistent 
between crystal structures and mutagenesis analysis [72,89,91]. Thus at present, no consistent 
clustering model can be described. Future studies will show, if a general clustering model 
emerges or if structural arrangements remain at least unique to the level of A- or B-subclass 
receptors. It might even be possible that structural arrangements are defined by subtype-
specific receptor/ligand combinations.  
 
Eph/ephrin extracellular steric seeding mechanism. An extracellular steric seeding 
mechanism is suggested for the formation of Eph/ephrin signaling hubs. In analogy to 
previous work the Eph Cys-rich domain may function as a unique protein-
interaction/dimerization module, which cooperates with ligand-dependent clustering to 
mediate the assembly of continuous oligomers also independent of ligand contact  
[72,90,91,104]. In such a scenario, ephrin binding at “nucleation” points may trigger a more 
widespread recruitment of EphAs into in-register arrays containing unbound receptor, thus 
facilitating, in a cooperative manner, additional ephrin binding [72]. However, it has to be 
shown in future studies, whether this nucleation mechanism is a general feature of Eph/ephrin 
cluster formation or if it is specific for EphAs/ephrinAs. 
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1.3 Mechanism of Eph receptor activation 
 
The activation of all RTKs follows some general rules. Ligand binding brings at least two 
catalytically repressed kinase-domains together [9,105], which phosphorylate each other in 
trans. Phosphorylation of the kinase activation loop leads to the exposure of the kinase-active 
site, which is usually blocked. In some RTKs like Eph, KIT, Flt3 (vascular endothelial growth 
factor receptor 3), PDGFβ (platelet derived growth factor β) and TrkB, the juxtamembrane 
region is also involved in regulation of the kinase activity [106,107]. In Ephs, catalytic 
activation correlates with phosphorylation of two tyrosines (Tyr604 and Tyr610, for murine 
EphB2) within the JM segment [108-110], and possibly the phosphorylation of a third 
tyrosine in the kinase activation segment (referred to as TyrAct788, for murine EphB2; 
TyrAct779 for EphA4). In vivo phosphorylation sites were reported to be Tyr667, Tyr744 and 
Tyr750 [111], however, their role for Eph receptor regulation is so far unknown.  
 
 
Fig. 1.4 Molecular mechanism of Eph receptor kinase activation. 
Schematic presentation of the proposed activation mechanism by means of EphB2/EphA4 structural 
studies [107,112]. For better understanding of the structural features in relation to EphB2 sequence 
alignment, an illustration is shown on the bottom. (A) Unphosphorylated, autoinhibited state: the N-
terminal lobe elements implicated in nucleotide binding are well ordered and adopt a prototypical 
protein kinase arrangement except for obvious distortions in helix αC and the G-loop. The G-loop 
plays an important role in coupling the β-strand movements to produce an altered twist to that of helix 
αC (indicated tachometer symbol). This overall structural scenario results from interactions with the JM 
segment (black arrows). In the C-lobe of the kinase domain, the activation segment, which is also 
located in the large catalytic lobe (not depicted here), is disordered (indicated by intensely scribbled 
light-blue line) and produces a steric contact with Tyr750 (indicated by red scribbled line), which 
adopts an alternate conformation impeding the activation segment from adopting a stabilizing path. 
The preceding JM segment is highly ordered forming αA’ and αB’ helices with intimate contact to αC 
helix of the N-terminal kinase lobe (black arrows) and limited interactions of the C-terminal lobe (black 
stippled arrow). This leads to an imposed kink on helix αC. The distortion couples to distortions of the 
N-terminal lobe elements, which appear to impinge on catalytic function by adversely affecting the 
coordination of the sugar and phosphate groups of the bound nucleotide (not depicted here). (B) 
Phosphorylated, active state: phosphorylation of Tyr604 and Tyr610 serves to destabilize the JM 
structure through electrostatic repulsion exerted by negatively charged phosphate groups. This 
abrogates the intimate contact to helix αC and the C-terminal lobe to cause overall enhanced interlobe 
dynamics comprising helix αC and the activation segment. Tyr750 adopts a conformation that no 
longer impedes the productive ordering of the activation loop. The dynamic conformational equilibrium 
is shifted from a kinked to a straight αC helix allowing the return of the N-terminal lobe to an 
undistorted active conformation. Conformational rearrangements are mediated via the G-loop to 
produce an altered twist in β-strand secondary structures (indicated by arrow in circle). The current 
idea is that catalysis is followed by dynamic fluctuations from a more stable conformation favoring a 
rather dynamic picture of Eph receptor kinase activation over the transition to a static active state. Red 
arrows indicate structural interactions. 
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X-ray crystallography of the juxtamembrane and kinase domains of EphB2 indicate a dual 
inhibition mechanism involving the kinase activation loop and the two conserved 
juxtamembrane tyrosine residues [107]. In its non-phosphorylated form, the JM segment folds 
back to form a well-ordered structure, interacting with the N-terminal lobe of the kinase, 
presumably causing the distortion of the key α-helix C leading to repression of the kinase 
activity (Fig. 1.4A). Interestingly, α-helix C possesses a kink not previously observed in 
active state protein kinase structures. In addition, limiting the JM segment contacts with the 
kinase domain C-lobe appear to prevent the activation segment from adopting an ordered 
active conformation. The JM segment bridges the N- and C-lobes of the kinase and thereby 
restricts inter-lobe flexibility. Together, these disruptive features are suggested to account for 
the repression of kinase activity of Eph receptors in their autoinhibited states. Upon 
phosphorylation of the JM tyrosines electrostatic repulsion would then lead to a relief of the 
structural constrains controlling kinase activity [107]. Mutation of these JM tyrosines to 
negatively charged glutamate (eeEph) in EphA4 leads to a constitutively kinase-active EphA4 
receptor, which remains sensitive to receptor ligation in vivo [113]. Exchange for uncharged 
phenylalanine (ffEph), in contrast, leads to a receptor frozen in its autoinhibited state [107]. 
Moreover, phosphorylation of the JM tyrosines enables docking of SH2-binding adaptor 
proteins (SH2 - Src homology domain 2) inducing further downstream signaling events [114].  
Recently, the Sicheri lab performed a much more detailed study of Eph kinase activation 
utilizing a combination of mutational and structural analyses, also including NMR 
spectroscopy, to draw a more dynamic picture of autoinhibited and active forms of EphB2 and 
EphA4 [112]. They provided direct evidence that phosphorylation of the JM segment residues 
Tyr604 and Tyr610 and a gain-of-function point mutation of Tyr750 to alanine in the C-lobe 
of the kinase domain induces disorder of the JM segment and its dissociation from the kinase 
domain (Fig. 1.4B). 
Interestingly, these induced disorders in the JM segment occur without major conformational 
changes to the kinase domain and with only partial ordering of the kinase domain activation 
segment. All these results suggest that rather a change in interlobe dynamics of the JM 
segment and kinase domain, than a transition to a static active conformation forms the 
mechanistic basis for Eph RTK activation [112].  
While the importance of JM tyrosine phosphorylation for Eph receptor activation is well 
established, phosphorylation of other residues, such as Tyr788, Tyr667, Tyr744 and Tyr750 
also seem to influence the stability of the autoinhibited structure and hence Eph receptor 
activity. [107,112].  
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1.4 Bi‐directional signaling of Eph/ephrin complexes 
 
Interactions between Eph receptors and ephrins activate a bi-directional signaling network 
transducing the signal in the Eph-receptor-expressing cell as well as in the ephrin-expressing 
cell. Signals into both cells are transferred along horizontal and vertical signaling cascades 
composed of various mediators, adaptors and effector proteins to eventually meet their 
intended cellular response tasks. Over the last years, a number of studies have been carried 
out to unravel the complex signaling networks configured by Eph/ephrin signaling (Fig. 1.5) 
(reviewed in [28,30,33]).  
 
1.4.1 Eph forward signaling mechanisms  
 
Eph-mediated signaling upon ligand binding in trans is by far the most heavily studied 
pathway of Eph/ephrin signaling. Eph receptors are activated through ligand binding, complex 
formation and subsequent higher-order cluster formation to activate the catalytic propensity of 
the kinase domain [33]. Phosphorylation of tyrosine residues leads to the emergence of 
signaling hubs for adaptor proteins on the JM segment, kinase and possibly the SAM and 
PDZ domain. Most of these adaptor proteins intrinsically lack catalytic function and bind 
through SH2/SH3 domains to phosphorylated tyrosines. Association of Src to Eph also assists 
in activation of many pathways by phosphorylation of downstream signaling components.  
 
Regulation of Rho GTPases - effects on the cytoskeleton. A key component in this 
signaling context is the Rho family of small GTPases including RhoA, Cdc42 (cell division 
cycle 42) and Rac [61]. GTPases function by cycling between an active GTP-bound form and 
an inactive GDP-bound form thereby constituting a bistable switch in activating specific 
downstream effectors. Rho proteins are key regulators of actin cytoskeleton dynamics in cells, 
in addition to regulating a variety of other important cellular processes [115-117]. In neuronal 
cell lines, RhoA regulates stress fiber and focal adhesion formation and cell contractility, 
whereas Rac1 and Cdc42 activation results in the formation of protrusive structures such as 
lamellipodia and filopodia, respectively [118]. RhoA acts through ROCK (RhoA kinase) and 
LIM kinase on Cofilin, which effectively reorganizes the actin cytoskeleton through acto-
myosin contractility [119]. In the case of mature neurons, activation of this pathway results in 
axon growth cone collapse [120-122].  
Rho GTPases are tightly regulated by guanine nucleotide exchange factors (GEFs), which 
stimulate the exchange of bound GDP for GTP, thus activating Rho GTPases and GTPase-
activating proteins (GAPs) like α2-chimaerin [123-126]. Upon Eph receptor activation, α2-
chimaerin binds through its SH2 domain and undergoes tyrosine phosphorylation, which 
enhances its GTPase-activating protein activity towards Rac1. Ephs recruit the GEFs of the 
ephexin family (Eph interacting exchange protein; specific for EphA4) with its most 
prominent member ephexin1, directly and in a constitutive manner regardless of the activation 
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state of the receptor [122,127]. Bound on inactive Eph, ephexin1 is not tyrosine 
phosphorylated and moderately activates RhoA, Rac1 and Cdc42 with the consequence that 
the balance of GTPase activity is maintained to promote axon outgrowth. Eph activation then 
leads to ephexin phosphorylation, most likely by Src [128] and a shift to strong stimulation of 
RhoA GDP/GTP exchange by ephexin. In ephexin1 knockout mice, growth cone collapse 
from retinal ganglion cells (RGCs) was significantly reduced in response to ephrinA1 
stimulation in comparison to controls [127]. 
Cdc42 is also activated by Eph receptor signaling mediated by ephexin1. It is, however, rather 
than being linked to contractility, proposed to regulate actin polymerization during dendritic 
spine morphogenesis [129]. EphB receptors, expressed in hippocampal neurons associate with 
other GEFs of the intersectin and kalirin family, which are exchange factors for Cdc42 and 
Rac [129,130]. Unlike the constitutive binding of ephexins and intersectins, kalirin only binds 
to activated Eph receptors. In endothelial cells it was shown that cell retraction and 
subsequent membrane respreading triggered by ephrinB2 is entirely dependent on myosin-II 
ATPase activity. In line with previous studies, it is only partially dependent on Rho-ROCK 
signaling but also to a significant degree on Cdc42 signaling [131-133].  
The Rho GEF Vav2, which has no preferences for either EphAs or EphBs, acts in the same 
fashion as ephexin1, and it plays an important role in Eph receptor endocytosis.  
Additionally Eph can regulate the organization of the actin cytoskeleton through the Ableson 
(Abl) family tyrosine kinases and Abl-related gene (Arg). Several protein interactions 
between Abl/Arg and EphA4/EphB2 were found in a yeast two-hybrid screen [134]. Abl/Arg 
have actin binding motifs in their carboxy-terminal tails and Abl and Ephs are localized in 
neuronal growth cones, which supports a role for Abl in regulating the actin cytoskeleton 
during Eph-mediated axon pathfinding. For instance, Abl plays a role in EphA-mediated axon 
guidance of retinal ganglion cells [135]. 
Overall, independent but also partially inter-connected pathways seem to exist to mediate the 
important Eph forward signaling response of cellular retraction via cytoskeletal 
rearrangements.  
 
Fig. 1.5 Eph/ephrin bi-directional signaling pathways. 
Schematic presentation of Eph/ephrin-induced signaling pathways as described in the main text. 
Arrows () denote a positive, (T)-indicators a negative regulation on downstream targets. Red arrows 
indicate the evenly balanced Rac/RhoA/Cdc42 activation prior to Eph receptor activation, which then 
shifts to stronger RhoA activation and weaker Rac/Cdc42 activation (stippled arrows). The location of 
the signaling proteins does not imply the involvement of a particular Eph/ephrin domain. (?) indicate 
signaling connections that have not been conclusively assessed in Eph/ephrin signaling. The relative 
activation of different pathways and their effects on cell behavior may depend on the Eph/ephrin 
levels, degree of ligand/receptor clustering and cellular context.  
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Regulation of Ras GTPases - effects on mitogenesis. Aside from the regulation of Rho 
GTPases Eph receptors also have an impact on the activity of Ras family proteins. H-Ras 
binds and activates a row of serine/threonine kinases, amongst those are the MAP (mitogen-
activated protein) kinases Erk1 (extracellular-signal-regulated kinase 1) and Erk2 [136,137]. 
The Ras/MAPK pathway is a key regulator of cell proliferation and transformation but was 
also implicated in influencing axon guidance and cell adhesion [138-140]. While most RTKs 
positively regulate H-Ras to cause increased MAP kinase activity, both EphAs and EphBs do 
the opposite [141-145], which may explain how the Eph receptors inhibit cell proliferation. H-
Ras signaling is regulated by an intricate balance of H-Ras activators and inhibitors such as 
p120RasGap or Grb2/SOS (son-of sevenless) [142,146-148], and may under certain 
circumstances even override neurite collapse inducing Rho/ROCK signaling to mediate 
neurite outgrowth [138,149].  
 
Implications for SAM/PDZ domain mediated signaling. A significant part of Eph signaling 
obviously relies on tyrosine phosphorylation of the JM region and the catalytic activity of the 
kinase domain. The functional relevance of the SAM or PDZ binding domains is not clear to 
date, and while cytosolic ligands for Eph PDZ-binding motifs were reported [150-152], 
truncation of the SAM or PDZ domain did not show a significant impact on EphA4 function 
in vivo or in vitro at the first glance [153,154]. Heterotypic interactions between the Eph 
receptor’s SAM domain and the SAM domain of the cytosolic ILK (integrin-linked kinase) 
was shown to inhibit cell spreading and migration by altering Rac1 and RhoA activity [155]. 
Heterotypic interactions to SHIP2 (Src homology 2 domain containing phosphoinositide 5-
phosphatase 2) maintain active Eph receptors on the cell surface by regulating endocytosis 
and subsequent receptor degradation [156]. Interestingly, Ephs are the only family of RTKs 
dependent on oligomerization for biological activity [31,34], and at the same time the only 
family to contain a SAM domain [105]. This peculiarity raises the possibility that homotypic 
SAM-SAM interactions between adjacent Eph receptors may serve to stabilize and participate 
in  receptor clustering [99,100,102]. In fact, SAM domains were shown to mediate protein-
protein interactions and homodimerization when present at high in vitro concentrations [101]. 
The PDZ-binding motifs at the C-terminal end of Eph receptors may also serve as 
phosphorylation independent adaptor sites for PDZ domain-containing proteins, including 
Syntenin, PICK1 (protein interacting with PRKCA 1), GRIP (glutamate receptor interacting 
protein), AF-6 (afadin), and SPAR (spine-associated RapGAP) [151,152,157,158]. Depending 
on the number of incorporated PDZ domains, adaptors could even interact with more than one 
Eph receptor simultaneously and thus serve as scaffolding proteins and alter Eph clustering 
and signaling as observed for ephrinBs [159,160]. This possibility was implicated in a study 
measuring mossy fiber LTP (long-term potentiation) upon infusion of soluble peptides 
interfering with binding of PDZ-adaptor proteins. Thus impaired Eph signaling causes the 
reduction of mossy fiber LTP implying that postsynaptic intracellular components may act on 
Eph signaling via PDZ-binding motif-mediated scaffolding of Eph receptors.  
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In conclusion, although the majority of proximal Eph receptor-induced signaling events 
appear to be phosphotyrosine-dependent, the SAM domain and PDZ-binding motif may have 
a modulating role on Eph clustering thereby altering Eph-specific signaling responses.  
 
Link to integrin function - effects on cell-substrate interactions. Eph receptors have been 
linked to the integrin signaling pathway via R-Ras [161], and Rap1 proteins [162], through 
mediators like SHEP1, p130Cas, Crk and the Rap1 exchange factor C3G [163], via FAK 
(focal adhesion kinase) [164,165] and via the recruitment of LMW-PTP (low-molecular-
weight protein tyrosine phosphatase) or SH2/SH3 adaptor protein Nck [166,167]. Moreover, 
PI3-kinase (phosphatidylinositol 3-kinase) activation is regulated by EphA8 kinase signaling 
through recruitment of the p110γ regulatory subunit to the plasma membrane acting on 
integrin function [168]. 
 
Kinase-deficient signaling. In some physiological scenarios Eph receptor function does not 
require forward signaling. EphB6 and EphA10 are known for their lack of kinase activity, 
which thereby does not allow kinase-dependent forward signaling responses [169]. However, 
kinase-independent signaling pathways emerging from kinase-null Ephs are implicated, e.g. 
the phosphorylation of EphB6 by the Src family kinase Fyn [170]. Another source for 
catalytically deficient Eph receptors is alternative splicing, which was shown to occur for 
EphA7 [171]. C-terminally truncated, spliced isoforms can intermingle with Eph signaling 
clusters and thereby impair signaling from full length receptors.   
The silencing of the forward signaling branch in bi-directional Eph/ephrin signaling does, 
however, not prevent reverse signaling by ephrins initiated by Eph/ephrin ectodomain 
complex formation. It was shown that in some cases the ectodomain of the receptor is 
sufficient to activate ephrin-mediated reverse signaling in neighboring cells [153,172,173].  
 
Negative regulation of Eph forward signaling. Cleavage and endocytosis will eventually 
lead to reduced Eph forward signaling [174]. However, these mechanisms of action are 
characterized by relocation and degradation and do not show per se how Eph signaling is 
inactivated. Increasing Eph surface densities lead to an increase in basal autoactivation of the 
Eph kinase activity of the receptor indicating a dynamic equilibrium between active and 
autoinhibited receptors which has to permanently be maintained by de-activation mechanisms 
[90,175]. De-activation mechanisms to convert Eph receptors into the autoinhibited, inactive 
state requires dephosphorylation of their juxtamembrane tyrosine residues. Recent work 
identified the phosphotyrosine-specific protein-tyrosine phosphatase receptor type O 
(PTPRO), LMW-PTP, PTP1B (protein tyrosine phosphatases 1B)  and PTPs in general to 
efficiently dephosphorylate EphAs and EphBs, which results in negatively regulating the 
ephrin-mediated downstream responses such as receptor internalization, axon growth cone 
collapse or insulin secretion from β-cells  [48,176-178]. The phosphatase LAR was shown to 
 
22 
 
INTRODUCTION 
reduce its dephosphorylation activity on EphB2 receptor after activation of FGFR1 signaling 
[179]. 
These results suggest phosphatases to be negative regulators of Eph forward signaling, which 
retain the fragile equilibrium between active and inactive Eph species prior to stimulation of 
ephrin. But they also have the capacity to alter ephrin-induced Eph activation and secondary 
processes.  
 
1.4.2 Eph receptor signaling crosstalk 
 
Eph signaling may incorporate crosstalk to signaling pathways from other receptor/ligand 
signaling systems by a direct physical interaction, also known as heterotypic Eph clustering, 
by directly affecting the interconnected receptor’s signaling capacity or by intersecting on 
common downstream signaling pathways (Fig. 1.5). Eph receptors may also signal in a 
cooperative manner without intersecting on downstream signaling pathways to mediate the 
same or opposite cellular responses. Inversely, Eph receptors may also be targeted by other 
receptor/ligand signaling systems affecting their signaling capacity.  
 
Direct biochemical crosstalk. An example of direct Eph receptor crosstalk through a 
signaling mediator like the PI3-kinase and others exists for the integrin receptor to mediate 
cell adhesion (cp. section 1.4.1 ) [168,180-183].  
 
Indirect biochemical crosstalk. Eph receptors are also known to crosstalk with other growth 
factor receptors, which leads to either attenuation or integration of signals. Activation of 
several Eph receptors by ephrins can attenuate the stimulation of the Ras/MAP kinase 
pathway induced by PDGF, VEGF (vascular endothelial growth factor), EGF (epidermal 
growth factor) and others suggesting crosstalk of the signals downstream of Eph receptors 
[141,146]. FGF (fibroblast growth factor) was shown to antagonize EphB2 receptor signaling 
by blocking a positive MAP kinase feedback loop in EphB2 signaling via the transcriptional 
target Sprouty by FGFR1 [179].  
 
Physical interaction. An important mutual inter-connection exists between Eph receptors and 
NMDARs (N-Methyl-D-Aspartate receptor). Active EphB2 receptors physically interact with 
NMDARs and promote clustering of these neurotransmitter receptors at synapses 
[42,184,185]. NMDARs get phosphorylated by EphB2, which increases NMDA-dependent 
calcium influx. Eph receptor signaling is in turn counter-regulated by intracellular 
mechanisms that cause degradation of EphB2 in response to increased calcium levels. This 
degradation process was shown to be solely triggered by calcium influx independent of ephrin 
binding [186]. NMDAR function is strongly related to Alzheimer’s disease [187]. In fact, 
reversing EphB2 depletion, which precedes memory decline in a murine Alzheimer model, 
rescues cognitive functions [58,59]. 
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Other physical associations with Eph receptors were shown for the kinase inactive Ryk 
receptor, which binds Wnt3 and acts in brain areas of retinotectal topographic mapping to 
counterbalance an ephrinB provided guidance signal [188-192]. Wnt3, which is expressed in 
an inverse pattern to ephrinB expression leads to avoidance by navigating retinal ganglion cell 
axons, which express EphBs. Here Wnt and ephrins work together to reinforce the same 
guidance trajectory in a cooperative manner [193,194].  
 
Cooperative signaling. Other studies involving GDNF (glial cell line-derived neurotrophic 
factor) and its cognate receptor Ret also show a cooperation of this signaling system with 
EphA4 in axon guidance decision at the sciatic plexus [195,196]. In the first study motor 
neurons belonging to the LMCL (lateral motor column) population were shown to require the 
cooperation of EphA4 and Ret signaling to project to the dorsal hindlimb [195]. In the second 
study, EphA4 and Ret signaling were shown to evoke opposite effects within the same growth 
cone to reinforce the same guidance decision. Indeed, EphA4/ephrinAs repel the LMCL axons 
from the ventral mesenchyme whereas Ret/GDNF attract them to the dorsal mesenchyme 
[197].  
 
1.4.3 Cis‐ versus trans‐interactions in Eph/ephrin signaling 
 
While binding of Ephs and ephrins expressed on opposing cells (in trans) represent the most 
common mechanism of interaction, growing evidence supports the importance of Eph/ephrin 
interactions in cis. In many regions of the developing brain, Ephs and ephrins are co-
expressed in the same cell raising the questions whether or not Ephs can interact with ephrins 
in cis and whether cis-interactions change the responsiveness to ephrins presented in trans 
[32]. In order to interact in cis Ephs and ephrins have to share the same membrane 
microdomains [198]. In vivo Eph/ephrin cis-interactions are implicated in retinotopic mapping 
of axons and spinal motor axon guidance, where highest EphA to ephrinA ratio densities lead 
to less responsiveness to ephrin presented in trans, i.e. cis-attenuation of Eph receptor 
signaling [199-201]. Cis-interactions can be divided in LBD-dependent and non-LBD-
dependent interactions [103]. Irrespective of the type of interaction, tyrosine phosphorylation 
and therefore forward signaling is greatly reduced for EphA, leaving retinal axons less 
sensitive to bath applied ephrinA5 in trans. The mechanism of how ephrins reduce Eph 
signaling through a cis-interaction is currently unknown. However, there is reason to 
speculate based on my work (see below) that Eph receptor clustering might be antagonized by 
steric interference with ephrins. Another possibility is the sequestration of Ephs into other 
membrane microdomains thereby preventing access to essential downstream signaling 
molecules [32]. Unlike the retinal system, co-expressed EphA4 and ephrinAs in chick motor 
neurons were observed to segregate into separate membrane microdomains. In that case, 
segregated Ephs and ephrins do not interact in cis and function as independent guidance 
receptors producing opposite effects on the growth cone  [202]. The simultaneous existence of 
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cis and trans configurations highlights the importance of the cellular context for Eph/ephrin 
signaling. 
 
1.4.4 Ephrin reverse signaling mechanisms 
 
While EphAs and EphBs share a great homology, differences in the domain organization of 
ephrinAs and ephrinBs are responsible for their divergent downstream signaling mechanisms.  
 
EphrinB reverse signaling. EphrinBs in contrast to ephrinAs possess a cytoplasmic domain 
with five conserved tyrosines, which are phosphorylated by recruited Src family kinases upon 
receptor binding and clustering [33,203,204]. The phosphorylated tyrosines and possibly a 
serine then serve as docking sites for SH2/SH3-domain containing proteins such as Grb4, 
which then in turn activate downstream signaling pathways targeting actin cytoskeleton 
rearrangements [205,206]. In neurons, ephrinB signaling is linked to dendritic spine 
morphogenesis through a molecular mechanism involving Grb4 and GIT 1 (G protein-coupled 
receptor kinase-interacting protein 1) and the exchange factor for Rac GTPase, PIX [207,208]. 
PIX in complex with GIT1 and PAK3 (α-p-21-activated kinase 3) regulates Rac activation 
acting on downstream PAK, which promotes formation of spine and dendritic protrusions 
[207]. By contrast, Grb4, Dock180 and PAK were shown to activate Rac-signaling regulating 
actin dynamics to cause growth cone collapse of murine hippocampal mossy fiber axons 
[209]. 
Src kinase is activated by Eph-induced metalloproteinase cleavage of ephrinB2 producing a 
C-terminal fragment (CTF) that is further processed by PS1/γ-secretase to produce the 
intracellular peptide ephrinB2/CTF2. This peptide then binds Src and inhibits its association 
with inhibitory kinase Csk allowing autophosphorylation of Src at residue Tyr418 [210]. 
Involvement of Src kinases has also been implicated downstream of ephrinB2 in reducing 
motility and reorganizing focal adhesions of smooth muscle cells [211].  
EphrinB1 reverse signaling may also be induced by Dsh (disheveled), which binds either 
directly to the cytoplasmic tail of ephrinB1 or indirectly through association with Grb4, and 
acts through Daam-1 on the planar cell polarity pathway in Xenopus [212-214]. 
EphrinBs can also activate downstream molecular targets independently of tyrosine 
phosphorylation by docking of PDZ-domain containing proteins to the PDZ-binding motif at 
the C-terminal end of the ligand. Transgenic mice lacking a functional ephrinB2 PDZ-binding 
motif exhibit major lymphatic defects as compared to mice with impairment of the five 
tyrosine phosphorylation sites [215].  
Enzymatically inert adaptor proteins, which could possibly mediate phosphotyrosine-
independent responses, are known to be GRIPs, Syntenin and PDZ-RGS3 [216-218]. Binding 
of these adaptor proteins cannot only trigger ephrin-dependent signaling cascades but also 
modulate signaling cascades from other receptors representing ligand to receptor crosstalk. 
For example, ephrinB1 activation inhibits G-protein-coupled receptor CXCR4 signaling via 
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recruitment of PDZ-RGS3. PDZ-RGS3 acts as a GAP for the subunit of trimeric G proteins 
thereby inactivating signaling mediators downstream of CXCR4 [218].  
EphrinB2 function also impacts on AMPA receptor trafficking through a PDZ-domain-
mediated interaction [206]. GRIP adaptor proteins scaffold ephrinB ligands and AMPA 
receptors to lower the constitutive internalization of AMPA receptors thereby maintaining 
synaptic transmission. GRIP1 over-expression was also sufficient to rescue an ephrinB3 
knockdown phenotype by restoring shaft synapse density [159]. In their model, the authors 
proposed GRIP to engage other subtype ephrinBs in reverse signaling by their scaffolding 
ability.   
Crosstalk to other membrane bound molecules is e.g. observed in the regulation of cell 
adhesion and inter-cellular permeability through claudins. They are components of epithelial 
tight junctions between cells and presumably potent in causing ephrinB1 tyrosine 
phosphorylation independent of Eph receptor engagement [192].  
 
EphrinA reverse signaling. In contrast to ephrinBs, ephrinAs present a GPI-anchor at their 
C-terminal tail tethering them to the outside of the plasma membrane. They are known to 
participate in reverse signaling events [219], genetically evidenced by important functions 
including axon guidance [220-222], cell migration [223], neurogenesis [224], insulin secretion 
[48] and cell adhesion [225-227]. Two different strategies have been proposed to address the 
intriguing question of how ephrinA activation gets relayed into the cell to trigger an ephrin-
specific signaling cascade of biological importance. 
GPI-anchored proteins including ephrinAs are often compartmentalized into cell membrane 
microdomains also known as lipid rafts, which are rich in cholesterol and sphingolipids [228-
230]. Eph-induced clustering of GPI-anchored proteins like ephrin may trigger the 
constitution of larger raft domains, which would recruit intracellular signaling mediators like 
Src [225,228].  
The other strategy suggests a signaling mechanism of ephrinAs interacting with either co-
receptor TrkB or p75 in cis thereby modulating their intrinsic activity in a way similar to 
GDNF receptors [221,231-233]. Association with the respective co-receptor, either p75 or 
TrkB, was reported to produce differential cellular responses, either axon repulsion or axon 
branching, respectively [232].  
 
1.4.5 Eph bi‐directional signaling networks and cell response promiscuity 
 
Signaling networks emerging from activated Eph receptors have become continuously more 
complex with more and more studies being carried out. While some signaling pathways like 
the RhoA/ROCK are shared by all Ephs, others seem to be much more subtype-specific. 
Similarly, mediators and adaptors also display mutuality and specificity among Eph receptors. 
This leads to confusion in allocating Eph induced signaling pathways and thereby connected 
mediators to respective cellular responses. The growing complexity in Eph signaling gives 
 
26 
 
INTRODUCTION 
rise to the concept of network-based signaling, which involves vertically and horizontally 
interconnected signaling chains [234]. In addition to that, the signaling network is embedded 
in a dynamic cellular context, which strongly influences respective signaling outcomes. For 
Ephs/ephrins in particular, bi-directional signaling and cell-contact dependence complicate 
the calculation of a cumulative signaling response [30]. In general, picking on one thread of 
the bi-directional signaling network causes fluctuations in the dynamic cellular signaling 
pattern on either cell side, which might explain cellular response promiscuity underlying 
Eph/ephrin signaling.  
 
1.5 Eph/Ephrin signaling complexes in trafficking and processing 
 
RTK signaling in general, but also Eph signaling in particular, is influenced by trafficking and 
processing prior and posterior to receptor activation. Upon ligand engagement, the amplitude 
and kinetics of signaling may be determined by a highly regulated endocytic process, which 
sorts activated receptors to degradation in lysosomes eventually leading to complete 
attenuation and termination of the initial signaling response (Fig. 1.6) [10,235]. 
 
Regulation of Eph internalization. Eph/ephrin complexes undergo internalization by 
endocytosis upon cluster formation and activation [174]. During this process, Eph/ephrin 
complexes at cell-contact interfaces are rapidly removed from the cell surface by trans-
endocytosis into both the Eph-expressing cell (forward endocytosis) and the ephrin-
expressing cell (reverse endocytosis) to terminate adhesion and allowing for contact-mediated 
repulsion  [236-239]. Interestingly, trans-endocytosed Eph/ephrin complexes are still 
associated to their original membrane domains leading to double-membrane-coated 
intracellular vesicle structures [237,240]. Furthermore, trans-endocytosed Eph/ephrin 
complexes persist in signaling suggesting that active signal transduction can be redirected into 
one or the other adjacent cell depending on the balance of endocytic processing [237,238]. To 
date, the underlying mechanism for this rather unusual process is not known. 
Activity of the small GTPase Rac1 is required for local rearrangements of the actin 
cytoskeleton to cause membrane ruffling for initiation of endocytic processes [156,237].  
 
 
Fig. 1.6 Eph/ephrin processing and endocytosis. 
Schematic presentation of Eph/ephrin processing by proteases, Eph pre/post-activation trafficking and 
surrounding signaling pathways as described in the main text. Arrows () denote a positive, (T)-
indicators a negative regulation on downstream targets. The location of the signaling proteins does not 
imply the involvement of a particular Eph/ephrin domain. The question marks indicate signaling 
connections that have not been conclusively assessed in Eph/ephrin signaling. Eph processing and 
trafficking may depend on the Eph/ephrin levels, degree of ligand/receptor clustering, and cellular 
context. Some of the mechanisms were derived from studies using soluble Fc fusion proteins and are 
not validated by cell-cell stimulation experiments. 
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Recent work has implicated the Rac exchange factor Vav (Vav1-3) in Eph receptor forward 
endocytosis. In contrast to the related ephexin1, Vav2 has no preferences for EphA or EphB 
and binds through its single SH2 domain to activated, phosphorylated JM-tyrosines 
subsequently enhancing Rac activation and Eph endocytosis [241]. Vav2/3 double knockout 
mice develop axon guidance defects, presumably due to the absence of Eph-mediated axon 
growth cone collapse in response to ephrinA1 [241]. Similar to Vav2 for EphA4, other GEFs 
like TIAM1 play an important role for EphA8-dependent Rac1 activation and its 
internalization [242].  
SHIP2 was discovered as a negative regulator of ligand-induced EphA2 endocytosis. It binds 
to EphA2 via a heterotypic SAM-SAM domain interaction [156]. SHIP2 dephosphorylates 
PIP3 (phosphatidylinositol 3,4,5-trisphosphate) thereby suppressing PI3K signaling, which in 
turn is required for enhancing Rac1 activation [243].  
 
Eph endocytic pathways. While it appears that Rac1 signaling generally enhances 
Eph/ephrin internalization [156,237], the exact role of the clathrin endocytosis machinery 
remains unclear [174]. To date, the only two studies linking Eph receptor internalization to 
the clathrin-dependent pathway show involvement of TIAM1 and synaptojanin1 [242,244]. 
Importantly, stimulation of cells with soluble Eph or ephrin fused to the Fc portion of human 
immunoglobulin likely activates endocytic pathways, which significantly differ from the ones 
induced by physiological cell-cell interactions. Indeed, a phospho-proteomic study has 
reported a different selection of targets and adaptors to be activated when soluble ephrin-Fc 
was used for stimulation [245]. 
In contradiction to a strictly clathrin-dependent mode of internalization, Ephs were also 
discovered to be concentrated in caveolae, and the EphB1 receptor to be associated with the 
protein caveolin-1 [246]. These few reports indicate that further work is required to elucidate 
the full molecular mechanism of Eph/ephrin endocytosis or identify other modes of 
internalization like caveolae or pinocytosis. 
 
Eph trafficking. Vesicles loaded with receptor cargo undergo extensive sorting and 
maturation to various endocytic compartments. The Rab GTPase proteins are highly 
compartmentalized in organelle membranes and together with their effectors coordinate these 
consecutive stages of transport, which comprise processes like vesicle formation, vesicle 
motility and tethering of vesicles to their target compartment [247]. Eph receptor trafficking 
prior to and post ligand-engagement and cluster formation has only been poorly addressed so 
far.  
Rin1 (Ras/Rab interactor 1) is a GEF for Rab5, which is known to control the fusion of 
endocytic vesicles and early endosomes. Like Vav, it was found to bind to EphA4 via its SH2 
domain and to become phosphorylated upon EphA4 activation, causing the EphA4-sorting in 
Rab5-positive compartments. In vivo, EphA4 and Rin1 control neuronal plasticity in opposite 
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ways, suggesting that Rin1 antagonizes EphA4 function through induction of an enhanced 
internalization response [248].  
The Eph receptor’s final fate upon ephrin engagement and internalization was speculated to 
be degradation in lysosomes as observed for other RTKs as a mechanism to shut down 
signaling [10]. In fact, ligand binding induces cbl-dependent ubiquitinylation and EphB1 
degradation through the lysosomal pathway, also marked by the late endosomal marker Rab7 
identified in a proteomics approach and co-localization studies with lysosomal compartments 
[104,249,250]. However, these studies rely on a strong stimulation with soluble ephrin-Fc, 
which might not reflect the physiological situation of Eph stimulation response in vivo. It may 
be speculated that a rather differential trafficking response comprising recycling components 
aside from the crude lysosomal fate may also apply for Eph receptors, which e.g. only 
undergo mild clustering.  
Ephs, as all other transmembrane receptors, are secreted from Golgi compartments to the 
plasma membrane, after translation and glycosylation [2]. For EphB2, in hippocampal 
neuronal cultures, a kinesin1-dependent anterograde transport mechanism to dendrites was 
observed involving the PDZ-adaptor protein GRIP1 [251] (Fig. 1.6).  
 
Ephrin reverse endocytosis. The clathrin-dependent pathway has also been implicated in 
reverse endocytosis. GFP-tagged ephrinB1 co-localizes in clathrin-coated vesicles, positive 
for the early endosome marker EEA1 (early endosome antigen 1) after stimulation with CHO 
(Chinese hamster ovary) cells expressing EphB1 [252] (Fig. 1.6). As small GTPases are also 
activated downstream of B-class ephrins [209,253,254], GEFs might be good candidates for 
the regulation of reverse endocytosis. 
EphrinB2 seems to be destined for degradation through the proteasomal pathway after 
stimulation with soluble EphB2-Fc. In Xenopus retina cultures, ephrinB2 degradation was 
inhibited by proteasome-specific inhibitors LnLL (N-acetyl-l-leucinyl-l-leucinal-l-
norleucinal) and lactacystin [236]. 
 
Eph/ephrin cleavage. Cleavage of Ephs and ephrins by ADAM (A-Disintegrin-And-
Metalloprotease) family metalloproteases and γ-secretase proteases is an additional 
mechanism to terminate Eph/ephrin contact. EphrinA2 was identified to associate with 
ADAM10, which cleaves the ephrinA ectodomain thus facilitating contact-repulsion of axons 
[255]. 
In addition, ADAM10 was also proven to interact with EphA3 and cleave ephrinA2 in trans 
only after binding to EphA3 [256,257] (Fig. 1.6).  
For ephrinBs, γ-secretase-dependent cleavage takes place in cis but not in trans [210,258].  
Recently, EphB2 ectodomain release to the extracellular space was evidenced following 
cleavage after EphB2 residue 543 insensitive to metalloproteinase inhibitor GM6001 [186]. 
Here, EphB2 is in addition cleaved by a presenilin-dependent γ-secretase activity releasing an 
intracellular peptide that contains the cytoplasmic domain of EphB2. Interestingly, cytosolic 
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peptides produced by the combined metalloproteinase/γ-secretase processing of cell surface 
proteins can function in signal transduction and protein phosphorylation [186]. Inhibition of 
ephrinB2-induced EphB2 cleavage also reduces Eph-mediated axon growth cone collapse 
[259]. Moreover, the released EphB2 intracellular peptide was shown to be important for 
NMDAR-subunit phosphorylation in primary neuronal cultures [260]. In the case of EphA4, 
intracellular peptide enhances preferentially Rac signaling [261].  
 
1.6 Mechanisms of receptor clustering 
 
In biological sciences, “clustering” is the widely used terminology to describe processes or 
states when a group of the same or similar elements are gathered or occurring closely 
together. Examples exist both on the genetic level (gene clusters) and on the protein level in 
different variations from cytoplasmic protein assemblies like the ribosome to receptor 
complexes on the cell surface. Limiting ourselves to the topic of receptor assemblies in 
membranes, i.e. receptor clustering, we miss a clear and common understanding of the 
underlying mechanisms and functional importance involved. 
 
1.6.1 Concepts and statistical mechanical models to describe receptor clustering 
 
Equilibrium and non-equilibrium receptor clustering. Receptor clustering comes in 
different flavors in the way of the grouping of elements of the same kind. While many cluster 
formation processes result in non-equilibrium states of protein assemblies on the cell surface, 
others are the result of a shift in the very dynamic equilibrium between monomeric receptor 
species and higher-order receptor oligomers [262].  
In complex systems like the immunological synapse, receptor clustering is most likely 
established and maintained by non-equilibrium processes involving, for example, the 
cytoskeleton to stabilize a conglomerate of membrane proteins [263,264]. Occasionally in this 
context, the terminology of “aggregation” fits much better because it points out the 
irreversible nature of the constitution of such complexes, which then exist semi-permanently 
in 2-dimensional arrays on the cell surface.  
In simpler systems, equilibrium thermodynamic interactions between receptors, ligands and 
associated proteins may be sufficient to explain the phenomenon of clustering and to shed 
light on the advantages it provides for transmembrane signal transduction. Extracellular 
ligands can cause the dimerization or oligomerization of receptors within the cell membrane 
and this in turn can activate signaling pathways within the cell. It is this rather dynamic 
formation of clusters in response to activation by an extracellular ligand, which will be 
explored in the following paragraphs [262]. 
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The basic statistical mechanical model of receptor clustering (Fig. 1.7A). A good starting 
point to best model receptor clustering is the description of freely diffusing single receptor 
molecules in the planar cell membrane. The simplest physical model to describe this process 
is the so-called  “lattice gas” [265], which describes density fluctuations of single elements. In 
this system, the membrane is abstracted to represent a 2-dimensional lattice of M sites. Each 
lattice-position may either be occupied by a protein or vacant. The interactions between single 
molecules are described by a decrease in the free energy of the system, by an amount J. This 
decrease in energy only occurs when two adjacent sites are simultaneously occupied by 
interacting proteins. In the next step the lattice gas model may be mapped onto the well-
known Ising model for statistical mechanics, which enables scientists to study phase 
transitions [266,267]. Respectively, the formation of clusters can be seen as a phase transition 
from single monomers to higher-order oligomers. The system energy E in receptor clustering 
gives: 
4
1
2
μ
2
μ
,
 
with the variable transformation to account for the model’s ferromagnetic spin s : 
2 1 
[266,267], where J is the coupling energy, ti = 1 (0) corresponds to an occupied (unoccupied) 
lattice site i, the sum over <ij> includes all nearest neighbors, z is the number of neighbors of 
a lattice site, M is the number of lattice sites. 
The Ising model can be solved exactly in 2 dimensions revealing the striking feature that there 
exists a critical coupling parameter Jc at which the nature of the solution changes abruptly to 
make a phase transition [268]. The above model may be transformed into the Bragg-Williams 
model of binary alloys since transmembrane receptors are not readily exchanged between the 
membrane and the cytosol and it is therefore appropriate to solve the model with the 
constraint of a fixed total number N of receptors in the membrane or, equivalently, a fixed 
surface coverage  [267,269,270]. It basically states, that for high coupling energies J> 
Jc and a sufficiently high surface coverage , phase separation occurs, i.e. results in the 
aggregation of receptors to a dense cluster. Again, the model reveals a critical parameter, this 
time for receptor surface coverage . For low  clusters are smaller and more transient, 
whereas for larger  clusters are more permanent, but continually exchange individual 
receptors or small aggregates of receptors.  
Note, that dissociation constants (Kd) can also be used to characterize the strength of receptor-
receptor cis-interactions in transmembrane receptor clustering systems. While the microscopic 
Kd of isolated receptor monomers in the dimerization process with other isolated receptor 
monomers can be considered as constant, the effective dissociation constant of a receptor 
located within a cluster is significantly decreased by several orders of magnitude.  
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Fig. 1.7 Mechanisms of receptor clustering. 
(A) Ising model to describe the allosteric behavior of receptor clustering. As outlined in the text, critical 
parameters are the coupling energies J (J > Jc) and receptor surface coverage   (   ) for phase 
transition, i.e. receptor clustering to occur. Clustering determinants like ligand or adaptor proteins act 
through their concentration c and dissociation constant on receptor coupling energies to give Japp. (B) 
Two-state and allosteric models of receptor regulation. The two-state model is based on 
conformational changes induced in receptors as a result of ligand binding. Changes in receptor activity 
directly reflect changes in ligand occupancy. The model does not reconsider coupling between 
receptors and thereby fails to explain features such as enhanced sensitivity and broader dynamic 
range in receptor cluster signaling systems. The MWC (Monod-Wyman-Changeux) model postulates 
independent receptor clusters to exist in all-or-none complexes fluctuating between active and inactive 
in concert. Ligand binding shifts the equilibrium to the active or inactive side. Whereas in the MWC 
model it only phenomenologically looks as if the ligand provokes the conformational transition, the 
KNF (Koshland-Néméthy-Filmer) model exactly incorporates this active role of the ligand to induce a 
conformational change in the receptor. The conformational change is then also seen to be the premise 
for receptor coupling in cis. The CS (conformational spread) model finally provides a natural 
integration of the MWC and KNF viewpoints. In addition to receptor-receptor interactions of receptors 
with bound ligand also receptors, which have not experienced ligand-induced conformational transition 
are incorporated into existing clusters. Arrows/red (X) indicate receptor coupling/no coupling. (C) 
Exemplary dose-response curve for receptor activity upon ligand engagement. For the case in which 
there is coupling between the receptors (red curve) overall sensitivity may be heightened by an order 
of magnitude (EC50 = 0.1 for coupled receptors as compared to EC50 = 1.0 for uncoupled receptors, 
red curve is shifted to the left). At the same time receptor clustering causes an increase in 
responsiveness to small variations in ligand concentration as represented by the slopes of the 
sigmoidal curves (Hill coefficient n for the activity increased from n= 0.8 to n= 3.0). Curves were 
generated with GraphPad Prism and parameters as indicated.  
 
 
Two-state and allosteric models of receptor clustering (Fig. 1.7B). While in theory both a 
sufficiently high drop in the coupling energies Ji and critical receptor membrane density  
are sufficient to cause receptor-autonomous clustering, this is often not observed to be the 
trigger for receptor activation and/or clustering in a rather biological context of low receptor 
densities. However, transmembrane receptors are also influenced from the outside by the 
extracellular concentration of their cognate ligands. Often, the binding of a ligand molecule 
affects the equilibrium between two conformational states, favoring, for example the active 
state resulting in receptor signaling. In the two-state model of receptor regulation, receptors 
function autonomously without interaction to adjacent other receptors. Changes in receptor 
occupancy thereby directly relate to changes in receptor activity. The two-state model fails to 
reconsider receptor-receptor interactions and does not allow the study of receptor clustering 
processes. On the contrary, allosteric models of multi-receptor complexes can be seen as an 
extension of the two-state model, including interactions between receptors. In general, 
descriptions of allostery have been limited to changes within a single oligomeric molecule, 
usually a compact oligomeric protein such as hemoglobin. However, the concepts of allostery 
can be transferred to multimolecular arrays of proteins and stochastic patterns of 
conformational change [271]. 
Characteristic patterns of activity can be predicted by three models of allostery: i) the MWC 
(Monod-Wyman-Changeux) model, ii) the KNF (Koshland-Néméthy-Filmer) model and iii) 
the CS (conformational spread) model. According to the MWC model all receptors within an 
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array adopt the same conformation at the same time and the microscopic binding constant for 
the ligand depends only on the conformational state of the protein [272]. In the KNF model, 
ligand molecules force the receptor to adopt an active conformation [273]. In fact, for many 
receptor-ligand systems broad structural rearrangements are usually observed in change from 
one state to the other. The structural rearrangements may be relayed into a change for 
enhanced receptor clustering propensity represented by the apparent coupling energy Japp, 
which then exceeds the critical coupling energies Jc causing phase transition and receptor 
aggregation. For soluble ligand, both ligand concentration cL and dissociation constant Kd 
determine the apparent coupling energies between receptors.  The KNF model accounts for 
this effect by reconsidering a stronger propensity of ligand binding of neighboring subunits in 
a macromolecular complex. In the CS model, individual subunits have a certain probability of 
being active or inactive depending on whether they are bound to a ligand and on the 
conformational states of their two neighbors [274]. This model allows for a nucleation 
mechanism, in which ligand may induce an assembly of active receptors clustered together. 
At the same time, those receptors that have no ligand bound are very likely to be active as 
well. All models support the notion of cooperative signaling behavior and are able to explain 
enhanced sensitivity and increase in sensitivity in such allosteric signaling systems.  
Popular mathematical models of allosteric behavior in receptor clustering are the CS model 
and the mean-field solution of the Ising-model as described in this study [274,275]. 
 
Clustering determinants. The statistical mechanical model for dynamic receptor clustering 
also allows for consideration of other clustering determinants apart from ligands, which may 
modulate the equilibrium thermodynamics of the cluster formation process (Fig 1.7A). A cell 
might dynamically control the formation of transmembrane receptors by the use of adaptor 
proteins that bind to the cytosolic domain of the receptors and modify receptor-receptor 
interactions. Adaptor protein binding to receptors can be controlled spatially and temporally 
in the cell by processes including synthesis, sequestration and buffering or enzymatic 
modifications like phosphorylation, methylation or cleavage of the adaptor protein. Either 
way, two parameters, cA (cytosolic concentration of the adaptor protein) and the intrinsic Kd 
are able to characterize adaptor binding propensity to receptors by their quotient value cA/Kd. 
Adaptor binding to receptors leads to a change in the coupling energies J between receptors. 
The formation of a cluster can be induced by raising the control parameter cA/Kd above a 
critical value which then acts through Japp (Japp adaptor) on clustering propensity. A similar 
change in the coupling energies J between receptors may be obtained by geometric constraints 
provoked by the curvature of the cell membrane. Here, the intrinsic shape of the individual 
transmembrane receptor might for example favor a rather hemispherical shaped geometry for 
clustering as observed at the caps of many cylindrical shaped bacteria. A localization of 
receptor molecules in this geometric environment would therefore lead to higher apparent 
coupling energies (Japp curved ) and a greater bias for clustering [267,276]. 
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1.6.2 Functional significance of clustering for receptor signaling 
 
Statistical mechanical models outlined above can most readily be discussed in the context of 
the bacterial chemotaxis system, for which extensive experimental investigation has provided 
enough knowledge about the composition of receptor clusters, their localization in the cell, 
and most important of all the role that clustering plays in signal transduction [277]. 
However, the phenomenon of cluster formation has emerged for various different receptor 
systems. The clustering feature of receptors ultimately raises the question for its common role 
in signaling. It has been postulated by modeling, and in specific cases experimentally 
confirmed that receptor clustering confers a wide range of advantages for signal transduction.  
One of the more obvious significant functions of dynamic receptor clustering is augmentation 
of sensitivity and increase in responsiveness in response to a ligand stimulus with subsequent 
receptor signaling (Fig. 1.7C) [278-280]. But in addition, receptor clustering also promotes a 
broader dynamic signaling range and enhanced specificity in response to the stimulus 
[280,281]. The concerted arrangement of receptors in a signaling array also enhances the 
simultaneity of the response and enables an analog logical computation of a response to more 
than one ligand at a time [282,283]. It has also been suggested that the segregation of different 
types of transmembrane receptors into separate clusters might limit cross-talk between 
signaling systems [267,284]. Another important feature of clustering is its intrinsic property to 
cause spatial organization of receptors on the sub-cellular level in cell surface membranes. 
This might also assist the enzymatic adaption of individual receptors within a cluster [285]. In 
the case of conformational spread, clustering can also serve in signal amplification, or “gain”. 
The most remarkable example in this context is the fact that individual Escherichia coli are 
able to detect the binding of just a few molecules of attractants, such as aspartate to their 
receptors [286]. Closely connected to the concept of signal amplification by clustering is 
robustness, i.e. toleration of the signaling system towards variations in protein concentrations, 
reaction rates and extrinsic and intrinsic noise of the signaling system [277,287]. Last but not 
least, inversely thought, clustering empowers the signaling system to return to the pre-
stimulus pathway activity with high precision following a change in the strength of the input 
stimulus. This mechanism leads to perfect adaptive signaling in response to e.g. graded or 
changing ligand concentrations, which might differ in time and/or space throughout the course 
of ligand stimulation [277].   
 
1.7 Role of Eph/ephrin clusters for cellular responses 
 
Bi-directional signaling versus higher-order cluster formation. The Eph/ephrin signaling 
system displays distinct features, which may account for the range of cellular responses 
possible: i) Ephs are the only RTKs activated by membrane-bound ligands enabling bi-
directional signaling [31,33]; ii) Ephs and ephrins oligomerize to produce higher-order cluster 
arrays. Both these processes may integrate in vivo to produce cumulative bi-directional 
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signaling responsible for a range of cellular responses possible [30]. However, for studying 
e.g. only the Eph signaling branch, soluble ephrin-Fc fusion proteins can be preclustered (with 
anti-Fc antibodies) into aggregates and be bath applied to stimulate the Eph-expressing cells 
[31]. This activates only Eph forward signaling and thereby associated cellular responses. But 
still, Eph signaling can lead to differential cellular readouts as observed for axon outgrowth or 
cell migration [288,289], which in part may rely on the remaining feature of Eph higher-order 
cluster formation. If one accepts ligand-densities as an obvious parameter in affecting Eph 
clustering, in vitro assays have demonstrated that low densities of ephrins promote outgrowth 
and integrin-mediated adhesion, whereas high densities trigger repulsion and de-adhesion 
[175,289]. Thus, the cell response appears to depend at least to some extent on the degree of 
receptor activation i.e. possibly Eph clustering and kinase activity to induce downstream 
signaling events. Interestingly, in vitro, in absence of ephrin stimulation an increase in Eph 
surface expression results in a concomitantly increase of Eph phosphorylation in a dose-
dependent manner [90,166], while ephrin-induced cell adhesion follows a biphasic response 
pattern with strong adhesion for high and low ephrin densities [165,166,168]. 
Considering the fact that Ephs in addition to phosphorylation undergo higher-order 
oligomerization the question arises, if the oligomerization state from monomer to multimer 
could be considered as an overriding control governing biological responses [290]. 
 
Implications of Eph clustering for cellular responses. The ability of Ephs and ephrins to 
form ordered multimeric assemblies suggests a potential architectural role that could either be 
separated or linked to their direct signaling role [70,80]. Their paradoxical feature to produce 
opposite cellular responses ranging from adhesion to repulsion may at least in parts be linked 
to their uniqueness in forming higher-order cluster assemblies at cell contact interfaces. 
However, the regulation of Eph/ephrin clustering under physiological conditions and its 
impact on cellular responses is only poorly understood.  
Recent x-ray crystallographic studies elucidate the structural basis of Eph/ephrin receptor 
clustering [72,91], but fail to establish a clear and direct link to functional signaling readouts. 
However, a few earlier studies addressed somehow indirectly the functional role of cluster 
formation for Eph signaling on a rather non-structural basis using soluble ephrinB2-Fc in its 
monomeric, dimeric or multimeric form to stimulate Eph-expressing cells. Since Ephs are the 
only RTKs activated by membrane-bound ligands, this presumably allows for Eph signaling 
to be regulated not only by receptor dimerization but also by the degree of ligand clustering. 
In fact, non-clustered ephrin-Fc can act as functional antagonist of Eph signaling [291]. Thus, 
in experiments by Stein and colleagues, preclustered, multimeric ephrinB1-Fc promotes 
endothelial capillary-like assembly in a two-dimensional in vitro assay using human renal 
microvascular endothelial cells (HRMEC) [292], whereas dimeric ephrin-B1/Fc does not [34]. 
In a P19 cell-based adhesion assay, preclustered ephrinB1-Fc multimers provoke P19 cell 
attachment to fibronectin. By contrast, applied in the same concentration, ephrin-B1/Fc 
dimers have a modest effect to decrease fibronectin attachment of a small subpopulation of 
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cells [34]. These functional effects correlate with LMW-PTP recruitment to EphB1 and 
EphB2 complexes upon stimulation with ephrinB1-Fc multimers and more specifically upon 
recruitment of ephrinB1-Fc tetramers to promote attachment. Growth cone collapse assays 
with ventral and dorsal retina neurons from Xenopus supported this finding by investigation of 
the bi-directional signaling mechanisms underlying stimulation with either pre- or unclustered 
EphB2 or ephrinB1 ectodomains [194]. Furthermore, in a kinetic analysis, the binding of 
monomeric, dimeric and multimeric ephrinB2s to EphB2 receptors expressed in neurons of rat 
hippocampal cultures show a dose-dependent growth cone collapse response, which correlates 
with an increase in apparent binding affinities measured in vitro by surface plasmon 
resonance [96].  
Similarly, in an approach using a monoclonal antibody against the ectodomain of EphA3 to 
cause clustering, activation of the receptor and subsequent cellular responses like contraction 
of the cytoskeleton and cell rounding are observed [293]. Moreover, simultaneous ephrinA5 
and antibody binding synergizes to activate the EphA3 receptor even stronger. The authors 
suggested that antibody binding triggers an EphA3 conformation, which is permissive for the 
assembly of EphA3/ephrinA5 signaling clusters.  
In a rather biophysical approach using artificial membranes displaying ephrinA1, the effect of 
EphA2 cluster size and mobility was studied in breast cancer cells [294]. Lateral transport of 
ephrinA1 was blocked by physical barriers nanofabricated onto the underlying substrate 
[295,296]. Depending on how ephrinA1 transport was constrained, EphA2 receptor 
engagement produced different cell responses to ephrinA1, as observed by changes in 
cytoskeleton morphology and recruitment of metalloprotease ADAM10. The EphA2-
expressing cell pulls the receptor laterally via an acto-myosin contractility process, and the 
outcome of the signaling process apparently depends on whether the ephrinA1 ligand in the 
apposed cell resists to this applied force. Thus, somewhere between receptor activation and 
the downstream signaling events, there is a signaling step that is sensitive to the large-scale 
spatial organization of the EphA2 receptors or possibly even the tensile forces acting on them. 
Intense cooperation between the cell membrane and cytoskeleton empowers this signaling 
system to respond to differences in the mechanical aspects of the microenvironment. 
Taken together, Eph receptors can indeed discriminate specific ligand oligomers, antibody-
induced Eph-ectodomain configurations or cluster sizes to determine alternative signaling 
complexes, attachment, assembly and trafficking responses, which most likely relies on their 
unique cluster formation properties. However, the mechanisms, which allow this 
discrimination of specific ligand oligomers or ectodomain configurations, are so far unknown 
and can only be speculated upon. Furthermore, these studies did not allow a direct and 
sensitive control of Eph clustering but clustering was provoked by external stimuli binding to 
the Eph ectodomain. Therefore, it will be extremely useful to design ways to gradually change 
clustering behavior of Ephs and ephrins in living cells [32].  
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Conformational spread mechanism for Eph receptors? Interestingly, experiments with 
ephrinA5 coated beads suggest that ephrins induce Eph clustering, but that cluster growth 
occurs independently of ephrin contacts and involves direct Eph-Eph interactions resembling 
an extracellular steric seeding or nucleation mechanism also confirmed by structural studies  
[72,91,104]. This rather uncontrolled clustering mechanism, which is somehow reminiscent of 
the conformational spread mechanism well characterized for bacterial chemotaxis receptors 
[274,297,298], is suited to recruit a proportion of receptors into a signaling cluster that would 
represent the overall receptor abundance of the cell and thereby control the strength of the 
signaling response (heightened sensitivity) (Fig. 1.7C). This concept allows for precisely 
adjusted cellular responses (heightened responsiveness) controlled by graded changes in 
ligand abundance and receptor/ligand occupancy, a characteristic feature of Eph-ephrin 
communication [104]. 
 
Implications of Eph clustering for in vivo scenarios. The only in vivo study to address the 
relative importance of kinase activation versus higher-order clustering genetically in the 
mouse was carried out by using the constitutively kinase-active receptor mutant eeEphA4 
[113]. Receptor eeEphA4 mediates normal midline guidance of corticospinal tract and 
commissural interneuron axons in the spinal cord, where there is a localized source of 
repulsive ephrinB3 (midline). However, in circumstances where EphA4-positive axons have 
to react to a smooth gradient of ephrinA, eeEphA4 signaling is impaired. This suggests that 
eeEphA4 engaged ephrins normally at choice points, though, in situations where EphA4-
positive axons have to react to a smooth gradient of ephrinA, eeEphA4 is unable to mediate 
the ephrin signal. Among other explanations, it was suggested that the ability to generate a 
graded response to ephrins might require a particularly tight regulation of Eph activation 
[113,299], presumably accomplished by graded clustering.  
In fact, various scenarios in vivo describe situations where Ephs have to respond to gradients 
of ligand expression to establish fine patterns of innervation as e.g. observed in the 
topographic mapping of the visual system [300-302]. In ephrin-directed pathfinding, the 
current model suggests that migration of Eph-bearing cells into a gradient of ephrin 
expression is controlled by Eph receptor affinity and abundance and by competition for ephrin 
targets [303-305], which may produce a respective Eph clustered state and signaling response.  
 
Heterotypic Eph/ephrin clustering. Another role for Eph/ephrin clustering at cell contact 
interfaces may be attributed to create stable membrane-associated platforms for the 
architectural organization of various cellular structures, e.g. in excitatory central nervous 
system synapses [306]. As already described (cp. section 1.4.2), EphB2 physically associates 
with NMDAR [184,307] to control both NMDAR density in postsynaptic clusters and the 
number of postsynaptic release sites [184]. 
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2. SCOPE 
 
The formation of higher-order signaling complexes is a unique feature of the Eph/ephrin 
family amongst all RTK families and is necessary to induce robust bi-directional signaling 
responses [31,33,34,113]. Structural work on Eph/ephrin complexes demonstrates an 
extracellular steric seeding or nucleation mechanism for Eph clustering [72,91,104]. 
However, clustering remains elusive when it comes down to establishing a clear link to 
kinase-dependent or -independent Eph signaling and cellular responses. Furthermore, current 
speculation about the role of cluster formation in producing graded cellular responses is based 
upon other receptor/ligand systems, implications from structural studies or mere intuition in 
the field of research. To date performed functional studies addressing the role of cluster 
formation fail to establish a clear and direct mechanistic link to clustering [34,113,293]. 
Instead, growing evidence points to a lack of consistency between Eph-induced signaling and 
thereby induced cellular responses. In this respect, I am convinced that clustering is a key 
element in determining adhesive versus repulsive Eph signaling responses.  
This study investigates the function of clustering in Eph-mediated cell responses, thus seeking 
to answer the following central questions: 
 
1) The formation of Eph clusters is a highly-ordered multistep process [80]. Is there a way to 
establish a system to artificially induce Eph/ephrin clusters independent of receptor/ligand-
contact, in a cell-autonomous manner and with tight control over cluster size, stability and 
complexity and link them to functional signaling readouts?  
 
2) Eph clustering is a prerequisite for robust kinase-dependent signaling [33]. Is there a direct 
correlation of Eph cluster sizes/stability to functional readouts? May clustering serve as a central 
control entity to elicit appropriate cellular responses? 
 
3) Eph/ephrin signaling induced cellular responses range from adhesion to repulsion [36]. May 
adhesive versus repulsive cellular responses be linked to the oligomerization state of the receptor?  
 
4) Eph receptors are subject to movement and processing [174]. What are the 
trafficking/processing effects upon transition from single receptor species to higher-order 
clusters?
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3. RESULTS 
3.1 Developing a strategy to control for Eph/ephrin cluster formation in 
living cells 
3.1.1 Formation and processing of Eph/ephrin complexes at cell‐contact 
interfaces 
 
To establish a suitable strategy for studying Eph/ephrin clustering in detail, it is highly 
beneficial to gain a general insight in surrounding processes leading to, and governing the 
formation and processing of Eph/ephrin complexes. The most feasible and physiological way 
to sample cluster formation and surrounding processes is by performing a co-culture assay 
with two populations of cells, one expressing Eph receptors, the other expressing ephrin 
ligands [238,245]. HeLa cells were chosen because they show a high mobility on laminin 
substrate, morphological flexibility and responsiveness, and thereby nicely mimic the in vivo 
modality of Eph/ephrin signaling as observed in axon growth cone collapse or boundary 
formation processes.  
Figure 3.1 depicts the formation and processing of Eph/ephrin complexes after cell contact. At 
the cell-contact interface, signals from fluorescence (FL) protein tagged Ephs/ephrins were 
formed as seen by the presence of entities, i.e. aggregates with higher FL intensity. As a 
control, co-expressed myr-mCherry FL remained diffuse at these sites (Fig. 3.1B-I) indicating 
that Ephs/ephrins were specifically clustered upon contact. These FL entities at cell edges 
were then rapidly processed into Eph+ and ephrin+ cells (Fig. 3.1B-IV/V,C,D). Entities 
emerging after cell-cell contact at the cell-edge were subsequently broken apart (Fig. 3.1C, D) 
over time with little fluorescent particles pinching off from the initial large complex. Entities, 
which were located in cut-off filopodia and/or not in direct contact to the cell’s membrane 
surface did not undergo processing (Fig. 3.1 B-V-VII). In Eph+ cells, the stimulation by 
ephrin ligand led to a signaling response resulting in retraction of the cell periphery (Fig. 
3.1B, dotted black line, compare I with VI), similar to growth cone collapse in axons. In 
ephrin+ cells, this cellular collapse response could not be observed. However, in contrast to 
the Eph+ cell, due to the lack of cell retraction, the processing of FL particles away from the 
cell-edge became more evident (Fig. 1D). Little fluorescent particles were constitutively 
pinching off from a bigger surface-trapped FL entity and were moving towards the inner of 
the cell, presumably being internalized into endocytic vesicles for degradation. In Eph+ cells, 
this process could not be so readily observed because of the simultaneous retraction of the cell 
periphery.  
Taken together, I conclude that live-cell imaging based co-culture assays are a justifiable 
method to display physiological Eph/ephrin complex formation and functionality on the 
cellular level. However, this general insight into the processes surrounding Eph/ephrin cluster 
formation emphasizes two major aspects that severely complicate the investigation of the role 
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of cluster formation in Eph/ephrin signaling. This not only holds true for co-culture assays but 
also for other Eph/ephrin single cell assays in general:  
 
1) Tangibility of the Eph/ephrin cluster. FL entities or aggregates are usually described as 
Eph/ephrin clusters based on their association to the experimentally proven structural feature 
of oligomerization. Yet the depiction of these FL entities as clusters is rather inaccurate and 
misleading since the limit of spatial resolution in epifluorescent imaging does not permit this 
degree of analysis. Upon formation, single FL entities could simultaneously be large, single 
clusters and assemblies of multiple Eph/ephrin complexes. Moreover, Eph/ephrin complexes 
are subject to rapid internalization processes, which in its initial steps, are accompanied by 
invagination processes of the membrane. These processes may very well lead to a crowding of 
multiple fluorescent complexes into one observed single FL entity. Presumably, FL entities 
observed at later stages after initiation of complex formation represent internalized Eph/ephrin 
in vesicles. 
Since we do not know the exact composition and origin of these FL entities, it is not possible 
to extrapolate observed FL Eph/ephrin entities from a mechanistic to functional way. 
Therefore, an alternative experimental strategy implementing a direct clustering readout to 
specifically address Eph/ephrin complex formation is required.  
 
 
 
Fig. 3.1 Formation and processing of Eph/Ephrin complexes at cell-contact interfaces. 
(A) Co-culture situation of HeLa cell populations one transiently expressing YFP-wtephrinB2, the other 
wtEphB2-CFP in low resolution. The cartoon delineates the physiological event of receptor/ligand co-
clustering at cell-contact interfaces. (B) Insets in higher resolution to outline the co-culture situation 
from (A) in time course.  Co-culture of HeLa cell populations, one transiently expressing YFP-
wtephrinB2, the other wtEphB2-CFP. Cell-contact events were imaged in time-lapse 35 min after 
seeding of ephrin expressing cells. Sequential time-lapse images show the processing of fluorescent 
(FL) entities over time. Dotted line serves as orientation for site of initial contact at start of imaging. 
During the time course of contact the Eph+ cell gradually moved away from the ephrin+ cell. (I) Arrows 
in blue indicate co-clustering of ligand and receptor but not myr-mCherry. (II) Arrows in green indicate 
an Eph/ephrin surface cluster on the Eph+ cell. (III) Arrows in red indicate an Eph/ephrin surface 
cluster on the ephrin+ cell. (IV) Arrows in green indicate an Eph/ephrin surface cluster beginning to be 
processed into the Eph+ cell. (V) Arrows in red indicate an Eph/ephrin surface cluster beginning to be 
processed into the ephrin+ cell. (V-VII) Red circles accentuate clusters at filopodia which are not 
subject to processing, presumably because they are not in contact to the active cell surface. (C) Image 
sequence starting from (B-II) outlines the processing of high-fluorescence entities into the Eph+ cell. 
Graph highlights the size degradation of one FL entity (red) into multiple particles (entities X) (D) 
Image sequence starting from (B-III) outlines the processing of FL entities into Eph+ cells. Image 
panels and graph (I) depict the size degradation of one FL entity (entity 1) into two particles (entities 2 
+ 3). Image panels and graph (II): pinched off FL particles were moving towards the center of the cell 
(displayed as distance [µm] to cell edge) whereas entity 1 remained stable at cell edge. Scale bar, 10 
µm. 
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2) Multi-parameter impact on cluster formation, processing and signaling. Another big 
issue is the handling of multiple parameters, which have, at least in parts, a significant 
influence on cluster constitution and processing. In addition to the amount and significance of 
parameters governing other RTK signaling systems, Eph/ephrin signaling is also subject to 
additional controls due to their unique features, such as cell-contact dependent receptor/ligand 
engagement. Furthermore, in consideration of temporal aspects, only few parameters can be 
seen as static (related to the time frame of observation), such as receptor/ligand density. Most 
parameters are also strongly influenced by temporal aspects e.g. the cell-contact interface, 
which varies over time. Eventually the nature of Eph/ephrin signaling also comprises spatial 
control on the sub-cellular level. Overall, parameters could be grouped in Eph/ephrin-specific 
and cell-specific determinants. A list of possible parameters that may be involved in 
governing clustering, processing, and signaling of Ephs/ephrins is shown in Fig. 3.3A, 
without claim to be complete.  
 
3.1.2 Generating an instant imaging‐readout for Eph clustering in living cells 
 
In awareness of the aspects stated above that complicate the study of Eph/ephrin clustering in 
a cellular and biochemical context, I tried to address certain issues step by step.  
 
Homo-FRET imaging. First, in order to compensate for the lack of spatial resolution in 
conventional FL live-cell imaging approaches, I searched for an alternative imaging technique 
retaining the live-cell readout ability but giving me the power to resolve cluster size 
distributions. I therefore implemented homo-FRET imaging into the Eph/ephrin system, in 
collaboration with the MPI of Molecular Physiology in Dortmund, Germany (Ola Sabet, 
Philippe Bastiaens). Homo-FRET imaging was shown to be a reliable readout for the study of 
dynamic oligomerization processes of cytoplasmic proteins or other membrane-bound 
receptors in living cells. Homo-FRET can be detected as a decrease in steady-state 
fluorescence anisotropy that results from energy transfer between identical fluorophores (for 
theoretical background refer to Experimental Procedures) [308-310]. When using homo-
FRET imaging one limitation is based on the fact that anisotropy values do not necessarily 
represent a homogeneous population of clusters. The anisotropy value of a single pixel is the 
additive result of FRET signals of the underlying cluster population. Since the use of homo-
FRET imaging is not a real improvement in optical resolution, it is rather possible to interpret 
certain anisotropy values as relative cluster size distributions than absolute cluster sizes. 
However, with homo-FRET we were able to dynamically visualize and quantify the relative 
degree of clustering with high sensitivity.  
For preparation of homo-FRET imaging, EphB2 receptor constructs were tagged with 
monomeric GFP (mGFP) (Fig. 3.4) carrying the A206K mutation (in addition to EGFP 
mutations) within the intracellular region [311]. In different experiments, expression 
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constructs were then transfected into COS-7 cells, which have a flat cell morphology and even 
membrane protein distribution ideal for imaging.  
 
Cluster size distribution upon cell-cell contact. In order to validate homo-FRET imaging 
for visualization of cluster size distributions in living cells, we performed a cell co-culture 
assay, which also represented the cluster formation process under the best physiological 
conditions possible (Fig. 3.2). COS-7 cells expressing kinase-dead (kd) EphB2-mGFP 
receptors were seeded with Hek293T cells expressing wildtype (wt) ephrinB2 (tagged with 
mCherry), serving as stimulating donor cells. We chose the kd Eph receptor over the wt 
variant to avoid complications from rapid internalization of the Eph receptor and downstream 
signaling. 
Low values of FL anisotropy were the result from an increased homo-FRET effect between 
aligned EphB2-receptor mGFP domains, which was caused by a higher degree of Eph 
oligomerization. By contrast, single monomeric receptor species did not enable homo-FRET 
transition between mGFPs, thereby leading to high values of FL anisotropy. Heterogeneous 
cluster size distributions were only observed at sites of cell contact, where pixel anisotropy 
values dropped dramatically. This effect is highlighted by the left-skewed anisotropy-
histogram with the color-coded pixel distribution mapped to the co-culture image of 
anisotropy (Fig. 3.2,V/V’). 
First of all, these results indicate that clustering is spatially limited to sites of cell contact, and 
that at these sites rather than single cluster species, heterogeneous cluster size distributions are 
formed - as visualized by the anisotropy histogram. Secondly, these results also support the 
notion that clustering of Eph receptors becomes - in contrast to a mere FL readout (as 
displayed in Fig. 3.1 or Fig. 3.2-I, II, III) - more tangible using homo-FRET imaging in living 
cells. However, due to the overwhelming number of parameters in co-culture assays and the 
lack of parameter control, this experimental setup does not allow a direct mechanistic to 
functional readout from Eph/ephrin cluster formation. Beyond an improvement in directly and 
instantly visualizing clustering by homo-FRET imaging, I needed to exclude, control, or 
measure the multiple parameters governing Eph/ephrin cluster formation, processing, and 
signaling. In addition, the lack of an uniform spatial and temporal clustering response 
complicated correlation to functional readouts even more and called for strategies 
circumventing these problems.   
 
 
 
 
 
 
 
 
 
46 
 
RESULTS 
 
Fig. 3.2 Non-uniform clustering response of kdEphB2 upon contact with ephrinB2-expressing 
cells. 
Non-uniform clustering response of kdEphB2 upon contact with ephrinB2-expressing cells. COS-7 
cells, transiently transfected with kdEphB2-mGFP (I) and co-cultured with HEK293T cells transiently 
expressing wildtype mCherry-ephrinB2 (II) were imaged on a dish heated at 37 °C. Homo-FRET 
between kdEphB2-mGFP was determined by FL anisotropy (IV). (V) Anisotropy-histogram of whole 
image plane from co-culture image. Color-coded anisotropy-histogram pixel distribution is mapped to 
co-culture image to show for the spatial distribution of clustering, which is strictly limited to sites of cell-
contact (V’). Zero-background pixel values were excluded from graphs. Higher power magnification is 
shown for region 2 (inset). Black pixels within areas of lower anisotropy are saturated in intensity and 
artifactual in anisotropy. Cells were imaged immediately upon contact after seeding of HeK293T cells. 
Representative experiment from a series of co-cultures (n= 20 cells analyzed). Experiment and 
calculation of all anisotropy values was carried out by Ola Sabet, MPI Dortmund, Germany 
according to Squire et al. [309]. 
  
 
Fig. 3.3 Overview of Eph/ephrin signaling and a strategic approach for studying the 
receptor/ligand clustering.  
(A) Table of possible parameters influencing Eph/ephrin clustering, processing and signaling 
scenarios. Parameters are classified as Eph/ephrin-specific and cell-specific. Table does not make a 
claim to be complete. (B) Strategic cell/receptor-autonomous approach deduced from the 
physiological cell-cell contact situation to study the mechanistic to functional effects of Eph/ephrin 
cluster formation in living cells. Schematic presentation of cell-cell contact highlighting important steps 
in the Eph/ephrin signaling cascade that qualify as stages for plausible readouts to study the functional 
side of clustering. Mechanistically, cluster formation can be controlled by the FKBP-system and 
visualized by homo-FRET imaging. Functionally, readouts are taken on a biochemical and cellular 
level. Abbreviations: N, cell nucleus; V, vesicle; P, Eph: auto/substrate-phosphorylation, ephrin: 
phosphorylation by Src-kinase.  
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3.1.3 Generation of the dimerizer‐induced system of Eph/ephrin clustering 
 
Strategic approach. The need of parameter reduction for the study of the Eph/ephrin cluster 
formation process was highlighted in the previous paragraph. To achieve this goal, we 
designed a way to induce Eph/ephrin clustering independently of Ephs/ephrins and in a cell- 
and receptor-autonomous way. Most importantly, the experimental approach needed to fulfill 
certain criteria apart from enabling parameter reduction. Firstly, a mechanistic to functional 
experimental approach should preserve the functional integrity of the receptor while allowing 
for physiological readouts (Fig. 3.3B,C). Secondly, to be able to study Eph/ephrin clustering 
in detail, clustering should be highly controllable and temporally inducible on the mechanistic 
side - in respect to producing clusters of different sizes and quality. Ideally, the 
oligomerization state should be controllable ranging from total inhibition of clustering, 
thereby keeping Ephs/ephrins as monomers, to the presence of stable higher-order clusters at 
discrete sizes. Structural features underlying Eph/ephrin clustering suggest multiple domain 
interactions, which are to some extent all responsible for the initiation of the oligomerization 
process, maturation, and maintenance of the Eph/ephrin clustered state. A possible strategy to 
study clustering could be a loss-of-function approach by knocking down numerous sites 
responsible for cluster formation. However, such a broad overall mutagenesis approach could 
also impair the functional integrity of the Ephs/ephrins, resulting in signaling deficient or 
dead mutants. Additionally, this approach would not allow a positive control of 
oligomerization, i.e. clustering.  
 
Implementation of the FKBP/FRB system. Thus, to assess the role of Eph/ephrin clustering 
cell-autonomously and in a mechanistic to functional way, a system to artificially produce 
Eph/ephrin clusters was introduced to meet all of the above mentioned requirements. The 
approach is based on the ARGENT® Regulated Homo(Hetero)dimerization kit from Ariad 
Pharmaceuticals (for details refer to Experimental Procedures).  
 
Fig. 3.4 Conceptional approach for the generation of synthetic dimerizer-induced Eph/ephrin 
clustering in living cells. 
(A) Domain and amino acid structure, and schematic model of Eph receptors showing sites of 
insertion for one to three FKBPs. Variants of fluorescent proteins (xFP) are in the cytoplasmic tail of 
EphB2 and EphA4. Model includes predicted homodimerizer-dependent receptor clustering of the 
different [1-3] FKBP isoforms. Homodimerizers AP20187 (IC50= 1.8 nM) or AP1887 (IC50= 40 nM) non-
covalently crosslink FKBP domains of neighboring Eph receptors. (B) Domain structure with sites of 
insertion for one to three FKBPs and xFP in the cytoplasmic tail of ephrinB2. (C) Model of inhibition of 
EphB2 clustering by steric hindrance through heterodimerization with myristoylated FRB-mCherry 
using the heterodimerizer AP21967. Hypothetically, it is expected that the inducible, non-covalent 
fusion of myr-FRB-mCherry through AP21967 to the side of the receptors keeps them in their 
monomeric state. Abbreviations: JM, juxtamembrane segment; FKBP, FK506 binding protein; xFP, 
fluorescent protein variant; myr, myristoylation signal sequence; FRB, 93 aa portion of FRAP (RAFT, 
mTOR), sufficient for binding the FKBP-rapamycin complex [312]. 
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Both dimerization kit components were used to establish a versatile dimerizer-induced system 
of Eph/ephrin cluster formation (Fig. 3.4). Previously constructed xFP-tagged wt and mutant 
EphB2/EphA4/ephrinB2 served as starting constructs for the insertion of one to three FKBP-
Fv clustering domains [238,239,313]. Sites of FKBP insertion for both ephrinB2 ligand and 
EphB2/EphA4 receptor were chosen directly downstream of the TM domain on the 
intracellular side of the ligand/receptor. This strategy permitted both the possibility for 
physiological Eph/ephrin stimulation and intracellular clustering initiation with the high-
affinity homodimerizer AP20187 and the low-affinity homodimerizer AP1887 while keeping 
the structural and functional integrity of the proteins unaffected. Theoretically, tagging the 
ligand/receptor with an increasing number of FKBP domains permits the constitution of 
clusters with increasing order, density and complexity; whereas, 1FKBP constructs only allow 
dimer-formation of tagged receptor/ligand molecules. However, it is likely that the dimerizer-
induced system does not only produce a population of same sized cluster species, but rather a 
distribution of different cluster species.  
In order to keep ligand/receptor molecules in their monomeric state in the membrane, FKBP 
constructs are co-expressed in combination with the inhibitory construct myr-FRB-mCherry, a 
myristoylated fusion of the FRB domain and mCherry (Fig 3.4C). 
 
Optimizing expression conditions of FKBP-tagged receptor/ligand isoforms. FKBP-
isoform expression was set under the control of the CMV-promoter in pcDNA3.1 backbone 
vectors (Invitrogen). Transfection into HeLa cells using the calcium phosphate transfection 
method resulted in an immediate strong over-expression of the ligand/receptor isoforms with 
intracellular protein inclusions in ER and Golgi (Fig 3.5A). I speculated, that in addition to 
the inherent strong protein expression from the CMV-promoter, fast expression kinetics with 
permanent protein translation overstrained the cell’s ability to process protein through the 
Golgi and ER accordingly. Moreover, incorporated FKBP-domains may have a latent, 
unspecific affinity to each other despite the absence of the dimerizer agent. The high protein 
density in Golgi and ER due to spatial limitations may then contribute to this aggregation, i.e. 
unspecific clustering phenotype. As an unfavorable result, less protein was trafficked to the 
cell surface membrane. To fight this scenario of quantitative over-expression, unspecific 
clustering and fast expression kinetics, I followed up two approaches. Firstly, I blocked sites 
for unspecific clustering on FKBP-domains by infusion of monomeric FK506 agent, which 
would bind to single FKBP-domains, preventing the unspecific interaction to neighboring 
FKBP domains. In fact, the presence of FK506 after transfection improved the redistribution 
of FKBP-tagged ligand/receptor isoforms in mammalian cells (Fig 3.5A). Secondly, to slow 
down expression kinetics in HeLa, I optimized calcium phosphate transfection parameters 
(low amount of DNA, co-transfection with empty backbone vector) in combination with 
screening for HeLa cell populations, which produced favorable characteristics, such as a 
decreased growth rate, leading to modest quantitative protein expression (data not shown) 
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[314]. A beneficial side effect was a flattened cell morphology and better cellular 
responsiveness to Eph signaling (Fig. 3.5B).   
While strategies for establishing correct expression patterns of FKBP-tagged receptor 
isoforms were rather straightforward for mammalian cell culture, primary hippocampal 
neurons obtained from rats at embryonic stage day 18.5 (E18.5) were more difficult to 
transfect and maintain after transfection. A popular way to obtain good transfection 
efficiencies in primary hippocampal neurons is by viral infection. I constituted Semliki Forest 
Virus FKBP-isoform expression variants and infected cultures overnight. Whereas infection 
of Hek293T cells showed a decent transfection efficiency and cell survival (Fig 3.5C), 
primary hippocampal neurons had difficulties in handling the virally induced strong 
expression of Eph receptor isoforms (Fig 3.5E). This led to inclusions and aggregation of 
receptor protein in somata despite the presence of FK506. Furthermore, neuronal cells were 
incapable of trafficking a significant amount of receptor protein to the neuronal periphery i.e. 
neurites and growth cones. Morphologically, cells had collapsed growth cones and rough 
somata. Immunoblotting from BHK-21 cells, which contain viral particles, was performed to 
verify for correct target size and domain integrity of target receptor isoforms (Fig. 3.5D). 
Some functionally relevant domains were tested for by immunoblotting to ensure the overall 
integrity of the receptor isoforms. A possible frame-shift in the open reading frame was 
thereby excluded, which might have been responsible for producing dysfunctional protein and 
causing the observed phenotype in neurons.  
As a consequence of these results, I stopped using Semliki Forest Virus as carrier for FKBP 
receptor isoforms, supposing that the induced expression is quantitatively and kinetically too 
strong. 
In exchange for a good transfection efficiency, I also transfected hippocampal neuronal 
cultures using the lipofectamin transfection method to obtain viable neurons that express 
receptor isoforms of interest. Transfection of receptors was only accomplished in a few cells, 
as seen by a correct protein receptor distribution without significant inclusions, and an intact 
growth cone (Fig 3.5F). Experimental possibilities were thereby greatly limited. In search for 
a compromise in obtaining a high transfection efficiency and morphologically intact neurons 
at the same time, I decided to truncate the FKBP-tagged Eph receptor isoforms at their N-
terminus. This step now permitted the use of the AMAXA® electroporation method, known to 
be unsuccessful at transfecting full-length Eph receptor constructs [313]. The reduction in 
receptor size with removal of most of the ectodomain may have led to better transfection and 
distribution in hippocampal neurons but may also have abolished engagement with 
endogenously expressed ephrin in cultures. Indeed, the N-terminal truncation in combination 
with AMAXA® transfection actually allowed for expression of all FKBP-isoforms with a 
decent transfection efficiency, expression strength, and healthy cell morphology displaying 
proper neurite branching, a clear axonal polarity, intact growth cone structures and an even 
receptor distribution (Fig. 3.5G). 
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Fig. 3.5 Strategies for optimizing culture and expression conditions of FKBP-tagged Eph 
receptor and ephrin ligand isoforms in mammalian cells. 
(A) Beneficial effect of the monomeric antagonist FK506 on expression conditions. HeLa cells were 
transfected with CFP-wtefnB2-2FKBP CMV-promoter controlled pcDNA3.1 expression constructs by 
calcium-phosphate transfection. Addition of FK506 (500 nM) improves the even expression and 
distribution of FKBP-tagged Eph/ephrin in the cell membrane. In absence of FK506, proteins get 
trapped and unspecifically clustered in the Golgi/ER of the cells (red arrows). (B) HeLa cell 
populations (population 2) selected for reduced expression kinetics and decreased total expression of 
target protein exhibit characteristics favorable for studying Eph/Ephrin clustering in living cells: a 
flattened cell morphology, decreased growth rate, better cellular responsiveness, reduced membrane 
ruffling (arrows) as compared to population 1. (C) Testing for Semliki-Forest-Virus mediated 
expression of wtEphB2-xFKBP-YFP constructs. Hek293T cells were infected overnight and imaged for 
expression the next day. BF/YFP FL overlay images show expression of FL protein (red arrows). 
Transfection efficiency is decreased for the 3FKBP receptor isoforms. (D) Receptor isoforms 
expressed from Semliki-Forest-Virus in BHK-21 cells have correct construct length and domain 
integrity for domains tested. 36 hrs after transfection with Semliki-Forest-Virus constructs, BHK-21 
cells were lysed and lysates subjected to SDS-PAGE and Western blotting using anti-FLAG, anti-
EphB2Sam and anti-FKBP antibodies. Western blot shows bands of predicted molecular weight (141.6 
kDa/0FKBP; 175.6 kDa/3FKBP). When probing with anti-FKBP, no band was detected for lysates 
containing wtEphB2-0FKBP-YFP, as expected. (E) Semliki-Forest-Virus infected hippocampal cultures 
(rat E18, infection DIV 1, imaged DIV2) cause toxic over-expression of target EphB2 receptor protein, 
somal trapping with lack of membrane protein distribution to neuron periphery (arrows). (F) 
Lipofectamin-transfected hippocampal cultures (rat E18.5, DIV1, imaging DIV2) have proper receptor 
isoform distribution and a healthy cell morphology (arrows). (G) Rat hippocampal neurons (rat E18.5, 
fixation DIV1) transfected via electroporation (AMAXA®, Lonza, Basel, Switzerland) and 
immunostained using the axon specific marker anti-Tau1, neurite specific marker phalloidin and anti-
YFP to visualize for expression of target proteins. Neurons are morphologically inconspicuous after 
transfection showing a clear neuronal polarity (anti-Tau1, arrows) and intact growth cones (phalloidin, 
lower arrow) with evenly distributed receptor protein (anti-FLAG, arrows). Scale bars, 10 µm. Image 
acquisition and processing: B,C,E,F, epifluorescent (epiFL) live-cell images, background corrected 
(bgcorr); A, epiFL fixed-cell images, bgcorr; G, 9x 0.5 µm z-stacked spinning-disc confocal FL images, 
maximum projected, bgcorr). Abbreviations: UNT, untransfected. Preparation, transfection and 
immunostaining of rat hippocampal cultures in (G) was carried out by Irina Dudanova.  
 
 
3.2 Dimerizer‐induced clustering is sufficient to produce Eph‐specific 
physiological signaling responses 
 
Establishment of a cell- and receptor-autonomous system for investigation of clustering 
requires the preservation of the physiological signaling functions of the receptor. This claim is 
not trivial, since it is well known, that such artificial modifications (total size insertion of ~64 
kDa for 3FKBP + xFP) on the receptor’s domain topology may very well lead to 
dysfunctional receptors. Moreover, clustering accomplished by the non-covalent crosslinking 
of FKBP domains does not necessarily activate receptors in a physiological way. It was 
therefore necessary to test for physiological signaling responses at the very beginning of this 
project (Fig. 3.3). To get a quick overview of the functionality of the FKBP system I selected 
receptor activation, i.e. autophosphorylation and cell collapse as Eph-specific readouts. 
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3.2.1 Dimerizer‐induced clustering causes receptor autophosphorylation and an 
overall phospho‐activated cell state 
 
Immediately following ligand engagement, Eph receptors start signaling via their intrinsic 
kinase activity, which causes phosphorylation of other neighboring receptors 
(autophosphorylation) and effector proteins (transphosphorylation). The autophosphorylation 
response qualifies as immediate readout for receptor activation since the autoinhibition of the 
kinase domain is only completely removed by phosphorylation of the two JM tyrosines 
Tyr604 and Tyr610 (for EphB2). Thus, using a JM phosphotyrosine specific antibody I tested 
for receptor activation of FKBP-tagged EphB2 receptors. Eph receptors undergo maximal 
autophosphorylation upon stimulation for 20 min with 100 nM AP20187 or more (Fig. 3.6A). 
In another approach, using the heterodimerizer AP21967 as competitor against AP20187, 
mixtures of both agents were used for stimulation of wtEphB2-3FKBP-YFP-expressing HeLa 
(Fig 3.6B). With increasing concentrations of AP21967 added, a gradual decrease in 
autophosphorylation was observed. For the subsequent dimerizer applications I decided to 
work with excess concentrations of 250 nM, and 20 min stimulations as a standard condition, 
to exclude concentration-dependent, dose-response effects. Therefore, cluster size 
distributions (see next sections) will be determined by the number of inserted FKBP domains. 
 
 
 
Fig. 3.6 Dimerizer-induced EphB2 clustering is sufficient to activate Eph receptors. 
 (A) Dose-response curve of dimerizer-induced Eph clustering using increasing concentrations of 
AP20187 (0.1 nM to 1000 nM) to stimulate (t= 20 min) HeLa cells expressing wtEphB2-3FKBP. After 
immunoprecipitation with anti-FLAG M2 resin and performance of a Western blot, EphB2 receptors 
were detected for phospho JM-Y604 using the anti-phospho-EphB antibody. After stripping, blots were 
probed for total receptor protein using anti-FLAG M2 antibody. Graph: the fraction of activated 
receptors for each condition tested was plotted on a logarithmic scale and fitted to a sigmoidal dose-
response curve. Saturation of receptor activation was reached with 100 nM AP20187. (B) Competitive 
binding dose-response curve of dimerizer-induced Eph clustering using dimerizer mix of AP20187 (at 
250 nM) and competitor AP21967 (2 nM to 200 nM) for stimulation (t= 20 min) on HeLa cells 
expressing wtEphB2-3FKBP. Immunoblotting for the fraction of activated receptors was performed on 
total cell lysates. Total receptor protein was probed for using the anti-FLAG M2 antibody. Graph: the 
fraction of activated receptors was plotted on a logarithmic scale and fitted to a sigmoidal dose-
response curve. With increasing amounts of competitive dimerizer AP21967 added, the fraction of 
activated receptor decreases. (C) Immunostainings of wtEphB2-[0,3]FKBP-YFP transfected HeLa 
stimulated with control stimuli (Fc), ephrinB2-Fc (2 µg/ml) and AP20187 dimerizer (250 nM) for 40 min 
before fixation. Images show an increase of the cell’s phosphorylation status visualized with 
phosphotyrosine specific antibody (clone 4G10) in ephrinB2-Fc and AP20187/3FKBP conditions. For 
AP20187/0FKBP no significant signal increase from 4G10 antibody binding can be observed. Image 
acquisition and processing: epiFL 8x 0.6 µm z-stacked images; optical densitiy correction (odc); 
adaptive-blind psf deconvolution; maximum projection. Graph: mean ratio ± SEM of total intensity (FL 
phospho4G10/FL YFPEphB2) from maximum projected images of n≥ 10 cells. Scale bars, 10 µm. 
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Following activation by autophosphorylation, Eph receptors also phosphorylate effector 
proteins in trans, thereby increasing the overall phosphorylation state of the cell. To test 
whether dimerizer-induced clustering also causes this positive shift in the steady-state of the 
phospho-activated, Eph-expressing cell, I utilized a substrate-unspecific general anti-
phosphotyrosine antibody (clone 4G10) in immunostainings (Fig. 3.6C). As expected, ephrin 
stimulation induces the Eph signaling response to elevate the cell’s phosphorylation status. 
Wildtype EphB2-3FKBP-YFP receptor stimulated with AP20187 dimerizer caused a similar 
increase, indicating that the clusters produced are functional in activating the Eph receptor’s 
trans-kinase activity leading to an elevated phospho-activated cell state.  
 
3.2.2 Dimerizer‐induced clustering causes a cellular collapse and recovery 
response 
 
A decisive cellular response to activated Eph receptor signaling is actin de-polymerization 
leading to cellular rounding and/or retraction of the cell periphery, as seen in the collapse of 
axonal growth cones. To investigate if dimerizer-induced cluster formation would cause the 
same cell response, I set up a cell collapse assay using HeLa cells imaged in time-lapse after 
stimulation (Fig. 3.7A). For both stimulation with soluble, preclustered ephrin ligand and 
dimerizer AP20187, I observed a similarly characteristic cellular response pattern with initial 
strong cellular contraction of the cell body (Fig. 3.7B, phase I) that resulted in a maximal 
collapse amplitude (Fig. 3.7B, phase II and Fig. 3.7C), followed by a recovery phase of the 
cell’s growth surface area (Fig. 3.7B, phase III). To verify that the cellular response pattern 
induced is indeed specific to Eph signaling caused by dimerizer AP20187, I impaired actin 
de-polymerization via the myosin-II inhibitor blebbistatin [133]. In presence of blebbistatin, 
cell collapse is significantly reduced at 30 min after stimulation with AP20187 (Fig. 3.7D). 
 
 
Fig. 3.7 Ligand-independent, dimerizer-induced EphB2 clustering is sufficient to cause cell 
rounding responses similar to an ephrinB2-Fc stimulation. 
(A) FL time-lapse imaging of HeLa cells transiently expressing wtEphB2-[0,3]FKBP receptors (carrying 
YFP) in the presence of ephrinB2-Fc or AP20187. Cell surface area was scored from BF and FL 
images (red circles around cells). Images for start (immediately after stimulation, 0 min), ~24 min and 
~65 min are displayed in BF and FL channels. Co-expressed, myristoylated mCherry served for better 
visualization of the cell during time-lapse imaging. Scale bars, 10 µm. (B) Curve graph of the 
characteristic cell response pattern from cells in (A). Cell collapse started immediately after stimulation 
(phase I) and reached a maximal collapse amplitude (minimal cell surface area) after about 20 min 
(phase II), followed by a re-spreading response of the cell (phase III). (C) Bar graph: changes in 
collapse amplitude (minimal area in percent relative to start of experiment) of cells within 60 min after 
stimulation (mean cell area ± SEM from n= 8-12 cells for each condition tested; *** p< 0.001, n.s. not 
significant; one-way ANOVA with posthoc Tukey-Kramer test, asterisks in red represent significance 
level to control situation of each data set). Cellular response pattern and collapse amplitude resulting 
from dimerizer-induced Eph clustering are similar to an ephrinB2-Fc induced clustering response. 
FKBP-tagging does not significantly affect the ephrinB2-Fc induced cell collapse response (see bar 
3FKBP/efnB2-Fc). (D) Cell-collapse assay using the myosin-II inhibitor blebbistatin. HeLa cells were 
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incubated in solvent DMSO or 10 µM blebbistatin/DMSO for 10 min. Following stimulation with 
AP20187 (250 nM) for 30 min, cell collapse was scored as described in (B). As control, collapse of 
untransfected HeLa cells was monitored both in presence of blebbistatin and AP20187. Bars 
represent mean cell surface ± SEM from n= 7-8 cells for each condition tested at time point 30 min 
post-stimulation; ** p< 0.01, *** p< 0.001, one-way ANOVA with posthoc Bonferroni test, asterisks in 
red represent significance level to control condition. 
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Overall, these functional assays demonstrate that dimerizer-induced cluster formation 
properly imitates an ephrin-Fc-induced clustering response. These important findings not only 
fulfill the premise for having an efficient tool to study cluster formation, but they also imply 
that ephrin-induced physiological effects can also be provoked in a ligand-independent way 
by artificially clustering the Eph receptor. This finding shifts the main focus of attention from 
ligand-mediated to receptor-mediated clustering as being the critical step in Eph receptor 
activation. 
 
 
 
Fig. 3.8 Phenotypic effects of Eph clustering in mammalian cells. 
(A) Upon AP20187 (250 nM) dimerizer-induced clustering, a ring-shaped FL intensity rise was 
observed for wtEphB2-3FKBP-YFP at cell edges emerging 5 min after stimulation (arrow) and lasting 
for several minutes (arrows in blowup) before disappearing (see also supplementary video 1). In the 
control co-transfected myr-mCherry FL channel this rise in FL intensity at the same site of the cell 
edge was not observed. Blowup images of both FL channels are shown from the region indicated by 
the red box. Image acquisition and processing: scanning-confocal time-lapse image acquisition, 1 
frame/min, maximum projection of 5x 3.1 µm z-stacked images, bgcorr. (B) As with (A) but using the 
kinase-dead kdEphB2-3FKBP-YFP receptor isoform, transfected COS-7 cells were stimulated with 
AP20187 (250 nM, start) and imaged at RT over time using scanning confocal time-lapse microscopy 
(10x 0.5 µm; 1frame/5 min; maximum projection). A blowup image is shown from the region indicated 
by the red box. Again, a FL intensity rise at the cell edge is observed, which in contrast to (A) is 
persistent over time. (C) EphrinB2-Fc induced clustering on kdEphB2-3FKBP-YFP causes the same 
phenotypic effect of FL intensity rise in the cell edge. HeLa cells transfected and stimulated with 
preclustered and Alexa594 labeled ephrinB2-Fc (2 µg/ml) were imaged in time-lapse. At 15 min post 
stimulation a significant rise in FL intensity could be observed (linescans) at cell edges in both Eph FL 
and ephrin FL channels indicating a ligand/receptor accumulation at the cell edge. Linescans 
measuring the average FL intensity per increment were performed over the whole cell body as 
indicated by the white line (indicated by asterisk). Image acquisition and processing: adaptive-blind psf 
deconvolved epiFL images from 6x 0.2 µm z-stacks; odc; maximum-projected. (D) Cell-surface 
applied anti-Ephecto antibody (23 µg/ml, t= ~40 min) causes receptor accumulation equitable to an 
ephrinB2-Fc (2 µg/ml, preclustered, t= ~40 min) administration (arrows). Image acquisition and 
processing: epiFL time-lapse recording of 8x 0.2 µm z-stacks; odc; adaptive-blind psf deconvolution; 
sum-projection; images of same cell detail are scaled equally. (E) Immunostaining of fixed COS-7 for 
surface EphB2 after transfection with kdEphB2-3FKBP-YFP and stimulation with AP20187 (250 nM, t= 
20 min). Surface kdEphB2-3FKBP-YFP was visualized by immunostaining with anti-FLAG antibody. 
Total protein was detected via YFP FL. Dimerizer-induced cluster formation causes a characteristic 
rise in FL intensity at cell edges of total and stained surface receptor, which persists over time without 
internalization of the kd receptor. Average intensity linescans from regions IV and V show a peak 
increase in FL intensity 20 min post-stimulation with AP20187 at cell edges for total and stained 
surface receptor (green/red line). In control-stimulated (EtOH) cells, fluorescence distribution in 
regions I and II remained diffuse. These results indicate a redistribution and accumulation of receptor 
protein to the lateral side (edge) of the cell. Image acquisition and processing: 10x 0.3 µm z-stacked 
scanning-confocal images, bgcorr., maximum-projected. Scale bars, 10 µm. 
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3.3 Dimerizer‐induced clustering produces distinct Eph receptor cluster 
size distributions in living cells 
 
Above I have shown that the dimerizer-inducible system is physiologically functional, and 
therefore a legitimate substitute for ephrin-Fc induced clustering. The design of the system 
suggests intrinsic properties that improve the system, such as tight controllability and 
inducibility, precision in clustering, and the possibility to implement available mechanistic 
readouts. Next I present experimental proof to corroborate the beneficial mechanistic assets 
and open up a detailed view on characteristic aspects of the dimerizer-inducible clustering 
system.  
 
3.3.1 Eph clustering causes the accumulation of receptors in cell edges  
 
I investigated the effects of dimerizer-induced clustering using both confocal and epiFL 
imaging. HeLa cells transfected with wtEphB2-3FKBP-YFP isoforms and clustered by the 
addition of AP20187 displayed a significant ring-shaped FL intensity rise at the cell edge that 
was specific to transfected Eph receptors (Fig. 3.8A). This phenotypic effect was only 
transient and disappeared within 10 min after stimulation upon the onset of secondary 
processes like internalization and cell collapse (supplementary video 1). In order to stabilize, 
and thereby clarify this phenomenon, I then utilized the kinase-dead variant of FKBP-receptor 
isoforms to exclude receptor activation-dependent secondary processes such as receptor 
internalization and cell collapse that most likely terminate the effect. Indeed, the AP20187 
induced FL intensity rise of kinase-dead EphB2 persisted more than 35 min longer (Fig. 3.8B) 
than wildtype receptor (Fig 3.8A and supplementary video 1).  
Next, I asked how this dimerizer-dependent phenotypic effect would compare to ephrin-
induced clustering. The dimerizer stimulation corresponds well to a soluble, preclustered 
ephrinB2-Fc exposure, which in the end turns out to show almost identical phenotypic effects 
upon stimulation (Fig 3.8C). Alexa-dye labeled ephrinB2-Fc provoked the same ring-shaped 
FL intensity rise as AP20187 homodimerizer and was stable over time when used on kd 
receptor isoforms. Interestingly, the same effect was caused by an antibody specific to the 
Eph ectodomain (Fig. 3.8D) thereby denoting that the phenotypic effect is not stimulus-
specific but rather receptor-specific. 
Finally the question remained, if the phenotypic effect of increased FL intensity at cell edges 
is indeed a true accumulation or crowding of Eph receptors at the lateral side of the cell. 
Therefore, immunostainings for kd surface receptor proteins were performed. In 
correspondence to the increase of FL intensity signals from receptor proteins, the 
stoichiometric equivalent portion of antibodies is bound to receptors resulting in the same 
phenotypic FL intensity rise upon stimulation with AP20187 visualized by linescan 
measurements (Fig. 3.8E).  
 
61 
 
RESULTS 
These results suggest that receptor proteins redistribute and accumulate upon clustering at the 
lateral side of the cell - irrespective of the kind of stimulus used.  
3.3.2 Dimerizer‐induced Eph clustering is self‐contained 
 
One reason for implementation of dimerizer-induced Eph clustering relies on the possibility to 
produce distinct Eph/ephrin cluster size distributions in living cells. A characteristic premise 
for this is the absence of a seeding (nucleation) mechanism, which would counteract the self-
containment of the system. A seeding mechanism was shown to take place for Eph receptors 
[72,104].  Existing Eph clusters, bound by ephrin ligand, recruit adjacent Eph monomers 
independent of ligand-contact to form 1-dimensional signaling arrays.  
I tested the dimerizer-inducible system as a priming mechanism for Eph activation, both 
mechanistically (using epiFL imaging), and functionally (in biochemical assays for receptor 
autophosphorylation to monitor receptor activation). For all experiments, in order to avoid 
secondary processes resulting from dimerizer-/ligand-induced clustering, only isoforms 
lacking kinase activity and internalization response were used (Fig. 3.9A). In the biochemical 
autophosphorylation assay, clustering was induced by application of dimerizer AP20187 on 
co-expressed full-length and C-terminally truncated EphB2-YFP receptor isoforms (Fig. 
3.9B). Autophosphorylation was exclusively observed in the presence of preclustered 
ephrinB2-Fc, which binds to the globular domain of both co-expressed isoforms and served as 
a positive control for the assay. In the presence of AP20187, which only clusters the 
catalytically-inactive FKBP-domain containing isoform, no autophosphorylation was 
detected. 
By performing epiFL imaging, AP20187-induced clustering of kdEphB2-3FKBP produced 
the same FL intensity rise at cell edges within 10 min after stimulation as described 
previously (Fig. 3.9C-I). The FL intensity distribution of co-transfected wtEphB2 lacking 
FKBP domains, however, remained unaffected (Fig. 3.9C-II), indicating that the two receptor 
variants do not interact under these conditions. In contrast, externally applied ephrinB2-Fc 
resulted in a co-localized increase in FL signals at cell edges (Fig. 3.9B-III,IV).  
Taken together, these results indicate that dimerizer-induced EphB2 clusters do not serve as 
nucleation points to which additional Eph receptors are recruited by Eph-Eph interactions. 
The system of dimerizer-inducible clustering is therefore self-contained, enabling the 
generation of distinct cluster size distributions in living cells. 
 
3.3.3 Dimerizer‐induced Eph clustering does not co‐precipitate an unidentified 
Eph interaction partner   
 
Next, I searched for Eph interaction partners that may be able to specifically discriminate an 
cluster depending on whether it is ephrinB2-Fc-induced, i.e. forming via its extracellular 
receptor entity or dimerizer-induced, i.e. forming via its intracellular receptor entity. Eph 
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receptors have been described to specifically and physically interact with other 
(trans)membrane proteins and may possibly also incorporate alien (trans)membrane proteins 
into their clusters [32,184,192,256].  To test for such a clustering-dependent interaction 
partner for Ephs, HeLa cells expressing wtEphB2-3FKBP-YFP were stimulated with either 
AP20187 dimerizer or preclustered ephrinB2-Fc (1.5 hrs), in the presence or absence of the 
dynamin-dependent endocytosis inhibitor dynasore (Fig. 3.9D). Inhibition of endocytosis was 
meant to counteract a possible fast degradation of the internalized Eph/interaction partner 
complex. After cell surface biotinylation to detect for (trans)membrane bound protein, lysates 
were subjected to immunoprecipitation using anti-FLAG resin. Blots were probed for 
biotinylated protein using streptavidin-hrp (hrp - horse radish peroxidase) and anti-EphB2Sam 
antibodies (Fig. 3.9D). Interestingly, dimerizer-induced clustering did not co-precipitate a 
protein of ~50-55 kDa as compared to an ephrinB2-Fc stimulation.  
Taken together, Eph receptor clusters differ in their ability to co-precipitate an unidentified 
interacting protein depending on whether they are induced by dimerizer or by ephrinB2-Fc. 
Although those clusters are indistinguishable in causing intracellular JM tyrosine 
phosphorylation and downstream cell collapse responses, distinct differences may exist in the 
configuration of the extracellular/intramembrane cluster entity. 
 
Fig. 3.9 Dimerizer-induced Eph clustering is mechanistically distinct from ephrinB2-Fc-induced 
clustering. 
(A) Cartoon depicting the experimental model to test whether AP20187-induced clusters of EphB2-
FKBP isoforms laterally recruit neighboring, co-transfected EphB2 receptors lacking FKBP domains. 
(B) Western blots of immunoprecipitated wtEphB2 lacking FKBP (carrying a Flag epitope tag) using 
anti-phosphoEphB2 antibodies (upper panel), followed by anti-EphB2 antibodies (against C-terminal 
SAM domain which was deleted from ∆CEphB2-3FKBP) to monitor expression (middle panel). Anti-
FLAG immunoprecipitates of co-transfected kdEphB2-3FKBP were probed with anti-FKBP antibodies 
(lower panel). Note that wtEphB2 lacking FKBP was autophosphorylated after ephrinB2-Fc 
stimulation, but not when ∆CEphB2-3FKBP was clustered with AP20187. (C) HeLa cells were co-
transfected with kdEphB2-3FKBP (tagged with EYFP) and wtEphB2 lacking FKBP (tagged with 
mCherry). Before stimulation with AP20187 or ephrinB2-Fc, both receptor isoforms are evenly 
distributed in the cell (upper panels). Upon stimulation (t= 30 min) with 250 nM AP20187, only 
kdEphB2-3FKBP accumulated in the lateral edge of the cell (I, arrow), whereas EphB2 lacking FKBP 
remains evenly distributed (II). Upon stimulation with ephrinB2-Fc both receptor variants accumulate at 
the lateral edge of the cell (III, IV, arrow). BF images on far left are low power magnifications. Red 
boxes indicate areas of higher magnifications. Image acquisition and processing: 6x 0.2 µm z-stacked 
epiFL images; odc; adaptive-blind psf deconvolution; sum-projection. Scale bars, 10 µM. Results from 
(B) and (C) indicate that there is no lateral recruitment into AP20187-induced clusters, possibly 
because the ephrin-unbound EphB2 ectodomain does not favor Eph-Eph interactions. Dimerizer-
induced Eph clustering is self-contained. (D) Western blot co-precipitation analysis of Eph clusters 
induced by dimerizer or ephrinB2-Fc in presence or absence of dynasore (80 µM). Cells were surface 
biotinylated after stimulation and lysates immunoprecipitated with anti-FLAG resin. Blot was probed 
with streptavidin-hrp to visualize for biotinylated membrane surface protein. Dimerizer-induced Eph 
clustering does not cause co-precipitation of a biotinylated 50-55 kDa protein. (*** anti-FLAG 
immunoprecipitated wtEphB2-3FKBP-YFP; ** co-precipitated ephrinB2-Fc; * IgG heavy chain; red* 
unidentified co-precipitated protein). The presence of dynasore (dyn) did not affect the co-precipitation 
analysis. The model depicts the possible co-clustering scenario of Eph receptors, ephrinB2-Fc and the 
unidentified (trans)membrane protein.  
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3.3.4 Dimerizer‐induced clustering produces distinct Eph cluster size 
distributions in living cells 
 
By implementation of the dimerizer-inducible system of cluster formation, I aimed at 
controlling Eph cluster size distributions. We have seen that in a cell co-culture assay (cp. Fig. 
3.2) homo-FRET is a suitable readout for Eph clustering to account for relative differences in 
cluster size distributions. However, absolute size distributions of Eph receptors remain elusive 
using such imaging techniques. A straightforward approach to resolve absolute cluster size 
distributions is blue-native polyacrylamide gel electrophoresis (PAGE) [315]. This approach 
allows for absolute quantification of single species from the total pool of varying cluster sizes. 
 
 
Fig. 3.10 Dimerizer-induced EphB2 clustering causes distinct cluster sizes. 
(A) AP20187 induced clusters of kdEphB2-FKBP-mGFP isoforms. Blue-native PAGE of unstimulated 
controls (CTRL) show only monomeric Eph receptor species with a shift in molecular weight in 
accordance to the number of FKBP domains inserted. Upon AP20187 stimulation (t= 20 min) 1FKBP 
isoforms produce mostly dimeric receptor species, whereas 2 and 3 FKBP isoforms lead to higher-
order clusters. Overall, molecular weights from blue-native PAGE are higher than calculated values, 
most likely due to an extended native receptor conformation. Graph: an incremental average optical 
density linescan was performed to give the distribution patterns with peaks indicating single resolvable 
cluster species. Incremented average optical density was normalized to the sum over all increments. 
(B) Steady-state FL anisotropy of dimerizer-induced EphB2 clusters in living cells. COS-7 cells 
transiently expressing kdEphB2 carrying different numbers of FKBP domains (fused to mGFP) were 
stimulated with 250 nM AP20187 in a heated (37 °C) dish holder. Anisotropy values of representative 
cells pre and 20 min post stimulation with AP20187 are shown. Anisotropy values decrease with 
increasing numbers of FKBP domains indicating a higher degree of homo-FRET. Scale bars in upper 
panels: 10 µM. The color coding of images is shown to the right. The graph shows quantified 
anisotropy plots of pre and post stimulation of 0 to 3 FKBP isoforms. Data represent mean anisotropy 
± SEM of n= 57, 28, 22 and 20 cells for 3FKBP, 2FKBP, 1FKBP and 0FKBP integrated over the whole 
image frame, respectively. Post-stimulation curves of 0-3FKBP are all significantly different to each 
other and to controls. (0/1FKBP, 0/2FKBP, 0/3FKBP, 1/3FKBP, 2/3FKBP: p< 0.001; 1/2FKBP: p< 
0.01; Mann-Whitney Wilcoxon nonparametric t-test). (C) Dimerizer-induced EphB2 clustering kinetics 
visualized by time-lapse FL anisotropy imaging. Receptor kdEphB2-[0-3]FKBP isoforms were 
transiently transfected into COS-7 cells. FL anisotropy recordings show a sigmoid decrease after 
AP20187 stimulation over time, reaching steady-state after 20 min. The rate of decline in FL 
anisotropy directly correlates with the number of inserted FKBP domains. (FL anisotropy in percent 
relative to start prior stimulation, normalized to 0FKBP/AP20187 control, curves are representative 
examples of time-lapse anisotropy measurements from single cells). (D) EphrinB2-Fc-induced cluster 
formation readout using homo-FRET. EphB2-xFKBP-mGFP transfected COS-7 cells were stimulated 
with either unclustered ephrinB2-Fc or preclustered ephrinB2-Fc. Anisotropy values of representative 
cells prior (upper panels) and 20 min post stimulation with AP20187 (lower panels) are shown. 
Anisotropy values decrease with increasing amounts of unclustered ephrinB2-Fc added indicating a 
higher degree of homo-FRET. For preclustered ephrinB2-Fc stimulation conditions saturating low 
anisotropy values were reached with as little as 1 µg/ml ephrinB2-Fc. Scale bars, 10 µM. The color 
coding of the lut is shown to the right. Data represent mean anisotropy ± SEM of n≥ 20 cells for each 
condition. Post-stimulation curves are all significantly different to each other and to controls; 
significance level as indicated with ** p< 0.01; *** p< 0.001; n.s. not significant; Mann-Whitney 
Wilcoxon nonparametric test. Calculation of all anisotropy values was carried out by Ola Sabet, 
MPI Dortmund, Germany according to Squire et al. [309]. 
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Upon transient expression in COS-7 cells and stimulation with the high-affinity dimerizer 
AP20187, lysates were subjected to blue-native PAGE. In order to obtain an immediate 
snapshot of the cluster size distribution after stimulation, inert kinase-dead receptor isoforms 
(kdEphB2-[1-3]FKBP-mGFP) were used. In anti-EphB2 immunoblots, single cluster species 
can be resolved as peaks (Fig. 3.10A). In the absence of AP20187, all receptor isoforms are 
predominantly monomeric. AP20187 stimulation of cells expressing the 1FKBP isoform 
resulted in the formation of dimers, with a minor residual amount of monomers present. 
Binding of AP20187 to 2FKBP isoforms resulted in the formation of EphB2 oligomers. 
Although dimers were still present, trimers became the predominant form, and oligomers up 
to pentamers could be distinguished. The presence of three FKBP domains shifted the 
distribution pattern towards bigger oligomers. Dimeric species were no longer present, trimers 
were no longer the predominant species, and hexamers could be detected. 
Next I asked if different EphB2 cluster size distributions would also cause graded changes in 
FL anisotropy in living cells (Fig. 3.10B). In control conditions all receptor isoforms 
displayed the same FL anisotropy across different FL intensities. Addition of AP20187 to 
transfected cells decreased FL anisotropy, with a large reduction observed when EphB2 was 
dimerized. Further significant reductions in FL anisotropy were detected in cells expressing 
the two and three FKBP domain isoforms, indicating that different EphB2 cluster size 
distributions were present in living cells. Cluster formation saturated within 20 min for all 
FKBP isoforms (supplementary video 2 & Fig. 3.10C). The rate of decline in FL anisotropy 
directly correlates with the number of inserted FKBP domains.  
EphrinB2-Fc stimulations on kd EphB2 receptor-expressing COS-7 also caused a significant 
drop in FL anisotropy due to clustering of mGFP-tagged Eph receptors (Fig. 3.10D). While 
low amounts of unclustered ephrinB2-Fc provoked only a mild clustering response with a 
very subtle drop in FL anisotropy, doses of 1 to 4 µg/ml preclustered ephrinB2-Fc led to 
saturation in homo-FRET. Overall, the decrease in anisotropy from 3FKBP/AP20187 
clustered receptors was stronger than from ephrinB2-Fc clustered receptors. 
 
 
Fig. 3.11 Comparison of dimerizer-induced Eph clustering using AP1887 or AP20187. 
(A) AP1887-induced clusters are less stable than AP20187-induced clusters. Blue-native PAGE of 
lysates from COS-7 cells transfected with wtEphB2-3FKBP and stimulated with either AP20187 or 
AP1887 for 20 min. After transfer, EphB2 receptor was blotted against anti-EphB2Sam. In contrast to 
the formation of multiple cluster sizes upon stimulation with AP20187 (cluster species dimer to 
tetramer and possibly of higher-order), application of AP1887 did not lead to the maturation of a stable 
cluster size distribution but solely monomers. Asterisks in blot indicate unspecific background smear. 
 (B) AP1887-induced clustering readout using homo-FRET. Kinase-dead EphB2-3FKBP-mGFP 
transfected COS-7 cells were stimulated with either AP20187 (250 nM) or AP1887 (250 nM). AP1887 
does not cause a decrease in anisotropy values. Data represent mean anisotropy ± SEM of n≥ 20 
cells for each condition; significance level as indicated with *** p< 0.001; n.s. not significant; Mann-
Whitney Wilcoxon nonparametric test. (C) AP20187 dimerizer-induced Eph clustering can only be 
reversed by competition for binding with AP21967. HeLa cells expressing kdEphB2-3FKBP-YFP and 
inhibitor construct myr-FRB-mCherry were imaged live while being stimulated with AP20187, then 
 
67 
 
RESULTS 
removing the stimulus, and finally incubating with dimerizer AP21967. Upon addition of AP20187, 
rapid and stable clustering was induced as shown before and visualized by the FL intensity rise at the 
cell edge (II). Removal of AP20187 by washing of the cells did not significantly reverse clustering (III), 
while addition of competitor AP21967 succeeded in reversing the clustering process gradually 
(IV,V,VI). Image acquisition and processing: 3x 0.2 µm z-stacked epiFL images; odc; adaptive-blind 
psf deconvolution; sum-projection. An average FL intensity linescan (dotted lines in panels I-IV) on cell 
edges was performed and values at different stages of the experiment were plotted in a 3-dimensional 
graph. Calculation of all anisotropy values was carried out by Ola Sabet, MPI Dortmund, 
Germany according to Squire et al. [309]. 
 
 
In summary, in excess of dimerizer, FKBP-induced clustering produces clusters of discrete 
size distributions depending on the number of FKBPs present. As expected, dimers are the 
highest order species possible for 1FKBP receptor isoforms, and the cluster formation process 
saturates within 20 min after stimulation for all FKBP isoforms. Homo-FRET imaging 
confirms the results obtained from blue-native PAGE on the single-cell level showing an 
inversely proportional decrease in FL anisotropy to cluster size distributions. For ephrinB2-
Fc-induced clustering, the decrease in FL anisotropy reaches saturation at a higher level as for 
3FKBP/AP20187-induced clustering. 
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3.3.5 Controlling the mechanical dynamics of dimerizer‐induced cluster 
formation allows for production of clusters of different stability or quality 
 
In the previous section, AP20187 was shown to produce cluster size distributions, which were 
stable enough to remain during the process of cell lysis or blue native-PAGE (cp. Fig. 3.10A).  
By contrast, the use of the alternative low-affinity dimerizer AP1887 did not result in higher-
order cluster species (Fig. 3.11A). Furthermore, addition of AP1887 to kdEphB2-3FKBP-
mGFP-expressing COS-7 did not result in a significant decrease of the steady-state anisotropy 
in homo-FRET imaging (Fig. 3.10B). In conclusion, the approximately 20 fold lower binding 
affinity of AP1887 in comparison to AP20187 [316], suggests the constitution of more 
transient clusters, which are less stable or cohesive, and thus cannot persist during the process 
of cell lysis or blue native-PAGE. It may, however, be assumed that cluster complexity is not 
affected by the dimerizer but by the number of inserted FKBP domains.   
For a closer investigation of AP20187-induced clustering, I also tested for reversibility of the 
phenotypic effect caused in cell edges. Myristoylated FRB-mCherry was co-transfected with 
kdEphB2-3FKBP-YFP into HeLa cells. Clustering was induced by addition of AP20187 to 
produce the characteristic effect of receptor accumulation at cell edges (Fig. 3.11C-I,II). 
Exchange for fresh imaging medium containing no AP20187 was then performed as a 
washing step, but did not reverse the phenotypic effect (Fig. 3.11C,III) supporting the notion 
that the off-rate in binding of the high-affinity dimerizer AP20187 is basically negligible.The 
formation of diffusion-limited cavities could also contribute to the irreversibility of AP20187 
mediated FKBP-FKBP binding, creating a state of strong cohesiveness between receptor 
molecules in AP20187-induced clusters. However, it is possible to abrogate AP20187 
receptor accumulation at cell edges by addition of heterodimerizer AP21967. Phenotypically, 
addition of AP21967 reverses the effect of FL intensity rise at cell edges back to a rather 
diffuse distribution of EphB2 receptor FL signal (Fig 3.11C-IV,V,VI). On the molecular level, 
the formation of FKBP-FRB complexes is likely to cause a neutralization of the FKBP-FKBP 
cohesiveness in a proactive way, since in the absence of myr-FRB-mCherry, addition of 
AP21967 does not reverse the phenotypic clustering effect (data not shown). 
Overall, these results give a deeper insight in mechanical aspects of the dimerizer-induced 
clustering system. They show that dimerizer-induced clustering can be reversed by 
competition with AP21967 in the presence of inhibitor construct myr-FRB-mCherry. 
Moreover, qualitative versatility of the system can be realized by use of the alternative low-
affinity homodimerizer AP1887. 
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3.4 Movement and processing of Eph receptor clusters in mammalian 
cells 
 
RTKs like EGFR that are embedded in the cell’s surface membrane, undergo constant lateral 
movement (within the cell surface membrane) and vertical trafficking (between membrane 
compartments) [317-319]. Vertical trafficking is characterized as a dynamic steady-state 
turnover of receptor molecules between the cell’s surface membrane and intracellular 
membrane compartments, such as the Golgi and ER, as well as exosomal and endosomal 
compartments. Receptor sequestration, i.e. internalization into degradative compartments like 
lysosomes, is also a well-known mechanism to shut down signaling responses after 
stimulation, a process that has also been studied for EphB2 [249]. All processes eventually 
leading to degradation, or change in the oligomerization state of Eph receptors following 
cluster formation will be termed “processing” below. Horizontal receptor movement is mostly 
based on passive diffusion, but also consists of active processes that lead to lateral transport 
within the membrane to different cell surfaces [294]. It is rather intuitive that higher-order 
entities such as clusters might behave differently in movement and processing as compared to 
monomeric or only dimeric species. I was therefore interested in characterizing the movement 
and processing of Eph receptors with respect to cluster entities induced by the FKBP-system 
or ephrinB2-Fc both prior and post stimulation. 
 
3.4.1 Receptor accumulation correlates with dimerizer‐induced cluster size 
distributions 
 
Eph clustering causes a FL intensity rise either as a ring-shaped FL syncytium around the 
stimulated cell (cp. Fig. 3.8) or as distinct FL entities (cp. Fig. 3.1). This phenomenon may be 
interpreted as receptor accumulation at the lateral side of the cell. For a more detailed study of 
this phenotypic effect I employed FKBP-tagged, kd Eph receptor variants and produced 
different cluster size distributions in living cells. Interestingly, the strength of receptor 
accumulation correlated with the [0-3]FKBP derived cluster size distributions induced by 
AP20187 dimerizer (Fig 3.12).  This result strengthens the already made assumption that 
receptor accumulation is the cause for the FL signal intensity rise in cell edges. As with 
AP20187, AP1887-induced clustering accumulation was present, but weak. Again, this result 
backs conclusions from the previous section stating that AP1887-induced clusters are less 
stable or cohesive.   
Overall, the tight correlation between AP-dimerizer/FKBP-induced cluster size distributions 
and receptor accumulation at the lateral side of the cell highlights a direct link between the 
formation of clusters and - in a secondary process - their redistribution to the lateral side of 
the cell in a size-dependent manner. 
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Fig. 3.12 The strength of the phenotypic effect of receptor accumulation at cell edges 
correlates with the number of inserted FKBP-domains. 
(A) HeLa cells expressing YFP-tagged kdEphB2-[0-3]FKBP were imaged in high resolution before 
(pre) and after stimulation (post, 10 min) with AP20187 and AP1887 dimerizer (each 250 nM). Arrows 
indicate sites of receptor/FL accumulation of different extent correlating to the number of FKBP 
domains and dimerizer agent used. Asterisk in uppermost left panel indicates membrane debris left 
behind from moving around HeLa cells. Pre and post images are equally scaled within the same group 
(pre/post). Representative cell samples were selected for alike receptor membrane density (60 < 
average intensity < 100 counts). Image acquisition and processing: epiFL 6x 0.2 µm z-stacks; odc; 
adaptive-blind psf deconvolution; sum-projection; bgcorr. Scale bar, 10 µm. (B) Quantification of cell 
edge receptor accumulation caused by clustering of FKBP isoforms. The approach is shown as 
screenshot from the analysis procedure in MetaMorph software (image: kdEphB2-2FKBP/AP20187). 
In FL-thresholded images two regions were defined, one to outline the cell edge where accumulation 
occurs, one to define a region close by to correct for receptor membrane density (baseline intensity). 
Images for analysis: maximum projection from 6x 0.2 µm z-stacks; bgcorr. Data represent mean fold 
above baseline intensity ± SEM of n= 15, 14, 15 and 17 region pairs from minimum 5 cells for 
3FKBP/AP20187, 2FKBP/AP20187, 3FKBP/AP1887 and 2FKBP/AP2087; *** p< 0.001, n.s., not 
significant; one-way ANOVA with posthoc Bonferroni test. 
 
 
3.4.2 Diffuse rapid receptor movement converts into distinct spatial signaling 
entities upon clustering 
 
One suitable approach to study processes in the basal cell surface membrane and proximity is 
the use of TIRF (total internal reflection fluorescence) microscopy. In live-cell applications it 
also empowers the user to visualize dynamic events. In collaboration with the MPI Dortmund, 
Germany (Ola Sabet, Philippe Bastiaens), I carried out experiments to investigate Eph 
receptor clustering-dependent movement and processing in detail. Again, both TIRF and 
epiFL/confocal microscopy produce images below the optical resolution for small, single 
cluster species, and can therefore only resolve pools of clusters of varying sizes as shown 
earlier (cp. Fig. 3.12).  
 
Static TIRF imaging of Eph receptor clustering. Thus, prior to generating a dynamic view 
of Eph clusters in the cell surface membrane, I assessed the phenotypic clustering effect from 
epiFL/confocal imaging at the lateral side of the cells, identified as receptor accumulation, in 
TIRF microscopy. COS-7 cells expressing myr-mCherry, and respective wt or kd Eph 
receptor isoforms were imaged in TIRF angle prior and post stimulation with either AP20187 
or ephrinB2-Fc (Fig. 3.13A). While for myr-mCherry no significant FL accumulation could 
be seen, clustering via ephrinB2-Fc or AP20187 caused the rise of a few single FL dots in the 
TIRF field of imaging. Note that soluble ephrinB2-Fc can theoretically only access the apical-
lateral side of the cell and not penetrate the basal membrane very well. Therefore, clusters 
form predominantly at the apical-lateral side of the cell outside the TIRF field of vision, and 
only to a small degree at basal side of the cell. In few cases, ephrinB2-Fc can access the 
membrane and cause clustering, which could be due to, for example, uneven basal membrane 
adhesion to the growth surface (often visible as dark patches and more common for HeLa cell  
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Fig. 3.13 Stationary FL foci appear in the basal membrane upon stimulation with ephrinB2-
Fc/AP20187 homodimerizer. 
TIRF (total internal reflection fluorescence) microscopy was used to image the basal membrane and 
its proximity. (A) HeLa cells transfected with respective [0,3]FKBP receptor isoforms were imaged 
prior and post stimulation (~30 min) with preclustered ephrinB2-Fc (2 µg/ml) or AP20187 (250 nM) 
dimerizer.  Receptor distribution changed from being diffuse to distinct foci (arrows) over the time 
course of stimulation. For comparison, co-transfected myr-mCherry was imaged in parallel, which 
retained its diffusive FL intensity pattern. The FL signals from EphB2 receptor protein were normalized 
to myr-mCherry to show the disparity in contrast, which reflects their plasma membrane localization. 
Color bar indicates normalized ratio (range 0-10) of pixel values. Single plane FL images, acquired in 
TIRF angle, were background corrected. Scale bars, 10 µm (B) EphrinB2-Fc induced clustering 
causes the constitution of high FL entities forming at the basolateral side of the wtEphB2-YFP 
transfected COS-7 cell. High power magnification image sequence (from region in red) shows the 
formation of high FL entities starting approximately 18 min after stimulation (green arrows; frames 301-
601). A fast acquisition image sequence (red arrows; frames 701-800) points out the static nature of 
the clusters formed. Note that in TIRF microscopy, the most lateral side of cells is not visible due to 
membrane bending at cell edges. 
 
 
TIRF imaging). In the case of homodimerizer stimulation, the compound can penetrate the 
whole cell, including the basal membrane. The formation of these FL foci is also very much 
limited in number and size and cannot be compared to the extensive phenotypic effect of FL 
intensity rise observed in epiFL/confocal imaging. In consequence, this result on the one hand 
indirectly supports the idea of clustering-dependent lateral receptor accumulation, while on 
the other hand proves that receptor accumulation is a secondary process following the initial 
cluster formation. 
 
Dynamic TIRF imaging of Eph receptor clustering. Next, I wanted to generate a more 
dynamic view of Eph clusters in the cell surface membrane using TIRF imaging in fast 
acquisition mode (250 ms/frame) to obtain high temporal resolution. COS-7 cells, transiently 
expressing wildtype EphB2-YFP receptor isoforms, were imaged while stimulated with 
preclustered ephrinB2-Fc (2 µg/ml) (Fig. 3.13B). About 15 min after addition of the stimulus, 
first FL foci appeared at the basolateral side of the cell, increasing in number and size over 
time (Fig. 3.13B, f301-f601). In addition to the live visualization of cluster formation upon 
ephrinB2-Fc stimulation, I also addressed the question of lateral cluster movement within the 
membrane. Clusters, which have formed upon ephrinB2-Fc stimulation, remained surprisingly 
stationary over an extended period of time (Fig. 3.13A, f701-f800).  
For proper validation of the finding that Eph receptor signaling entities, caused by clustering, 
are stationary in localization, I investigated Eph receptor movement and processing prior to 
clustering. To do so, HeLa cells were transfected with wt (Fig. 3.14A) or kd (Fig 3.14B) 
EphB2 receptors tagged with YFP and imaged in fast acquisition mode using live-cell TIRF 
imaging. High magnification images from sequential frames were then analyzed pixel by 
pixel over time, measuring the range of FL intensity fluctuations and standard deviation in FL 
intensity. For comparison, co-transfected myr-mCherry was also analyzed accordingly in 
parallel. Fluctuation curves indicating range and standard deviation of the FL intensity per 
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pixel over time describe a representative population of 100 pixels from all pixels averaged in 
bar graphs. Color coded FL intensity panels from the region of interest (red rectangle) reveal 
stable FL intensity patterns for myr-mCherry as compared to wtEphB2-YFP, highlighting 
increased dynamics in Eph receptor movement. Both for kd and wt Eph receptor isoforms, 
movement was significantly enhanced as compared to myr-mCherry, although wtEphB2-YFP 
receptors are significantly bigger in size (about 30 kDa as compared to 140 kDa, 
respectively).  
Taken together, these results outline rapid lateral movement of Eph receptors prior to ligand 
engagement, which, upon ligand binding, is converted into the establishment of spatial Eph 
receptor signaling entities. Furthermore, these clusters seem to be rather static in localization 
at the lateral side of the cell surface plasma membrane. 
 
 
 
 
Fig. 3.14 High receptor density fluctuations in the cell membrane prior to clustering. 
Receptor density fluctuation analysis using TIRF time-lapse microscopy in rapid acquisition mode from 
HeLa cells transfected with kd or wt EphB2-YFP. (A) Pixel intensity fluctuations from TRFP (myr-
mCherry) and TGFP (wtEphB2-YFP) were analyzed over time (∆t= 2s/frame) from region (30x30 
pixels) indicated by red boxes. The higher FL intensity level for myr-mCherry was corrected by 
normalization to the FL intensity from wtEphB2-YFP. The FL intensity standard deviation and the total 
range in FL intensity (min/max pixel intensities) were determined over time. A representative 
population of 100 pixels are plotted against the FL intensity standard deviation over time (green/red 
error bars) and range (min/max; lower/upper black line) of total FL intensity over time. Bar graphs: 
mean FL intensity range over time ± SEM of n= 900 pixels for each TGFP/TRFP channel; *** p< 
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0.001, student t-test. Small panels are representative blowups for 3 consecutive time frames of the 
indicated region for visualization purpose of density fluctuation (color code shown to the right). While 
for TRFP (mCherry) a constant FL intensity pattern over time can be observed (black dotted regions), 
TGFP (wtEphB2-YFP) undergoes enhanced fluctuations. (B) Pixel intensity fluctuations over time 
measured from kdEphB2-YFP in comparison to co-transfected myr-mCherry in the HeLa cell’s basal 
membrane and proximity. Analysis and data presentation as described in (A) within a region of 30x30 
pixels (∆t= 650ms/frame. Bar graphs: mean FL intensity range over time ± SEM of n= 900 pixels for 
each TGFP/TRFP channel; *** p< 0.001, student t-test. Scale bars, 10 µm. 
 
3.4.3 Processing of spatial signaling entities 
 
In studying vertical aspects of receptor movement, i.e. trafficking between membrane 
compartments, I conducted TIRF experiments to visualize dynamic events surrounding Eph 
clustering and subsequent processing. In presence of ephrinB2-Fc, kd Ephs form stationary 
receptor accumulations at the lateral side of the HeLa cell, visible in the TIRF field (Fig. 
3.15A) and presented in detail for one FL entity in high power magnification sequential 
images (Fig. 3.15A’). While stationary accumulations from kd receptors persisted over time 
without further processing, newly synthesized receptor protein was delivered to the cell’s 
surface membrane in vesicles: a FL entity appears in f1 (Fig. 3.15A’) and travels along the 
trajectory outlined in green over a time of approximately 130 s until it disappears in f200. A 
kymograph (Fig. 3.15B) serves for determination of vesicle velocity, and for better 
visualization of the vesicles. Vesicle speed varied from almost a standstill to 0.57 µm/sec, 
suggesting a guided vesicle transport along microtubules as described by others [251]. At the 
end of the trajectory, the vesicle enlarged, increasing in FL intensity, and diffused out into the 
membrane periphery, a phenomenon that points to a membrane fusion event simultaneous 
with cargo delivery [320]. By contrast, stationary kd Eph receptor FL foci represent signaling 
entities on the cell surface plasma membrane (Fig. 3.15A’, red arrow). 
By contrast to kinase-dead EphB2 receptor, wildtype EphB2 receptor signaling entities at the 
cell surface were subsequently “processed” (Fig. 3.16). Following the formation of spatial 
signaling entities within 15 min after stimulation (data not shown), a proportion of clusters 
underwent decay over time until they disappeared totally (Fig 3.16, panel 37’20’’continuing). 
Others remained stable and stationary (green arrow). Here, AP20187-induced clustering 
produced the same FL foci as seen for an ephrinB2-Fc stimulation (cp. Fig. 3.13A), visible in 
the TIRF field of imaging of COS-7 cells that were transfected with the 3FKBP-tagged wt 
receptor isoform.  
 
Processing of clusters in neurons. While dynamics of movement and processing of Eph 
clusters may also encompass a cell-specific component, it is important to check for the same 
results in a different, and biologically more relevant cellular background, such as neurons. For 
this, hippocampal neurons obtained from rat embryos at embryonic stage 18.5 days were 
taken in culture and transfected with 3FKBP-tagged wt and kd Eph receptor isoforms using 
the lipofectamin transfection method (Fig. 3.17).  
 
76 
 
RESULTS 
 
 
 
Fig. 3.15 Eph receptors are transported in vesicles to the cell surface where upon ephrin 
contact stationary clusters are formed. 
TIRF time-lapse microscopy in fast acquisition mode (total ~130 s; ∆t= 650 ms/frame) was performed 
performed after stimulation of kdEphB2-YFP-expressing HeLa cells with preclustered ephrinB2-Fc (2 
µg/ml). (A) After stimulation, high FL entities are visible in the TIRF field at the lateral side of the cell 
representing Eph clusters. (A’) Sequential TIRF time-lapse (high power magnification) images from 
region in (A). The green line in the first panel outlines the trajectory, the high-FL particle (green arrow) 
is taking in the time period of observation (frame 1 to 200) until it starts to disappear in frame 175. The 
red arrow indicates a stationary cluster, typically present after an ephrinB2-Fc induced stimulation (cp. 
Fig. 13). Note, that kd EphB2 receptor clusters do not undergo immediate processing and degradation. 
(B) Kymograph of trajectory (outlined as green line in A’) with its start point indicated by an red 
asterisk (corresponding to start point indicated by asterisk in A’). The velocity of the vesicle under 
observation ranges from 0.04 to 0.57 µm/s along its trajectory. Starting in frame 145 the vesicle comes 
to a complete stop, increases in size and FL intensity and subsequently vanishes to produce a diffuse 
FL intensity signal. This phenomenon is typical for a vesicle fusing with the outer cell membrane to 
deliver its cargo [320]. Single plane FL images, acquired in TIRF angle at high speed were 
background corrected. All images were scaled equally. Scale bars, 10 µm.  
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Upon stimulation (time point 0 min) with AP20187 dimerizer, both wt and kd receptors 
formed FL foci at the tips of axon growth cones. As with previous results, clusters remained 
rather stationary at the basis of the axon growth cone and along the axon when kd Eph 
receptor was present (red arrows). In contrast, wildtype receptor accumulations (green arrows) 
were less prominent and rapidly “processed” retrograde along the axon.  
Overall, the presented results describe processes surrounding Eph receptor signaling entities 
that have formed upon clustering with AP20187 or ephrinB2-Fc. Irrespective to the stimulus 
used to induce clustering, wildtype receptors undergo decay and rapid anterograde processing 
in hippocampal neurons after a static retention period at the cell surface membrane. Moreover, 
receptor protein is delivered to the cell surface in vesicles which move along defined 
trajectories. 
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Fig. 3.16 Clusters are subject to decay. 
COS-7 cells expressing wtEphB2-3FKBP-YFP and stimulated with dimerizer AP20187 (250 nM) were 
imaged in fast acquisition mode using TIRF microscopy starting at time point ~33 min after stimulation 
(sequential blowups from red region). One of the stationary clusters (green arrows) starts to decay 
over time (red arrows, dotted region) vanishing from the TIRF field of imaging (red x). All images were 
scaled equally. Scale bar, 10 µm. 
 
 
Fig. 3.17 Processing of clusters in primary hippocampal neurons. 
Hippocampal neuronal cultures (rat, E18.5) were transfected (DIV 1) with kdEphB2-3FKBP-YFP or 
wtEphB2-3FKBP-YFP and stimulated with AP20187 (DIV2, 250 nM) at timepoint 0 min while imaging 
in epiFL time-lapse microscopy (single focal plane). Immediately after addition of the compound, FL 
foci form at the tips of the axon growth cones. Whereas clusters in neurons expressing kinase-dead 
receptor remain rather stationary (purple and red arrows), clusters from wildtype receptor undergo 
rapid retrograde processing (green arrow). For better visualization, blowup images of wt axons are 
shown. Images were corrected for background FL. Scale bars, 10 µm. 
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3.4.4 Dimerizer‐induced Eph receptor signaling clusters are sequestered from 
the cell surface membrane 
 
Clustering of Eph receptors causes activation and signaling from spatial entities, which are 
gradually removed from the cell’s surface membrane by internalization processes. To 
investigate if dimerizer-induced clustering is also sufficient to produce spatial signaling 
entities prone for internalization, I conducted confocal time-lapse imaging experiments and 
immunocytochemistry to test for proper internalization into Eph transfected HeLa. AP20187 
and ephrinB2-Fc stimulation caused both rapid clustering, collapse of the HeLa cell, and the 
formation of focal FL entities pinching off the cell’s lateral side (Fig. 3.18A, supplementary 
video 1). In corroboration with these results, immunocytochemistry experiments were 
performed to determine the internalized fraction of protein, which is not stained by a surface-
applied antibody (Fig. 3.18B). Clusters present in both the merge and total protein panels that 
do not co-stain with the surface signal are internalized Eph receptors. Quantifications of 
surface versus total receptor protein FL intensities confirm the visual results and reveal no 
significant difference between AP20187 and ephrinB2-Fc induced internalization under the 
given conditions (Fig. 3.18C). 
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As for wildtype receptor internalization, constitutively active eeEphB2 receptors internalized 
upon stimulation with either AP20187 or ephrinB2-Fc (Fig. 3.18B). Here, the exchange of 
residues Tyr604Glu and Tyr610Glu, which represent SH2 binding sites for downstream 
adaptor proteins, does not seem to affect AP20187-induced or soluble ephrinB2-Fc-induced 
receptor internalization.   
In summary, it appears that the process of disintegration observed in TIRF imaging at the 
surface plasma membrane is accompanied by internalization of Eph receptor signaling entities 
upon clustering. Receptor-autonomous clustering is sufficient to cause internalization 
irrespective of ligand engagement.  
 
3.5 Eph receptor clustering correlates with cellular responses 
 
As shown previously, the dimerizer-inducible system provides a tight regulation of cluster 
size distributions in living cells. Next, I therefore asked if the degree of higher-order 
clustering would cause a graded signaling response. With the use of the low and high-affinity 
dimerizers AP1887 and AP20187, it was possible to study the signaling process in detail from 
receptor activation, kinase activity and cell collapse responses to gain detailed insights in 
clustering-related signaling dynamics.  
 
3.5.1 EphB2 clustering correlates with the strength of cellular response 
 
Correlation of cluster size distributions with Eph signaling was assessed at the ultimate 
response of cell contraction using the collapse assays as described before. Dimerizer-induced 
cluster size distribution patterns were translated into a corresponding cellular response both in 
terms of total collapse magnitude as well as a time-dependent response pattern (Fig. 3.19A). 
As expected, the formation of EphB2 dimers produced very mild responses. In contrast, cells 
expressing the 2FKBP isoform responded to AP20187 with pronounced cell collapse. 
Importantly, cells expressing the 3FKBP isoform showed a significantly stronger cell collapse 
response, both in terms of kinetics and degree of cell contraction. In an alternative approach 
using the 3FKBP isoform clustered with AP20187 in mix with competitor AP21967 the total 
collapse amplitude decreased significantly, whereas kinetics of collapse remained rather 
similar (Fig 3.19B).  
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Fig. 3.18 Dimerizer-induced clustering is sufficient to induce receptor internalization. 
(A) Confocal time-lapse to visualize for Eph receptor internalization upon stimulation with ephrinB2-Fc 
or AP20187 in transfected HeLa cells as indicated. Distinct FL foci appear 60 min after stimulation 
away from the cell edge (arrows in blowups), indicating internal vesicles loaded with EphB2 receptors. 
For better visualization and comparison, HeLa cells were co-transfected with myr-mCherry, which did 
not show the formation of FL foci (see also supplementary video 1). (B) Immunostaining to test for 
internalization upon stimulation with ephrinB2-Fc or AP20187. HeLa cells transiently expressing 
[wt/ee]EphB2-3FKBP receptors (carrying EYFP) were either mock stimulated (CTRL: Fc/EtOH), 
stimulated with 2 µg/ml preclustered ephrinB2-Fc or 250 nM AP20187 for 90 min, then fixed without 
permeabilization and stained for surface EphB2 with anti-FLAG antibodies. YFP clusters, which do not 
co-localize with anti-FLAG staining (green in the merge), represent intracellular clusters. Yellow or red 
clusters in the merge represent surface clusters. Qualitatively, there was no difference in the 
internalization response between wildtype and constitutively kinase-active Eph receptors. Image 
acquisition and processing: 7x 0.2 µm z-stacked epiFL images; odc; adaptive-blind psf deconvolution; 
maximum-projection). (C) Wildtype receptor internalization was quantified by the mean ratio of FL 
intensity (surface/total) ± SEM from clustered sub-cellular regions of n≥ 5 cells. (*** p< 0.001; n.s., not 
significant; one-way ANOVA with posthoc Bonferroni test).  
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Together these results indicate that i) a mix of clusters with predominantly EphB2 trimers (cp. 
Fig. 3.10) is physiologically active, (ii) there is a positive correlation between the degree of 
EphB2 clustering and the strength of the response.  
I also analyzed the effects of the low-affinity dimerizer AP1887, which may lead to similarly 
complex, yet less stable clusters with decreased cohesiveness between the monomeric 
elements. Compared to AP20187, the AP1887-induced cell collapse response was slower, 
weaker and of different response quality with flattened response curves (Fig. 3.19C). They 
resemble the response curves elicited with the low-affinity ligand ephrinA5-Fc [70], which 
are also weaker than those triggered by ephrinB2-Fc, ephrinB3-Fc or an anti-EphB2 antibody 
(Fig. 3.19D). These externally binding stimuli differ in their respective affinities towards the 
Eph LBD [70,96]. As with AP1887-induced clustering, they may provoke the constitution of 
clusters of different stability, which directly translates into the respective cellular response 
pattern. These results suggest that the stability or turnover of EphB2 clusters also determine 
the strength of the cellular response.  
 
 
Fig. 3.19 Correlation between EphB2 cluster size and strength of cellular response. 
(A) Images of representative HeLa cells in BF and FL, expressing equal and moderate levels of 
wtEphB2 carrying 0 to 3 FKBP domains, before and after stimulation with 250 nM AP20187. Cell 
collapse was scored by measuring the cell’s surface area (red circles around cells, see Methods). 
Curve graph: changes in mean cell area ± SEM from n= 10 cells for each isoform over time (in percent 
relative to the start of the experiment) induced by AP20187 (p< 0.01 for 0FKBP/1FKBP, p< 0.001 for 
all other curves, Mann-Whitney nonparametric t-test). Bar graph: changes in collapse amplitude 
(minimal surface area in percent relative to start of experiment) of cells within 40 min after stimulation 
(mean cell area ± SEM from n= 30 cells for each isoform; ** p< 0.01, Student’s t-test). Scale bars, 10 
µm. (B) Quantification of cell collapse responses of cells expressing wtEphB2-3FKBP-YFP induced 
simultaneously by equal concentrations of AP20187 (250 nM) and AP21967 in concentrations as 
indicated. As a control, cell collapse from untransfected cells (UNT) was measured upon AP20187 
(250 nM) addition. (mean cell area ± SEM from n= 8 cells for condition 5 nM AP21967, n= 10 for 
conditions UNT, 10 nM AP21967, no AP21967; * p< 0.05, *** p< 0.001; Mann-Whitney nonparametric 
t-test; asterisks in red indicate significance level to UNT control). (C) Quantification of cell collapse 
responses of cells expressing the wtEphB2-3FKBP or eeEphB2-3FKBP isoform induced by the low-
affinity dimerizer AP1887 compared to AP20187  (each 250 nM; mean cell area ± SEM from n= 17, 
16, 12 cells for conditions AP20187, AP1887, CTRL; p< 0.001 for all curves, Mann-Whitney 
nonparametric t-test). Note that the response induced by AP1887 is slower, weaker and more 
flattened. The constitutively kinase-active ee mutant exhibits a smaller total collapse amplitude. (D) 
Quantification of cell collapse responses of cells expressing wtEphB2 induced by equal concentrations 
(2 µg/ml) of preclustered ephrinB2-Fc and ephrinB3-Fc compared to the low-affinity ligand ephrinA5-
Fc and ectodomain-specific anti-EphB2 antibody (11.1 µg/ml). As a control, cell collapse from 
untransfected cells (UNT) was measured upon efnB2-Fc stimulation. (mean cell area ± SEM from n= 
13, 14, 15, 11, 8 cells for conditions efnB2-Fc, efnB3-Fc, efnA5-Fc, anti-EphB2, UNT/efnB2-Fc; 
significance level for time period 0-40 min, * p< 0.05, ** p< 0.01; Mann-Whitney nonparametric t-test).  
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In parallel, constitutively kinase-active eeEph receptors were tested for their propensity to 
cause cell collapse upon clustering with dimerizer agents (Fig. 3.19C). Surprisingly, for 
eeEphB2, AP1887 or AP20187, stimulation still produced a marked collapse response with 
similar kinetics, yet decreased absolute collapse magnitude as compared to wtEphB2. These 
results support the notion that Eph clustering is a critical parameter in Eph signaling, even for 
receptor mutants with an enhanced kinase-active state. 
Taken together, these results indicate that clustering not only seems to be a mere signaling 
step for Ephs but even more a sensitive determinant in eliciting graded cellular responses as 
seen for [0-3]FKBP/AP20187-induced and 3FKBP/AP20187/AP21967-induced clustering. 
Moreover, the quality, i.e. stability of clusters plays a crucial role in provoking unique cell 
collapse response patterns as observed for dimerizer AP1887 or external stimuli like 
ephrinA5-Fc.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.20 Eph clustering correlates with receptor activation in single cells. 
(A) Representative FL images from immunostainings of HeLa cells expressing YFP-tagged wtEphB2-
[0-3]FKBP isoforms used for quantification in (B). Cells were stimulated with control stimuli (CTRL) 
and dimerizer AP20187 (250 nM), AP1887 (250 nM) or preclustered ephrinB2-Fc (2 µg/ml) for 30 min. 
After fixation and permeabilization, cells were stained with a primary phospho-specific anti-EphB 
antibody and a Cy3 secondary antibody and imaged. FL YFP shows total receptor protein, whereas FL 
anti-phospho Y594 labels the fraction of phosphorylated protein.  Image acquisition and processing: 
12x 0.2 µm z-stacked epiFL images; odc; adaptive-blind psf deconvolution; maximum-projection; 
equal scaling over all FL YFP and FL phospho images. Scale bar, 10 µm. (B) Quantification of EphB2 
activation by immunostaining of individual transfected cells. Bar graph displays mean ratio ± SEM of 
phosphorylated versus total EphB2 protein (YFP-tag) over n= 25- 46 HeLa cells (FL intensity total 
protein <2000 [a.u.]) per condition tested as indicated. (* p<  0.05, ** p<  0.01, *** p< 0.001, n.s., not 
significant; one-way ANOVA with post-hoc Tukey-Kramer test; asterisks in red represent significance 
level to Fc/EtOH control stimulation of each individual data set). 
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3.5.2 Eph clustering correlates with receptor activation and kinase activity   
 
Remarkably, Eph clustering strictly correlates to cell collapse, which marks the ultimate 
functional cellular readout at the end of the Eph signaling cascade. It seemed therefore 
reasonable to also analyze the signaling vertices in between clustering and the cellular 
collapse response.  
Starting with receptor activation at the single cell level, I stained for phosphotyrosine in Eph 
receptor isoform-expressing HeLa after conditioning the cells with the respective stimuli for 
30 min (Fig. 3.20.A). Eph expression levels in single cells are accounted for by normalization 
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to total Eph receptor expressed (measured from FL signals) giving the relative Eph 
phosphorylation state per cell. Upon AP20187 stimulation, there was a positive correlation 
between the number of inserted FKBP domains and the EphB2 autophosphorylation state 
(Fig. 3.20A,B). AP1887 stimulation gave rise to low autophosphorylation levels for 3FKBP 
receptors, significantly differing from control but much weaker as compared to an AP20187 
stimulation. Surprisingly, preclustered ephrinB2-Fc did not cause the same level of activation 
as compared to [2,3]FKBP receptor isoforms clustered with AP20187 in this assay. 
Interestingly, receptor activation did not significantly depend on Eph receptor densities, as 
measured by total FL intensities (data not shown). 
Next, I determined EphB2 autophosphorylation of whole cell populations by immunoblotting. 
Stimulation with saturating doses of AP20187 (250 nM) modestly increased 
autophosphorylation of EphB2-1FKBP isoforms (Fig. 3.21A). Increasing numbers of FKBP 
domains also increased EphB2 autophosphorylation to levels equal or higher than those 
obtained with preclustered ephrinB2-Fc (Fig. 3.21A). A time course of EphB2 
autophosphorylation carrying two or three FKBP domains revealed similar kinetics, but 
overall slightly higher and sustained autophosphorylation levels in 3FKBP compared to 
2FKBP isoforms (Fig. 3.21B).  
To determine the relative contribution of different Eph cluster sizes to the pool of activated 
receptors, I analyzed the phosphorylation levels of single oligomeric species using blue-native 
PAGE. The cluster size distribution pattern of wildtype EphB2 was similar to kd EphB2 (Fig. 
3.21C cp. to Fig. 3.10A). EphB2 monomers across all isoforms displayed baseline 
autophosphorylation, whereas EphB2 dimers were markedly and similarly higher 
phosphorylated (Fig. 3.21C, bar graph). Surprisingly, trimers and tetramers saturated at levels 
~2-fold over the autophosphorylation level displayed by EphB2 dimers. Hence, the higher and 
sustained autophosphorylation levels that I observed in the 3FKBP isoform are due to the shift 
from hypophosphorylated EphB2 dimers to fully phosphorylated oligomers.  
Next, I tested if the reduced effectiveness of the low-affinity dimerizer AP1887 correlated 
with reduced EphB2 autophosphorylation. AP1887 stimulation caused the pool of activated 
receptors to increase slowly over time but eventually resulted in a similar abundance of 
activated receptors - as observed for AP20187 stimulation (Fig. 3.21D). Since activation of 
Ephs is autocatalytic, i.e. autophosphorylation results in Eph kinase activation, I conclude that 
AP1887 is less effective in this autocatalytic activation. 
In blue-native PAGE, AP1887-induced higher-order clusters could not be detected most likely 
due to weak cohesiveness between receptor molecules (cp. Fig. 3.11B). However, in AP1887-
stimulated cell lysates, autophosphorylation levels of EphB2 monomers were slightly elevated 
as compared to control (Fig 3.21E), indicating that AP1887-induced clustering forms at least 
transient interactions, which are sufficient to activate a small pool of receptor molecules. 
These results suggest that cluster quality or stability in addition to cluster size plays a role in 
receptor activation.  
 
87 
 
RESULTS 
In analogy to the cell collapse assay using different external stimuli like ephrins and the anti-
EphB2 antibody (cp. Fig. 3.19D), receptor activation was assessed through detection of 
autophosphorylation as done before (Fig 3.21F). Whereas preclustered ephrinB2-Fc and 
ephrinB3-Fc activated approximately the same pool of receptors, preclustered ephrinA5-Fc 
and anti-EphB2 antibody did not succeed in doing so.  
To uncouple the intrinsic kinase/substrate bivalency of Ephs and to study kinase activity 
directly, I employed a substrate phosphorylation assay [113]. Since this assay is based on the 
related EphA4 receptor which also binds ephrinB ligands [321], I constructed EphA4-2FKBP 
and -3FKBP isoforms. I carried out a cell collapse assay for wtEphA4-3FKBP-YFP 
transfected HeLa stimulated with AP20187 to verify that these isoforms behave similarly to 
EphB2 in physiological activity (Fig. 3.22A). Receptor activation was tested by 
immunoblotting for autophosphorylation of the JM tyrosines (Fig. 3.22B). Since in eeEphA4-
[2,3]FKBP-YFP Tyr604 and Tyr610 residues are mutated to glutamate, the JM tyrosine 
phospho-specific antibody failed to detect them. Substrate phosphorylation levels of cells 
transiently expressing 2 or 3FKBP wt isoforms, stimulated with ephrinB3-Fc were similarly 
increased (Fig. 3.22C). By contrast, dimerizer-induced clustering of the 3FKBP isoform 
caused stronger substrate phosphorylation than the 2FKBP isoform. For eeEphA4 receptor 
isoforms baseline substrate phosphorylation from control stimulated conditions was 
significantly increased as compared to wt constructs. This was due to the constitutive kinase 
activity of eeEphA4 receptors. Surprisingly, kinase activity can still be enhanced by clustering 
with either ephrinB3-Fc or AP20187. However, there is no difference in substrate 
phosphorylation between 2FKBP and 3FKBP isoforms stimulated with AP20187 dimerizer. 
Kinase activity, which may still be enhanced by induction of higher-order cluster size 
distributions through AP-induced clustering of 2 to 3 FKBP wt receptor isoforms, remained 
steady in the case of eeEphA4 isoforms.  
This result indicates that eeEphA4 receptors are indifferent towards higher-order cluster sizes 
in respect to their kinase activity. In consequence, eeEphA4 receptors in contrast to wtEphA4 
show a loss in signaling sensitivity towards surrounding clustering determinants.  
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Fig. 3.21 Eph clustering correlates with receptor activation in whole cell populations. 
(A)  Western blot of anti-FLAG immunoprecipitated EphB2-FKBP isoforms (with 0 to 3 FKBP domains 
as indicated) using anti-phosphoEphB2 antibodies; blots were stripped and reblotted for total EphB2 
protein levels. Autophosphorylation analysis of cells stimulated with Fc/EtOH control or AP20187 (250 
nM, t= 20 min) indicates a positive correlation between the fraction of autophosphorylated EphB2 
(numbers below IP-blot) and the number of FKBP domains relative to a positive control stimulation 
with 2 µg/ml of preclustered ephrinB2-Fc. Scatter graph: quantification of phosphorylation (n= 3-4 
experiments) relative to the positive control stimulation with 2 µg/ml of ephrinB2-Fc. Note, that 
AP20187 stimulation of the 1 FKBP isoform causes EphB2 autophosphorylation that is about 13-40 % 
of preclustered ephrinB2-Fc. (B) Representative time course of activation of EphB2 carrying 2 or 3 
FKBP constructs. Experiment and quantifications were done as in (A). Note that phosphorylation 
levels of the 3FKBP construct are higher than the 2FKBP construct over all time points (graph and 
numbers below IP-blot). (C) Phosphorylation analysis of single EphB2 oligomeric species. Blue-native 
PAGE of lysates of COS-7 cells expressing different FKBP isoforms of wtEphB2 and stimulated with 
either vehicle (-) or AP20187 (250 nM for 20 min). Western blot was performed with anti-phospho-
EphB2 antibodies (left blot); blots were stripped and reblotted for total EphB2 protein (right blot). 
EphB2 oligomers are indicated with numbers (1, monomers; 2, dimers; etc.). Bar graph: quantification 
of relative phosphorylation levels (± SEM, from n= 2 blots) of single oligomeric species sorted to 
different FKBP isoforms. All EphB2 monomers (irrespective of the number of FKBP domains present) 
exhibited only a small fraction of autophosphorylated receptors. EphB2 dimers were 
hypophosphorylated relative to trimers and tetramers. (D) Time course of EphB2 autophosphorylation 
induced by the low-affinity dimerizer AP1887. Experiment and quantifications (graph and number 
below blot) were done as in (A). EphB2-3FKBP-expressing cells were incubated with AP1887, 
AP20187 (at both 10 nM and 250 nM), or preclustered ephrinB2-Fc for 10 or 20 min. Note that the 
kinetics of EphB2 autophosphorylation is slower for AP1887 compared to AP20187 (in the case of 
both concentrations). After 20 min, 250 nM AP1887 is as effective as AP20187, and ephrinB2-Fc (2 
µg/ml). (E) Phosphorylation analysis of the EphB2 monomeric species from stimulation with AP1887. 
Blue-native PAGE of lysates of COS-7 cells expressing the 3FKBP isoform of wtEphB2, stimulated 
with either vehicle (CTRL) or AP1887 (250 nM for 20 min). Western blot was performed as described 
in (C); AP1887-induced Eph complexes are not stable enough to be resolved in blue-native PAGE and 
appear as monomeric species hyperphosphorylated as compared to CTRL monomeric species. 
Graph: quantification of relative phosphorylation levels from 2 blots. Values are normalized to CTRL (= 
1.0). (F) Western blot of total lysates from EphB2-YFP-expressing HeLa cells stimulated (t= 20 min) 
with preclustered ephrinX-Fc (2 µg/ml) and anti-EphB2 (11.1 µg/ml) antibody as indicated. Anti-
phospho-EphB2 antibodies to detect receptor autophosphorylation and anti-Tubulin antibodies to 
ensure equal load per lane were used. Blots were stripped and reblotted for total EphB2 protein levels. 
Autophosphorylation analysis was done as described in (A) and indicates differences in the fraction of 
activated receptors upon different external stimuli (numbers below blot). For phosphorylation analysis 
of all blots, all levels were normalized to the ephrinB2-Fc stimulation condition (t= 20 min; 2 µg/ml) to 
give the arbitrary value of 1.0. 
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Fig. 3.22 Eph clustering correlates with receptor kinase activity. 
(A) Fluorescence time-lapse imaging of HeLa cells transiently expressing wtEphA4-3FKBP receptors 
(carrying YFP) in the presence of AP20187. Cells show the same response pattern as presented in 
Fig. 3.7. Images for start (immediately before stimulation), ~21 min and ~54 min are displayed in BF 
and FL channels. Co-expressed, myristoylated mCherry was used for better visualization of the cell 
during time-lapse imaging. Scale bars, 10 µm. (B) Western blot analysis of total lysates from 
[wt/ee]EphA4-[2,3]FKBP-YFP transfected HeLa to test for proper residue exchange from tyrosine to 
glutamate. Upon stimulation with control, ephrinB3-Fc (2 µg/ml) or AP20187 (250 nM) for 40 min 
constitutively kinase-active eeEphA4 was not autophosphorylated, as expected and shown by probing 
with a JM phosphotyrosine specific EphA4 antibody. AP20187 induced clustering was sufficient to 
activate wtEphA4 receptors as shown for EphB2. (C) Western blot of exogenous substrate 
phosphorylation by wildtype and constitutively active EphA4 (eeEphA4). The exogenous EphA4 
substrate (JMA4-GST) consists of Glutathione S-transferase (GST) and the JM segment of EphA4 
[113]. HeLa cells were transfected with JMA4-GST alone, or together with [wt/ee]EphA4-[2,3]FKBP. 
Cells were stimulated with either control stimuli (Fc/EtOH), preclustered ephrinB3-Fc or AP20187 for 
40 min. JMA4-GST was immunoprecipitated from cell lysates and probed with anti-phosphotyrosine 
(clone 4G10) antibodies or anti-GST antibodies. Overall levels of EphA4 and Tubulin are shown as 
indicated. Numbers in blots and graph indicate relative substrate phosphorylation levels quantified 
from blots with unsaturated exposure normalized to ephrinB3-Fc stimulation. Lower band in JMA4-
GST blot is likely to be endogenous GST (**), since it is also present in untransfected cells. Clustering 
by ephrinB3-Fc or AP20187 led to a further increase in substrate phosphorylation. Differences in 
kinase activity between eeEphA4-2/3FKBP are very small as compared to wtEphA4-2/3FKBP (for 
visualization see bar graph). 
 
 
3.5.3 Dimerizer‐induced Eph clusters cause growth cone collapse in neurons 
 
Next, we asked if dimerizer-induced EphB2 clusters were able to trigger physiological cell 
responses such as growth cone collapse (GCC) in neurons (in collaboration with Irina 
Dudanova). Kinase-active EphB2 receptors carrying 3 FKBP domains were over-expressed in 
primary rat hippocampal neurons and dimerizer-induced GCC was measured. To do so, I 
constructed EphB2 isoforms lacking most of the ectodomain including the Eph receptor LBD 
(∆NEphB2-3FKBP, Fig. 3.23A), because over-expression of full-length EphB2-3FKBP was 
not tolerated by primary neurons (cp. Fig. 3.5). ∆NEphB2 carrying 3 FKBP caused the same 
cell response pattern upon stimulation with AP20187 as compared to full-length EphB2-
3FKBP (Fig. 3.23E) and also displayed normal activation and autophosphorylation (Fig. 
3.23B). Neurons expressing ∆NEphB2-3FKBP in the absence of AP20187, or expressing 
∆NEphB2 lacking FKBP domains, were indistinguishable from neurons transfected with a 
control YFP plasmid (Fig. 3.23C). AP20187 caused GCC of neurons expressing the 3FKBP, 
but not 0FKBP isoforms, to a similar extent as bath applied preclustered ephrinB2-Fc (Fig 
3.23C,D). The low-affinity dimerizer AP1887 significantly increased the fraction of fully 
collapsed growth cones, but to a lesser extent than AP20187 (Fig. 3.23D). These results 
indicate that dimerizer-induced EphB2 clusters elicit physiological responses in neurons and 
further suggest that cluster stability or turnover determines the robustness of the response. 
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Altogether these findings about correlation of clustering to cellular responses suggest that the 
composition of higher-order clusters controls the Eph signaling cascade from 
autophosphorylation to substrate phosphorylation and that these biochemical differences 
underlie the observed graded physiological responses. Moreover, cluster quality or stability 
has a tremendous effect on the resulting cellular responses. 
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Fig. 3.23 Dimerizer-induced EphB2 clusters cause growth cone collapse in neurons. 
(A) Domain structure of ∆NEphB2-3FKBP lacking the complete ectodomain except for the proximal 
FNIII domain (N-terminal signal peptide and FLAG epitope are not indicated). (B) Western blot of anti-
FLAG-immunoprecipitated ∆NEphB2 with or without 3 FKBP domains probing against phospho-
EphB2. Cells were previously stimulated either with control stimuli (Fc/EtOH), 2 µg/ml preclustered 
ephrinB2-Fc or 250 nM AP20187. An increase in EphB2 autophosphorylation over background is only 
seen after AP20187 stimulation of the 3FKBP isoform. EphrinB2-Fc is inactive due to the deletion of 
the Eph receptor LBD. Blot was stripped and reblotted with anti-EphB2 antibodies. (C) Dimerizer-
induced growth cone collapse (GCC) of E18 rat hippocampal neurons (1 day in vitro). Neuronal 
cultures were either transfected with YFP, ∆NEphB2-0FKBP, or ∆NEphB2-3FKBP (all carrying a FLAG 
epitope tag), and stimulated with either control stimuli (Fc/EtOH), 2 µg/ml ephrinB2-Fc, or 250 nM 
AP20187 for 30 min, then fixed and stained with anti-GFP antibodies (green), and phalloidin (red) to 
visualize f-actin rich growth cones. Only the status of growth cones of the longest neurites (the axon) 
was quantified. Insets, indicated by stippled boxes, show growth cones. Scale bar, 30 µm. (D) 
Quantification of total GCC (mean ± SEM in percent of all growth cones counted). EphrinB2-Fc 
induced GCC in all cultures. AP20187 is as efficient as ephrinB2-Fc in inducing GCC in neurons 
expressing the 3FKBP isoform, whereas stimulation with AP1887 leads to an intermediate response 
(n= 3 experiments, *** p< 0.001, ** p< 0.01, * p< 0.05, Student’s t-test; asterisks in red represent 
significance level to Fc/EtOH control stimulation of each data set). (E) Cell collapse assay comparing 
cells expressing 3FKBP isoforms of ∆NEphB2 or full-length EphB2. Cell responses do not significantly 
differ from each other (mean cell area ± SEM of n=5 and n=9 cells of full-length EphB2 and ∆NEphB2 
cells respectively; p= 0.27, Mann-Whitney nonparametric t-test). Data and analysis from panels (D) 
and (E) were contributed by Irina Dudanova.  
 
 
3.6 Eph receptor clustering is an integrator of signaling  
3.6.1 Intracellular clustering determinants synergize with extracellular ephrins 
 
Dimerizer-induced Eph clustering occurs intracellularly and may resemble intracellular 
mechanisms of Eph clustering, which can occur when scaffolding proteins interact via the 
PDZ-binding motif [151,251]. This prompted me to test whether extracellular ephrins would 
synergize with intracellular clustering mechanisms. I over-expressed EphB2 carrying a single 
FKBP domain in cells and stimulated with either AP20187 or sub-threshold doses of 
unclustered ephrinB2-Fc, or both (Fig. 3.24A). Mere dimerization by AP20187 caused on 
average a 2.3-fold higher fraction of activated receptor species (Figure 3.24.B). Sub-threshold 
doses of unclustered ephrinB2-Fc did not increase EphB2 autophosphorylation. However, co-
stimulation with AP20187 and ephrinB2-Fc had a synergistic effect on EphB2 activation (Fig. 
3.24B). This synergistic effect on receptor activation was also visible in cell collapse 
responses (Fig. 3.24C,D). Simultaneous application of both sub-threshold ephrinB2-Fc and 
AP20187 dimerizer led to a pronounced cell collapse response by about 40% of the initial cell 
surface area, whereas stimulation with sub-threshold ephrin was indistinguishable from 
control. AP20187 stimulation alone caused only a mild collapse response as already described 
earlier (cp. Fig. 3.19A).  
Next, I tested if PDZ-adaptor proteins like GRIP1, GRIP2 and PICK1, which are known to 
bind EphB2 [151], would act in the same way as AP20187-induced dimerization, thereby 
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priming the cells for an external ephrin stimulus. In presence of PDZ-adaptor proteins, Eph 
receptor autophosphorylation increased despite the absence of an ephrin stimulus. As a 
control, co-transfected YFP kept EphB2 autophosphorylation levels at baseline. 
Autophosphorylation levels could not be significantly increased further by stimulation with 
ephrinB2-Fc in the case of co-expressed PDZ-adaptor proteins. Taken together, Eph kinase-
dependent signaling, which was shown before to solely rely on receptor clustering, can serve 
as an integrative computational device for various clustering determinants - no matter if they 
provoke the clustered state of the receptor from the outside or the inside of the cell. 
 
3.6.2 Inhibition of clustering by intracellular determinants antagonizes ephrin‐
induced responses  
 
Next, I asked if the converse were true, i.e. if intracellular components or components in cis 
that prevent EphB2 from clustering would antagonize ephrinB2-Fc-induced effects. Hence, I 
co-expressed myr-FRB-mCherry together with wtEphB2-3FKBP-YFP and stimulated the 
cells with a high-affinity heterodimerizer AP21967, thereby coupling the EphB2-FKBP and 
FRB domains [312,322] (Fig. 3.25A). The presence of AP21967 prevented ephrinB2-Fc from 
inducing EphB2 clustering, autophosphorylation, and cell collapse (Fig. 3.25B,C,D).  
 
 
Fig. 3.24 EphB2 dimerization sensitizes cells towards extracellular ephrinB2. 
(A) Model showing possible synergistic response between extracellular (ephrinB2-Fc) and intracellular 
(dimerizer) clustering determinants. EphB2-1FKBP dimers form in the presence of AP20187. Both 
ephrin ligand and AP20187 together can form functional oligomers. (B) Western blots of anti-Flag 
immunoprecipitated EphB2-1FKBP over-expressed in HeLa cells probing against anti-phospho-EphB2 
antibodies; blot was stripped and re-probed for total EphB2. Cells were previously stimulated with 
control (EtOH) or AP20187 (250 nM), in the absence or presence of 5 ng/ml (+) or 10 ng/ml (++) 
unclustered ephrinB2-Fc for 10 min.  The fraction of activated Eph receptors was significantly higher, 
when both AP20187 and ephrinB2-Fc were added. Numbers below the blots indicate fold change in 
phosphorylation compared to Fc/ethanol control (1.0), normalized to total receptor protein levels 
(representative blot of 3 separate experiments). (C) Images of representative HeLa cells in BF and FL, 
expressing equal and low levels of wtEphB2 carrying 1 FKBP domain, before and after stimulation with 
the indicated combinations of stimuli. Cell collapse was scored from cell surface area measurements 
over time (red circles around cells). (D) Quantification of cell collapse responses from (C). (mean cell 
area ± SEM from n= 9 cells for condition efnB2/EtOH, Fc/EtOH, n= 10 cells for condition 
+efnb2/AP20187, ++efnB2/AP20187, n= 8, 11 for conditions ++efnB2/EtOH, Fc/AP20187; p< 0.01; 
Mann-Whitney nonparametric t-test). (E) Western blot of anti-FLAG-immunoprecipitated wtEphB2 
probing against phospho-EphB2 and total EphB2 after stripping of the blot. Below, Western blot of 
total cell lysates (TCL) containing co-expressed proteins YFP, GRIP1, myc-tagged GRIP2 and PICK1 
probed with antibodies anti-GFP, anti-GRIP1, anti-myc, anti-PICK1, respectively. Cells were previously 
stimulated either with control stimuli (Fc), 0.5 µg/ml unclustered ephrinB2-Fc for 10 min. An increase in 
EphB2 autophosphorylation is only seen when PDZ-adaptor proteins are co-transfected but not for 
YFP. Stimulation does not significantly enhance autophosphorylation levels of EphB2 when PDZ-
adaptor proteins are co-transfected but for YFP. Asterisks in TCL blots indicate antibody-specific 
bands.  
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Interestingly, when AP21967 was added about 18 min after stimulation with ephrinB2-Fc, 
cell collapse came to an abrupt stop (Fig. 3.25E). The cell stopped responding immediately 
and the cell surface area remained constant over an extended period of time. 
AP21967 also changed Eph-ephrin signaling in a cell-cell stimulation assay. In the absence of 
AP21967, EphB2 clusters, which emerge at the contact site between the two opposing cells, 
were internalized bi-directionally into both cells and trigger the typical repulsion response 
(Fig. 3.26A). In the presence of AP21967, however, EphB2 signaling entities remained static 
at cell edges without being internalized and cell repulsion was converted to an adhesive 
response (Fig. 3.26B).  
Overall, the results from studying integration of clustering determinants indicate that the 
oligomerization state of EphB2, regulated by intracellular interactions, can affect the cell’s 
sensitivity towards extracellular ephrinB2. Intracellular components that precluster EphB2 
synergize, whereas those that keep EphB2 unclustered, antagonize with extracellular 
ephrinB2. In the context of a cell-cell stimulation assay intracellular inhibition of EphB2 
clustering converts kinase-dependent repulsion to adhesion. 
 
 
 
 
 
Fig. 3.25 Intracellular inhibition of EphB2 clustering negatively regulates kinase-dependent cell 
responses. 
(A) Model showing intracellular steric hindrance (using myr-FRB-mCherry) of extracellular (ephrinB2-
Fc-induced) clustering. In the presence of heterodimerizer AP21967 the co-expressed inhibitory 
construct myr-FRB-mCherry couples to the wtEphB2-3FKBP receptor keeping it as monomer. 
EphrinB2-Fc can still bind to the ectodomain of the receptor. (B) Representative images of HeLa cells 
transiently expressing kdEphB2-3FKBP-YFP and myr-FRB-mCherry, stimulated with ephrinB2-Fc 
alone or ephrinB2-Fc together with AP21967 (t= 10min). Stimulation with ephrinB2-Fc alone leads to 
accumulation of EphB2 in the plasma membrane of cell edges (lower left panel); the presence of 
AP21967 prevents this effect (lower right panel). Scale bar, 10 µm. Image processing: 9x 0.2 µm z-
stacked epiFL images; odc; adaptive-blind psf deconvolution; sum-projection; equal scaling over all 
images. (C) Western blot of immunoprecipitated wtEphB2-3FKBP (carrying a Flag epitope-tag) using 
the anti-phospho-EphB2 antibody; blot was stripped and reblotted for total EphB2. Cells transfected 
with both wtEphB2-3FKBP and myr-FRB-mCherry were stimulated with ephrinB2-Fc in the presence 
or absence of AP21967. The presence of AP21967 prevents EphB2 autophosphorylation. (D) 
Quantification of cell collapse assays (images not shown). The presence of AP21967 prevents EphB2-
3FKBP transfected cells to collapse in response to ephrinB2-Fc. (mean ± SEM cell area percentage of 
n= 9 imaged cells for each condition tested; p< 0.001, Mann-Whitney nonparametric t-test). (E) 
Representative images of HeLa cells transiently expressing wtEphB2-1FKBP-YFP and myr-FRB-
mCherry stimulated with ephrinB2-Fc imaged using epiFL time-lapse. AP21967 or control (EtOH) was 
added 18 min after addition of ephrinB2-Fc and imaging was continued. In the presence of AP21967 
cell collapse stops and adopts a steady state, whereas in control stimulated cells ephrin-induced 
collapse progresses normally. Graph: quantification of cell collapse assays as described previously 
from representative images above. (mean ± SEM cell area percentage of n= 8 imaged cells for each 
condition tested; p< 0.001, Mann-Whitney nonparametric t-test). 
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Fig. 3.26 Conversion of repulsive to adhesive Eph cellular responses. 
Co-culture assay of HeLa cells co-expressing wtEphB2-3FKBP-YFP and myr-FRB-mCherry with HeLa 
cells expressing wildtype ephrinB2-CFP. EphB2 clusters (red arrows) can be seen in the contact 
region of the two cells. In the absence of AP21967, EphB2 clusters are internalized and the EphB2+ 
cell (indicated by asterisk) retracts away from the ephrinB2+ cell (the initial position of the EphB2+ cell 
is marked by a stippled line); in the presence of 250 nM AP21967, EphB2 clusters stay near the 
contact-zone and cell repulsion is converted to an adhesive response. Scale bars, 10 µm. 
Abbreviations: n.d., not determined – imaging frame not acquired. 
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3.7 Ephrin clustering causes rapid reverse internalization 
 
As outlined in Fig. 3.4, the dimerizer-inducible clustering system was also implemented for 
clustering the ligand with the same autonomous features as for Eph receptors. Primary focus 
was set on studying the role of cluster formation on the receptor side since cellular readouts 
are more accessible. However, I also performed initial experiments for ephrin ligand 
characterization of the AP-induced clustering response with promising results for a much 
more detailed further study. 
 
3.7.1 Ephrin clustering causes fluorescence intensity rise in cell edges  
 
Starting to study the mechanistic effects on the visual level using the dimerizer-induced 
system, it seemed reasonable to approach ephrin clustering by basic epiFL techniques. 
HeLa cells, co-transfected with YFP-tagged ∆CephrinB2-3FKBP and control myr-mCherry 
constructs, were stimulated with dimerizer AP20187 while imaging in epiFL time-lapse (Fig. 
3.27A). Approximately 8 to 13 min after addition of the compound, a significant FL intensity 
rise occurred at cell edges - in analogy to the phenotypic effect observed when clustering 
kdEphB2-3FKBP receptor isoforms (cp. Fig 3.8). By contrast, co-transfected myr-mCherry 
remained diffuse at cell edges, indicating the ephrin specificity of the readout. In analogy to 
Eph receptor clustering, I concluded that ligands also accumulate in the lateral part of the cell 
plasma membrane.  
Inhibition of clustering could also be accomplished via co-transfection of the inhibitory 
construct myr-FRB-mCherry, which upon AP21967 addition couples with its FRB portion to 
the FKBP portion of the tagged ephrinB2 ligand isoform (Fig. 3.27B). This resulted in 
suppression of the phenotypic effect observed in Fig 3.27A for cells with medium to high 
expression levels of the inhibitory construct. In the control case under co-expression of myr-
mCherry lacking the FRB domain or in cells with very low expression of myr-FRB-mCherry, 
ligand accumulation was still present (Fig. 3.27B,C). In total, measurements from multiple 
cells showed a negative correlation between myr-FRB-mCherry expression levels and the 
strength of the phenotypic effect (Fig. 3.27B). For cells expressing control construct myr-
mCherry, a correlation to increasing myr-mCherry expression levels was not observed (Fig. 
3.27B).  
We see that the overall effects from ephrin clustering in FL imaging very much correspond to 
those monitored in Eph receptor clustering. Ligand accumulation at the lateral side of the cell 
was evident upon clustering. Ligand clustering can also be inhibited by application of the 
inhibitory construct myr-FRB-mCherry to keep ligands as monomers. Note that the AP21967 
induced FRB-FKBP complex formation cannot be reversed, even not by the addition of 
AP20187 homodimerizer (data not shown).  
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Fig. 3.27 Phenotypic effects of ephrin clustering in mammalian cells. 
(A) HeLa cells were transfected with C-terminally truncated YFP-∆CephrinB2-3FKBP and stimulated 
with AP20187 (100 nM) while imaging in single focal plane epiFL time-lapse. As a control and for 
better visualization of the cell, myr-mCherry was co-expressed. Upon stimulation, a strong FL intensity 
rise is observed for YFP FL at cell edges but not for mCherry FL. Images are background corrected. A 
linescan graph is shown to visualize time-dependent FL intensity. (B) HeLa cells expressing YFP-
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∆CephrinB2-3FKBP and myr-FRB-mCherry or control myr-mCherry were incubated with AP21967 
(100 nM) for 1 hr, then stimulated with AP20187 (100 nM) for 1 hr and imaged for epiFL. Depending 
on low expression levels of myr-FRB-mCherry (Cell A, asterisk), which antagonizes ephrin clustering, 
ephrinB2 accumulation can be seen in the plasma membrane of cell edges (Cell A, FL YFP channel). 
Scale bars, 10 µm. (C) Linescans over cell edges (as indicated by red dotted lines in B) were 
performed from cells in both conditions to measure the strength of the phenotypic effect of FL intensity 
rise as displayed for cell A/B from panels in (B). The FL peak intensity in each linescan was 
normalized to the baseline average FL intensity beyond the cell edge on the inside of the cell. (D) FL 
peak intensity above baseline values, determined from linescans as described in (C), were plotted 
against the relative expression level, i.e. FL intensity signals from respective proteins. Note, that there 
is a negative correlation between myr-FRB-mCherry expression level and the strength of the 
phenotypic effect. 
 
 
 
 
Fig. 3.28 Dimerizer-induced ephrin clustering is self-contained. 
HeLa cells were co-transfected with YFP-∆CephrinB2-3FKBP and CFP-tagged wtephrinB2 lacking 
FKBP (Cfp-wtephrinB2). Before stimulation with either AP20187 or ephrinB2-Fc, both ligand isoforms 
are evenly distributed in the cell (upper panels). Upon stimulation (t= 20 min) with 250 nM AP20187 
YFP-∆CephrinB2-3FKBP accumulates in the lateral edge of the cell (I- arrow), whereas EphB2 lacking 
FKBP remains evenly distributed (II). BF images on far left are low power magnifications. Red boxes 
indicate areas of higher magnifications. Scale bars, 10 µM. Image acquisition and processing: 3x 0.8 
µm z-stacked epiFL images; odc; adaptive-blind psf deconvolution; sum-projection. 
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wildtype ephrinB2 version were stimulated with AP20187. As described earlier, the addition 
of AP20187 caused the phenotypic effect of FL intensity rise at cell edges i.e. ligand 
accumulation for YFP-∆CephrinB2-3FKBP (Fig. 3.28-I). The FL intensity distribution of co-
transfected wtephrinB2 lacking FKBP domains, however, remained unaffected (Fig. 3.28-II), 
indicating that the two ligand variants did not interact under these conditions.  
This result indicates that dimerizer-induced ephrinB2 clusters do not serve as nucleation 
points to which additional ephrin ligands are recruited by ephrin-ephrin interactions. The 
system of dimerizer-inducible clustering is therefore self-contained enabling the constitution 
of distinct ephrin cluster size distributions in living cells. 
 
3.7.3 Dimerizer‐induced clustering is sufficient to cause rapid ephrin 
internalization 
 
In analogy to the investigation of dimerizer-induced Eph clustering, I asked how dimerizer-
induced ephrin clustering would impact on cellular responses. Performing epiFL time-lapse of 
HeLa cells expressing YFP-ephrinB2-2FKBP isoforms stimulated with AP20187 led to 
transient ephrin ligand accumulation at cell edges and subsequent rapid processing of FL 
particles to the center of the cell (Fig. 3.29A). These particles pinched off from a bigger FL 
entity, which is located at the very cell edge (Fig. 3.29A, blowup image sequence). To further 
investigate this processing phenomenon, I also conducted immunocytochemistry experiments. 
HeLa cells expressing YFP-ephrinB2-2FKBP ligand isoforms were stimulated with either 
increasing concentrations of AP20187 dimerizer or positive control preclustered EphB2-Fc 
(Fig. 3.29B).  
 
Fig. 3.29 Clustering correlates with the strength of ephrin internalization. 
 (A) Time-lapse epiFL image sequence (single focal plane) of HeLa cells expressing wildtype YFP-
ephrinB2-2FKBP, stimulated with AP20187 (100 nM). A transient FL intensity rise was observed at cell 
edges indicating a temporary ligand accumulation (green arrows, blowup from green region outline). 
Subsequently, FL entities at cell edges (purple arrows, small panel blowups) are successively 
processed towards the center of the cell by pinching off from small particles (red arrows). Cells do not 
collapse upon clustering of ephrin ligand. (B) HeLa cells expressing the YFP-wtephrinB2-2FKBP 
ligand isoform were stimulated with either AP20187 (100 nM), preclustered EphB2-Fc (2 µg/ml) or 
control stimuli (EtOH or Fc) for 30 min, fixed and immunostained for surface ephrinB2 using the anti-
GFP antibody (Invitrogen). Total ephrinB2 protein was visualized by the YFP-tag. Both for EphB2-Fc 
and AP20187 stimulation, internalized focal inclusions, not stained by the surface staining, become 
visible. Image acquisition and processing: 3x 0.8 µm z-stacked epiFL images; max-projection; bgcorr. 
(C) Quantification of internalized ligand ephrinB2 upon stimulation for 30 min with various 
concentrations of AP20187 and EphB2-Fc as indicated. The fraction of surface ligand to total ligand 
protein was determined by integrated FL intensity measurements over the whole cell surface area 
(mean ratio of FL surface/FL total ± SEM of n = 21-25 cells per condition; n.s., not significant, * p< 
0.05, *** p< 0.001, student’s t- test; asterisks in red indicate significance level to control EtOH). Note, 
that the strength of internalization correlates to the concentration of applied dimerizer. Scale bars, 10 
µm. 
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After fixation, staining and imaging, the fraction of internalized protein was visible as small 
FL dots devoid of surface staining, which could be seen upon stimulation with AP20187 or 
EphB2-Fc. Quantification for surface versus total protein corroborated the visual impression 
and showed a clear dose-response dependence for the strength of the internalization response 
(Fig 3.29C).  
In contrast to Eph-mediated cell collapse, ephrin-expressing cells did not collapse in response 
to dimerizer-induced clustering (Fig 3.29A) complying with EphB2-Fc-induced cell responses 
(data not shown).  
Overall, studying the obvious physiological ephrin-induced cellular responses, receptor-
independent clustering with AP20187 dimerizer did not reveal significant differences as 
compared to receptor-dependent clustering. However, a closer look at clustering-dependent 
ephrin phosphorylation of C-terminal tyrosine residues by Src was not taken at that point of 
the study. For future investigations of ephrin clustering and its role for controlling signaling 
responses, the here established system of dimerizer-inducible ephrin clustering may serve the 
same aims in mimicking physiological responses as the system for Eph receptor clustering. 
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4. DISCUSSION 
4.1 The system of dimerizer‐induced clustering is a versatile tool to 
induce physiological Eph signaling responses. 
 
A closer look at the constitution and processing of Eph/ephrin signaling entities in co-cultures 
of living cells immediately suggested, that unconventional strategies had to be implemented to 
meet the needs for a detailed mechanistic to functional study of the Eph/ephrin cluster 
formation process.  
The intention to reduce and control parameters around the event of Eph/ephrin clustering led 
to the cell- and receptor/ligand-autonomous approach of dimerizer-induced cluster formation. 
Based on structural studies, it was clear to me, that multiple Eph-Eph domain interactions are 
necessary to produce extended signaling arrays [72,80,91,106], and that abrogation of 
interaction interfaces through site-directed mutagenesis might lead to dysfunctional receptor 
protein.  A site-directed mutagenesis approach to impair clustering did therefore not seem 
reasonable.  
 
Implementation of the FKBP/FRB system. Placing Eph clustering under the control of the 
FKBP homodimerization system in combination with the FRB heterodimerization system not 
only allows for a positive but also a negative control of clustering through steric hindrance by 
myr-FRB-mCherry. The FKBP-system has been used for other growth factor receptors, where 
the insertion of a single FKBP domain has previously been shown to be sufficient for 
dimerizer-induced activation of growth factor receptors, including FGFR1 (fibroblast growth 
factor receptor 1), ErbB receptors including EGFR, insulin receptor and PDGF receptors 
[323-328]. Insertion of up to 3 tandem copies of the FKBP domain was described for the 
transmembrane glycoprotein platelet endothelial cell adhesion molecule 1 (PECAM-1), 
FGFR1, ErB1/2 receptors, EGFR and serine/threonine kinase receptor transforming growth 
factor-β (TGF-β) leading to partially functional signaling [329-331]. While the focus in these 
studies was mainly set on the mere activation or dimerization of the target protein, later 
studies also employed the FKBP-system to specifically produce oligomer size distributions of 
EGFR-FKBP fusions for the testing of homo-FRET imaging approaches and to draw 
underlying functional conclusions [327,328]. To my knowledge, this study is the first to 
implement the FKBP/FRB-system for Ephs/ephrins, with special focus to produce different 
cluster size distributions, to alter cluster propensity by the use of the low-affinity 
homodimerizer AP1887 and to generate a range of functional readouts.  
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4.1.1 Features of the FKBP‐system  
 
Important features have emerged from the detailed investigation of the properties of the Eph 
dimerizer-inducible clustering system in comparison to ephrinB2-Fc induced clustering. An 
overview of different modes of clustering-induction is provided in Fig. 4.1A. Some specific 
aspects are elaborated in the following paragraphs and upcoming sections.  
 
Specific Eph isoform receptor activation. Practically and in respect to the usability of the 
FKBP/dimerizer-induced system for Eph clustering, single Eph receptor isoforms can now be 
selectively clustered and activated in vitro but theoretically also in vivo. Ephrin stimulation on 
Eph receptors usually results in signal amplification of more than one Eph receptor, also of 
endogenously expressed Eph receptors, since most ephrins are cross-specific to several Eph 
isoforms. This fact points to the superiority of the dimerizer-inducible system in selectively 
studying one specific Eph isoform.  
 
High controllability of clustering. AP-induced clustering is highly controllable. Fast 
diffusion rates and penetration of the whole cell ensure a high simultaneity of clustering 
induction on a small time scale, independent of recombinant protein quality as it is the case 
for ephrinB2-Fc.  Dimerizer-induced clustering is, in contrast to ephrinB2-Fc clustering, 
reversible by the use of myr-FRB-mCherry co-expression and AP21967 application. 
Clustering may also be totally inhibited enabling the study of cellular responses over the 
whole range of cluster sizes from forced monomers to oligomers. Furthermore, the use of 
EphB2-FKBP isoforms lacking the LBD allows for a highly-controlled activation of Eph 
kinase-dependent signaling without unwanted signaling induction by endogenously expressed 
ephrin.  
 
Available mechanistic readouts. Readouts for measuring absolute Eph cluster size 
distributions are difficult to produce. Whereas ephrinB2-Fc produces stoichiometrically 
undefined complexes together with Eph receptors, dimerizer-induced clusters are 
stoichiometrically well defined and may be visualized using blue-native PAGE.  
 
Fig. 4.1 Dimerizer/ephrinB2-induced cluster configurations. 
(A) Favorable assets of different modes of clustering-induction. (?) indicates a possible, experimentally 
not confirmed feature. (B) Model of ephrinB2-induced versus dimerizer-induced clusters. The Eph 
cluster platform is categorized into an extra- and intracellular cluster entity to mediate “cell-surface” 
and intracellular signaling, respectively. The way clustering is induced by either dimerizer or soluble 
ephrinB2-Fc may produce differential kinase-independent signaling responses based on the 
configuration of the extra-/intracellular cluster entities. (C) FKBP-induced cluster configurations. The 
number of FKBP domains is proposed to determine the complexity of the signaling arrays. Under 
certain assumptions (only in-register crosslinking of FKBP domains, no intra-receptor FKBP 
crosslinking, as indicated by red connectors in left cartoon) 2FKBP constructs may only form 1d-arrays 
and ring-like complexes whereas 3FKBP constructs may form 2d-platforms of denser packing. 
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4.1.2 Ephrin‐induced versus dimerizer‐induced clusters  
 
Eph receptor seeding mechanism. Detailed analysis of the mechanistic aspects of the 
dimerizer-inducible Eph receptor clustering system has revealed that in contrast to an 
ephrinB2 stimulation, a nucleation or seeding effect is absent (this study and [104]). Seeding 
of Eph receptors was shown to be mediated by the extracellular receptor part [72,91,104], by 
contrast, dimerizer-induced clustering is induced by non-covalent crosslinking at the 
intracellular receptor part. This fundamental difference in the way clustering is provoked for 
Eph receptors can explain the absence of a seeding mechanism for dimerizer-induced 
clustering. Structural biologists claim that ephrin binding does not cause structural 
rearrangements on the intracellular receptor part but that conformational changes remain 
strictly limited to extracellular domains (personal communication with Elena Seiradake and 
[106]). In consequence, intra- and extracellular parts of Eph receptors are structurally most 
likely mutually inert to conformational changes. A clustering seed, originating from the 
intracellular part of the receptor, would thereby not be mediated to the outside structural part 
of the receptor and vice versa. By contrast, ephrin engagement as extracellular clustering 
trigger causes Eph receptors to snap in register to produce extended 1-dimensional signaling 
arrays or 2-dimensional platform-like structures [72,79,89,332]. For dimerizer-induced 
clustering this trigger is obviously missing, signaling array-like structures are, however, 
produced by distinct dimerizer-induced clustering (Fig. 4.1C). This lack of uncontrolled 
seeding ensures the distinctness of cluster size distributions as observed for the FKBP-system 
and shown by homo-FRET imaging and blue-native PAGE.  
Overall, this difference in the mode of ephrin-induced versus dimerizer-induced cluster 
formation raises the question if thereby induced spatial signaling entities may differ in their 
cluster architecture influencing downstream signaling events. Cluster architecture can be 
categorized into an extracellular steric seeding platform consisting of Eph/ephrin ectodomain 
complexes (Fig 4.1B extracellular cluster entity) and an intracellular steric platform (Fig. 
4.1B, intracellular cluster entity).  
 
Signaling via the intracellular signaling platform. Intracellular kinase activation is the 
major consequence of Eph clustering and most important for biological functions in vivo 
[28,31]. However, receptor clustering may also provide a kinase-independent, sensitive 
intracellular structural configuration, which is sufficient or in addition to receptor 
autophosphorylation necessary for docking of signaling adaptors. Interestingly, the well-
studied adaptor protein ephexin1 binds to EphA4 receptors (intersectin in the case of EphB 
receptors) in a constitutive manner [122,127,129], and its activation through phosphorylation 
is controlled by Eph clustering [113]. This modification is also mediated by kinase-active 
eeEphA4, suggesting that this is a process that happens largely independent of the regulation 
of EphA4 kinase activity. It was suggested that ephexin1 is recruited into higher-order 
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clusters of EphA4 along with Src family kinases and possibly other adaptor proteins. This 
then leads to the activation of Src kinase and subsequent ephexin1 phosphorylation by Src.  
My study reports, that dimerizer-induced clustering is sufficient to activate wtEph and N-
terminally truncated Eph receptors and induce physiological signaling responses in 
heterologous cells and neurons. In light of the mechanistic aspects of the dimerizer-induced 
clustering system, it is highly unlikely that dimerizer-induced clustering forces the 
cytoplasmic domains by chance into an ordered signaling array that resembles the ephrin-
induced physiological situation. Therefore a defined intracellular cluster configuration that 
might arrange specific interfaces for adaptor proteins is lacking and still, physiological Eph 
signaling responses are produced. Cell contraction responses are mainly mediated through the 
RhoA/ROCK/LIM kinase pathway through ephexin1 or intersectin to ultimately produce actin 
rearrangements [122,127,129]. Thus I conclude that dimerizer-induced clustering is sufficient 
to activate this pathway irrespective of producing a specific intracellular inter-receptor 
domain configuration [80]. Furthermore, recruitment of additional signaling components 
might either not be necessary to mediate kinase-dependent signaling responses or arbitrarily 
configured clusters are also sufficient for recruitment, e.g. through an unspecific co-clustering 
process.   
 
Cell-surface signaling via the extracellular steric seeding platform. The extracellular 
cluster entity consists of multiple Eph/ephrin high-affinity interactions, which presumably 
potentiate along with growing cluster sizes to mediate strong adhesion to the opposing cell. 
This is, however, only the case in cell co-culture scenarios, where the cognate ligand is 
membrane-bound to the opposing cell. Dimer EphB2/ephrinB2 binding affinities are strong 
and dissociation constants (Kd)  range in a sub-nanomolar order of magnitude [70,96]. The 
idea of extracellular strong and passive adhesive forces between cells can therefore be easily 
appreciated. This adhesive component of kinase-independent Eph function may be solely 
attributed to the extracellular steric seeding platform and reflects a pure passive mode of 
signaling mechanism. By contrast, kinase activity leading to trans-endocytosis of both 
receptor and ligand was shown to turn initial strong adhesion into contact-repulsion [237,238] 
involving an active kinase-dependent signaling process. 
In this respect, both the FKBP-system and clustering with soluble ligand obviously fail to 
incorporate this kinase-independent mode of signaling through passive Eph/ephrin binding 
mediated adhesion. However, a secondary kinase-independent function may underlie the 
extracellular steric seeding platform. It may be able to evoke a signaling propensity, referred 
to as cell-surface signaling. The extracellular cluster entity may unspecifically co-cluster or 
specifically incorporate alien membrane proteins, i.e. produce cluster inclusions of alien 
(trans)membrane proteins,  and thereby activate them. 
Indeed, in this study, ephrinB2-Fc-induced clustering led to co-precipitation of an unidentified 
50-55 kDa trans(membrane) protein. (Trans)membrane interacting partners in cis have been 
reported to be matrix metalloproteinases, γ-secretases, NMDA receptors [184,186,259], and 
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other, so far unknown, specific or unspecific Eph cluster inclusions of alien (trans)membrane 
proteins are suspected. ADAM10 recruitment was demonstrated to correlate with cluster sizes 
produced by mechanical restriction of EphA2 [294], highlighting a possible kinase-
independent role of cell surface signaling. In this respect my focus was not set on identifying 
the co-precipitated protein nor the mode of interaction but to find differences in ephrinB2-Fc 
induced versus dimerizer-induced clustering and thereby learn more about the molecular basis 
of receptor functioning. Interestingly, dimerizer-induced clustering failed to co-precipitate the 
unidentified protein. This difference in producing a competent cluster configuration for co-
clustering of the alien (trans)membrane protein between ephrinB2-Fc induced and dimerizer-
induced clustering may rely on the fact, that dimerizer-induced clustering is initiated 
intracellularly. Hence, this mode of clustering then fails to produce an extracellular steric 
seeding platform competent for recruiting cell surface, trans(membrane) signaling partners or 
effectors and furthermore accentuates an important mechanistic difference between 
ephringB2-Fc and dimerizer-induced clustering. Dimerizer-induced clustering most likely 
does not produce an extracellular steric configuration. 
4.1.3 Relevance of cluster size distributions and cluster quality 
 
Quantitative assets of dimerizer-induced clustering based on theoretical and 
experimental considerations. The self-containment of the FKBP/dimerizer-induced Eph 
clustering system was shown to be a prerequisite for inducing discrete cluster size 
distributions in living cells. While correlation between the formation of higher-order 
oligomers and increasing numbers of FKBP domains is, based on theoretical mathematical 
combinatorics, rather intuitive, the situation in practice might differ considerably. Structural 
constraints exerted by the receptor environment may impair full rotational freedom of inserted 
FKBP domains due to FKBP-insertion within the polypeptide chain of the Eph receptor. 
Moreover, depending on the structural inter-domain flexibility, FKBP domains may also only 
interact with other FKBPs, which are situated in register in adjacent receptors determined for 
cross-linking. In the end, all these parameters not only contribute to controlling the actual 
cluster size distribution, but also the complexity of clusters, ranging from discrete dimers 
(1FKBP) over 1-dimensional arrays and ring-like cluster configurations (2FKBP) to 2-
dimensional cluster platforms (3FKBP)  (Fig 4.1C).  
Blue-native PAGE represented a reliable method to resolve absolute cluster size distributions 
produced by the dimerizer-system. As predicted, dimers were the only higher-order species 
present when clustering 1FKBP isoforms with AP20187. For [2,3]FKBP isoforms, higher-
order cluster size distributions became evident which were shifted to bigger oligomers in the 
case of 3FKBP isoforms. Surprisingly, however, the species of highest order distinguishable 
in blue-native PAGE are only of hexa-, potentially heptameric order. This indicates a rather 
early saturation in the cluster formation process using the FKBP/dimerizer system. 
Interestingly, the cluster size distribution for the 2FKBP variant was remarkably similar to the 
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one observed by Bader and colleagues despite the fact that a totally different system 
relationship was existent [328].  
Similarly, homo-FRET imaging may be employed to relatively quantify cluster sizes as well 
as cluster size distributions [310]. Indeed, application of the high-affinity homodimerizer led 
to a strong decrease in FL anisotropy upon dimer formation and further subtle decreases for 
[2,3]FKBP cluster size distributions. Potentially, homo-FRET can be induced by nanoscale 
biochemical interactions or a high-FL concentration distribution due to over-expression. 
However, the drop in FL anisotropy must indeed rely on a nanometer-scale organization 
which can be conveniently discriminated from a FL concentration distribution by the lack of a 
positive correlation between intensity (fluorophore concentration) and the corresponding 
anisotropy (degree of homo-FRET) [333]. Thus, the observed drop in anisotropy is due to 
clustering of mGFP-tagged Eph receptors, as it is confirmed by cluster size distributions from 
blue-native PAGE. For the most part, the differences in anisotropy between the [1-3]FKBP 
dimerizer-induced clustering conditions rely on the number of proteins in a cluster but 
potentially also on the energy transfer efficiency between the fluorophores. The divergence in 
transfer efficiency may be due to variations of the reciprocal orientation of the fluorophores 
caused by differences in the complexity of clusters (this study and [309,310]). 
 
Qualitative assets of dimerizer-induced clustering based on theoretical and experimental 
considerations. Complexity of clusters may be considered as a qualitative asset of dimerizer-
induced clusters (Fig. 4.1C). As a thought-provoking impulse, cluster complexity can also be 
closely linked to cluster density and the geometry concept of the densest packing of spheres, 
if single receptor monomers in a lattice cluster are considered as spheres. This concept 
becomes immediately clear when comparing e.g. a cluster as a chain of 4 receptor monomers 
with a cluster as a ring-shaped 4 receptor entity. However, this qualitative parameter is 
inherent to the system of dimerizer-induced clustering and cannot be controlled by the 
experimenter.  
Another qualitative aspect of cluster formation can be addressed by application of the low-
affinity homodimerizer AP1887. AP1887-induced clustering presumably does not impact the 
complexity but rather the stability and cohesiveness of those oligomeric shapes. Moreover, it 
may attribute increased dynamics and a reduced half-time existence of clusters, which is owed 
to its increased off-rate in binding. Indeed, the use of the alternative low-affinity 
homodimerizer was a controllable means to vary the quality or stability of Eph clusters as 
could be experimentally proven. AP1887-induced clustering species were most likely not 
stable enough to overcome cell lysis and/or blue-native PAGE and AP1887-induced 
clustering also failed to generate a positive readout in homo-FRET imaging. Here the 
transience in the clustered state did most likely not allow the energy transfer efficiency to 
cause a decline in FL anisotropy. Note that the absence of a homo-FRET signal does not 
exclude the existence of clustering. Clusters that do not provide the stability fail to enable 
energy transfer between aligned mGFPs [310]. AP1887-dimerizer application must have 
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provoked the formation of low stability clusters, since on the functional side, it was sufficient 
to activate Eph receptors and induce signaling.  
In summary, the FKBP-system is able to give control over quantitative and qualitative aspects 
of Eph clusters and thereby allows for the study of the respective functional outcomes.  
 
Implications for physiological ephrin-induced Eph clustering. Cluster properties were also 
assessed by homo-FRET imaging upon stimulation with ephrinB2-Fc ligand. Interestingly, a 
drop of steady-state anisotropy upon clustering with increasing concentrations of ephrinB2-Fc 
saturated on a level higher than for dimerizer-induced clustering. This finding points to an 
increased intracellular structural flexibility in the vicinity of the mGFP. Since for ephrinB2-Fc 
clustering is induced externally, this mode of clustering might allow greater intracellular 
structural flexibility as compared to AP20187-induced clustering, where crosslinking takes 
place right next to the mGFP producing the FL anisotropy readout. Hence, one has to be 
careful with correlating absolute dimerizer-induced cluster properties with ephrinB2-induced 
clustering. However, relative conclusions and interpretations may be confidently assigned to 
ephrin-induced clustering.  
 
Allosteric model for Eph clustering? An extracellular steric seeding mechanism has been 
implicated for Eph clustering which would allow ephrin-independent receptor recruitment 
upon ephrin binding [72,91,334]. This rather uncontrolled clustering mechanism, which is 
somehow reminiscent of the conformational spread mechanism, well characterized for 
bacterial chemotaxis receptors [274,297,298], is suited to recruit a proportion of receptors into 
a signaling cluster that would represent the overall receptor abundance of the cell. This 
concept was proposed to allow precisely adjusted cellular responses (heightened 
responsiveness) controlled by graded changes in ligand abundance and receptor/ligand 
occupancy, a characteristic feature of Eph-ephrin communication [104]. In light of the here 
presented results, I can neither confirm nor disprove the idea of an ephrin-independent 
extracellular steric seeding mechanism. However, I conclude from my results that a 
conformational spread mechanism may be strictly limited to sites of receptor contact. Homo-
FRET imaging experiments using soluble ephrinB2-Fc or co-cultures reveal differential 
cluster size distributions for the overall stimulated cell or at sites of cell contact. This stands in 
slight contrast to the idea of a widespread Eph receptor seeding which would erase the fine 
differences in clustering upon ephrin stimulation. Revisiting the concept of conformational 
spread for Eph receptors, I suggest a limited recruitment of Eph receptors into existing 
clusters, which might not reflect the overall abundance of Eph receptors but the size or cluster 
perimeter. Eph receptor engagement into existing clusters might then saturate at the cluster 
edge and eventually come to a halt. Eph receptors, which line up at the edge of clusters, may 
not be conformationally competent to recruit further Eph receptors independent of ligand 
contact. I suggest the KNF model of allosteric ligand-receptor systems to come closest to the 
hereby elaborated concept of Eph cluster formation (cp. section 1.6.1 & [271,277]). 
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4.2 Eph receptor clustering serves as analog‐to‐digital converter to 
produce graded cellular signaling responses 
 
4.2.1 Eph‐Eph cis‐interactions are sufficient to induce physiological signaling 
responses 
 
Mechanisms that couple the event of ligand binding and dimerization to activation of the 
intracellular tyrosine kinase domains are surprisingly diverse for RTKs [9]. While ligand-
binding for some RTKs like EGF receptor requires the precise positioning of receptors during 
dimer formation to activate the kinase, others are more tolerant in respect to inter-molecular 
orientation and positioning for kinase activation.  
Until now, it was not clear if Eph receptors require the precise positioning of receptors in a 
dimer or cluster to activate the kinase. Binding of an ephrin ligand to the Eph LBD has been 
shown to provoke secondary-structure rearrangements, which are strictly localized to the 
interaction interface. Therefore it was proposed that downstream signaling is most likely 
triggered in the cytoplasmic sides, not through the conformational changes in the interacting 
ligands and receptors, but through their translocational rearrangements and repositioning 
relative to each other [70,80].  
My present work shows that physiological Eph clusters can indeed be formed solely by Eph-
Eph cis-interactions suggesting that ephrin trans-interactions may be necessary to trigger 
clustering, but not be required to form a highly-ordered array and elicit kinase-dependent cell 
responses. Dimerizer-induced clustering does most likely not allow specific translocational 
rearrangements and repositioning of receptors to each other supporting the hypothesis of 
packing density or crowding as being sufficient for kinase activation.  Although it cannot be 
fully excluded, it seems unlikely that dimerizer-induced clustering may force the cytoplasmic 
domains into an ordered signaling array that resembles the ephrin-induced physiological 
situation. I consider dimerizer-induced EphB2 clusters to be disordered and to be simply 
crowded through non-covalent cross-linking by the homodimerizer. 
 
4.2.2 Composition and quality of cluster size distributions determine the cellular 
response 
 
Eph receptors form higher-order oligomers upon ephrin engagement leading to extended cell 
surface signaling arrays, which exert functional kinase-dependent signaling responses 
[31,34,72,91]. This unique feature immediately raises the question if clustering may govern 
these downstream signaling responses depending on the size and/or quality of clusters and the 
surrounding cellular context [32,290]. However, a direct and reliable correlation of Eph 
clustering to kinase-dependent Eph signaling has so far been missing. Moreover, a direct 
control over the Eph oligomerization state or quality of clusters was not possible to date. The 
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phenomenon of  Eph clustering has so far only been indirectly addressed through application 
of distinct ephrin oligomeric species, produced by gel filtration or through application of an 
Eph antibody binding to the ectodomain [34,293]. Eph receptors were thereby reported to be 
able to discriminate these oligomeric species showing alternative signaling responses. 
However, an underlying mechanistic model, which explains these functional outcomes, 
remained elusive.  The dimerizer-inducible system of Eph clustering made it now possible to 
bridge this gap by giving direct control over qualitative and quantitative properties of Eph 
clustering.   
 
Functional effect of Eph cluster size distributions. AP20187-induced Eph cluster size 
distributions exerted respective kinase-dependent graded signaling responses with an overall 
enhancement of the phospho-activated cell state. Cluster size distributions positively 
correlated with every step in the Eph signaling cascade, from Eph receptor activation, 
indicated by phosphorylation of the JM tyrosines, to downstream cellular collapse responses, 
reflected by the degree in total collapse (collapse amplitude) and overall cell response pattern. 
By analyzing the fraction of activated Eph receptors engaged in single Eph cluster species 
using blue-native PAGE, I found that the composition of the EphB2 cluster sizes determined 
the strength of the cellular response. This is based on the fact that different oligomer sizes 
have distinct activation states. While EphB2 dimers were hypophosphorylated and largely 
inactive, EphB2 trimers were close to being fully activated, to an extent comparable with 
EphB2 tetramers. Hence, cluster populations significantly abundant in dimers (as generated 
by the 2 FKBP isoforms) would elicit a weaker cellular response than a cluster population 
consisting of predominantly higher-order oligomers.  
The early saturation in receptor activation on the analytical level of cluster species was quite 
surprising to find and is reminiscent of an ON-OFF mechanism of receptor activation. 
However, the technical demands and low resolution of the single species analysis in blue-
native PAGE must be taken into consideration. Furthermore, an ON-OFF mechanism of 
receptor activation might not exist for physiological ephrin-induced clustering since thereby 
induced clusters might be of different quality. This might convert an ON-OFF into a graded 
signaling output.    
 
Functional effect of stability/quality of Eph clusters. My results with the low-affinity 
dimerizer indicated that stability of EphB2 oligomers also determined the strength of the 
response. AP1887-induced clustering caused a delay in Eph activation through the 
autocatalytic loop, supposedly due to the low stability of thereby induced clusters. 
Interestingly, stimulation with the low-affinity ephrinA5 led to the same result in receptor 
activation and cellular collapse response indicating that ligand-affinity and thereby caused 
receptor cohesiveness (stability) are closely linked and cause a difference in the collapse 
kinetics but not necessarily in the overall strength of the response. High-affinity interactions 
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like the ones with ephrinB1, ephrinB2 or an anti-Eph antibody resemble an AP20187-induced 
response reflecting high receptor cohesiveness in cis. 
The modulatory effect of cluster stability also became evident in axon growth cone collapse 
assays using rat hippocampal neurons. The number of collapsed growth cones was reduced 
for AP1887-induced as compared to AP20187-induced clustering, which best reproduces an 
ephrinB2-Fc induced collapse. Upon AP1887 stimulation, Eph receptors engaged in clusters 
also displayed a slightly elevated activation level after separation in blue-native PAGE. 
However, stability of AP1887-induced clusters was fairly low resulting in absence of homo-
FRET and monomeric receptor species in blue-native PAGE.  
Initially, a study by Himanen and colleagues discovered the physiological ephrinA5-EphB2 
interaction which also caused growth cone collapse in hippocampal neuronal cultures 
resembling the AP1887-induced collapse of my study [70]. Although genetic evidence is still 
missing, cross-subclass Eph/ephrin interactions, such as the one described between EphB2 
and ephrinA5, are likely to be involved in important steps during development and are thereby 
of physiological relevance. AP1887-induced clustering of altered quality generating very 
similar cellular responses as ephrinA5-induced clustering may be likewise of biological 
significance. It may be speculated that low quality clustering is most likely not a general 
phenomenon of the Eph signaling system. Rather it is constrained to a relatively small but 
strategic subset of Eph/ephrin signaling scenarios in vivo. 
 
4.2.3 Eph clustering is an analog‐to‐digital converter for signaling 
 
The above discussed findings about quantitative and qualitative Eph clustering imply the 
introduction of an analog-to-digital converter concept for Eph signaling. Typically, an analog-
to-digital converter (ADC) is an electronic device that converts a continuous analog quantity, 
i.e. voltage or current to a discrete time digital representation as number proportional to the 
magnitude of the input [335]. Thus, digitization is the process of approximating a continuous 
range of values using a finite set of discrete values or quanta. 
Implementation of an ADC for Eph clustering requires certain characteristics of the signaling 
system, which are as follows. Firstly, Eph clustering in cis was proven to be sufficient for 
signaling, accentuating clustering as the solely critical and necessary step in inducing Eph 
signaling. Secondly, Eph signaling was shown to correlate to clustering in two ways - on the 
quantitative level depending on cluster size distributions and on the qualitative level 
depending on cluster stability. In clustering, considered as ADC device, the continuous analog 
input from various determinants, as for example ephrin ligand concentration, may be 
converted into a discrete digital representation, the respective clustered state, represented by 
cluster size and/or cluster quality, which will in the end solely determine an intracellular, 
kinase-dependent signaling response (Fig. 4.2). 
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Fig. 4.2 Clustering as analog-to-digital converter of Eph signaling. 
Ephrin engagement by Eph receptors produces discrete clustered states at sites of cell contact (left 
cartoon). These clustered states represent cluster size distributions of a certain cluster quality derived 
from multichannel analog inputs. Clustering may thereby be interpreted as an analog-to-digital 
converter to produce a uniform digital output. The conversion of analog signals into digits is computed 
as indicated by operators, however, only exemplary and vaguely based on experimental results. 
 
 
Similarly, this concept was previously proposed for Ras-mediated EGF receptor signaling. 
Ras proteins are small GTPase molecular switches, which sit on membranes and, following 
activation by cell surface receptors, act as adaptors that recruit and facilitate activation of a 
wide variety of effectors [336]. Activated EGF receptors trigger the formation of Ras 
nanoswitches at the plasma membrane in direct proportion to the external EGF input through 
an unknown mechanism [337]. The plasma membrane thus digitizes analog EGF inputs using 
individual Ras nanoswitches as discrete quanta, functioning as a linear ADC. Ras 
nanoswitches are bistable, thereby functioning in a strictly switchlike ON-OFF mode. As 
already discussed above, a switchlike ON-OFF mode is also conceivable for Eph receptor 
activation. The immediate switchlike jump from low dimer activity, both on the level of 
receptor activation and cellular collapse response, to almost saturating signaling responses 
from [2,3]FKBP cluster size distributions comprising mainly trimers and tetramers is 
strikingly obvious. Similar to the Ras nanoswitches, the quanta of trimers or tetramers might 
then determine the overall signaling output. The digital pulses from individual Eph oligomers 
are then summed to give a final analog kinase-signaling output. However, a graded signaling 
output from single cluster species cannot be excluded due to weakness in resolution of the 
cluster species phosphorylation analysis. Moreover, physiological ephrin-induced cluster 
species might behave differently in terms of receptor activation mechanics. This graded 
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signaling output I accounted for by introducing distinct activation states for specific cluster 
species (Fig. 4.2 - quantitative converter) rather than only two ON-OFF switchlike low and 
high activation steady states.  
Furthermore, I connected a second digitizing converter in series to the first one, which unlike 
the first digitizing converter does not reconsider the quantitative but qualitative aspects of 
clustering, also inherent to clusters as shown by experiments using the low-affinity AP1887 
compound or low-affinity ephrinA5 ligand for EphB2 (Fig. 4.2 - quantitative converter). Both 
digitizing converters then synergize to generate one digital signaling output. Again, the ADC 
in Figure 4.2 is configured by a rather graded computation of both converters, which 
improves the resolution of the digital output. However, other more switch-like ON-OFF 
configurations might also be possible, since resolution of blue-native PAGE analysis did not 
allow an unbiased conclusion. Future in silico analysis of Eph clustering implemented as 
ADC device may generate more confidence in the configuration of the clustering ADC.   
 
What is the benefit of a clustering ADC for Eph biological responses? Eph receptor 
signaling is very much limited to a sub-cellular scale of activation by membrane-bound ephrin 
ligand [33,238]. This stands in contrast to other RTK signaling systems, where receptor 
activation is less spatially restricted due to the soluble nature of ligand stimulators. Eph 
receptor signaling is also required to remain localized to sub-cellular regions and domains to 
mediate proper axon growth cone collapse or boundary formation processes. This situation 
requires a high fidelity of the signaling system to account for fine-tuned spatial cellular 
responses. Fidelity is defined as the similarity between the input (e.g. ephrin ligand) and 
output signals (e.g. kinase signaling). Indeed, an analog-digital-analog circuit relay generates 
a high-fidelity in signal transmission over a vast range of signaling inputs [287]. 
Another benefit of ADC signaling is the robustness of the response, which is a fundamental 
characteristic of all biological systems and is defined as “a property that allows a system to 
maintain its functions against internal and external perturbations” [338]. All biological 
systems are subject to a variety of random disturbances or variations, collectively referred to 
as noise. Eph receptor signaling suffers more than any other RTK signaling system from both 
extrinsic noise (generated external to the system), and intrinsic noise (noise inherent to the 
system itself). Purely analog systems are particularly vulnerable to distortion by noise when 
transmitting the growth factor signal across the membrane. Because of the small fraction of 
activated receptors upon ligand engagement as compared to the whole cell receptor 
population, a two-state signaling mode (cp. section 1.6.1), as observed for singular receptor 
signaling systems would be highly susceptible to intrinsic noise.  
Lastly, one of the most striking features of a digitization step through clustering is the 
possibility to fuse various analog signals into one simple digital output, in a process of 
integration. Indeed, Eph/ephrins comprise the largest subgroup of all RTKs with high 
combinatory cross-specificity between subtype Ephs and ephrins. In terms of evolutionary 
aspects, it is therefore conceivable that the system had to invent a strategy to compute various 
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analog signals of different quality and strength into one single output, namely kinase activity. 
Other more cell-specific analog signals may also be integrated to finally produce the 
Eph/ephrin system’s graded signaling nature. 
In summary, the beauty of the ADC concept relies on its simplicity to integrate various analog 
signals in one robust digital output. Clustering ensures a high fidelity of response which 
enables graded, kinase-dependent signaling.   
 
4.3 Clustering is a mechanistic relay for Eph receptor kinase activation 
 
Clustering may be considered as an analog-digital converter to produce discrete digital 
outputs to cause graded kinase-dependent Eph signaling. However, the question, how this 
digital output is reconverted into an analog signal, which may be interpreted by the cell 
through downstream signaling pathways, remains unsolved so far. In the following 
paragraphs, I offer a model for a digital-to-analog converter, which is intrinsic to the 
mechanism of kinase activation of Eph receptors and allows for graded signaling responses.  
 
Role of Eph oligomerization. The importance and possible role of Eph clustering for 
activation of signaling responses may be considered e.g. in direct comparison to kinase 
activation of other RTKs like EGFR to point out valuable functional features for Eph 
dimerization and oligomerization. 
The current activation model of the EGFR predicts that binding of EGF results in 
dimerization of the EGFR, leading to the allosteric activation of the intracellular tyrosine 
kinase [17,339]. Although EGF binding and dimerization seem to be strictly connected, both 
microscopic and biochemical studies have demonstrated that in resting cells, the receptor is 
already found on the cell surface as non-active dimers, the so-called predimers 
[21,22,328,340-347]. Recent structural data also showed that the dimerization of the C-
terminal part of the kinase prevents kinase activation and represents a mechanism through 
which the EGFR tyrosine kinase is inhibited in resting cells [18]. For Eph receptors, the pre-
existence of such dimers might also be the case and has been suggested previously for rising 
Eph surface densities [80,106]. EGFR predimers must be inter-converted into functional 
dimers through EGF binding which re-orientates and re-positions the intracellular kinase 
domains of two EGFRs to enable full signal amplification in an ON-OFF mode. By contrast, 
full kinase signal amplification cannot be observed for Eph dimer formation, however, Eph 
receptors engaged in dimer species are activated to a small degree (this study).  
Full Eph receptor activation is obtained upon higher-order clustering, which is permissive for 
full signal amplification and caused by ligand engagement. Recently a new study, which also 
used homo-FRET imaging to visualize oligomerization states, showed that EGFR also 
oligomerizes but that in contrast to Eph receptors, kinase activity is required to enable this 
process [327]. However, EGFR dimerization and oligomerization led to receptor 
internalization. This indicates a fundamental difference in the mechanistic and functional role 
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of oligomerization of both receptors. For Ephs, oligomerization may be seen as an overriding 
control, which acts as a mechanistic relay to cause kinase activity in a very sensitive manner, 
whereas for EGFR, oligomerization is not permissive but a secondary effect of receptor 
activation. In the latter, oligomerization may enhance catalytic substrate turnover through an 
enzymatic/substrate concentration effect [348]. For Ephs, this effect might also be true, but of 
subordinate role. More importantly, Eph receptors excel by their unique kinase activation 
mechanism, which was outlined in detail in section 1.3. Kinase activity is mainly controlled 
by JM tyrosine phosphorylation. However, this phosphorylation event does not result in an 
ON-OFF switch of kinase activation. Latest structural studies using NMR-technology also 
suggested that a further change in conformational dynamics underlies kinase activation. 
Kinase activity is therefore likely to be governed by a shift in the thermodynamic equilibrium 
between an open and closed kinase conformational state. This may serve as an analog signal 
which determines a graded kinase activity acting on downstream signaling effectors like Src 
or ephexin.  
My work with the constitutively kinase-active eeEph receptor provides a more detailed insight 
into the kinase activation mechanism and its link to clustering. Although the opposite was 
published for neuronal cultures [113], eeEph receptor kinase activity could further be 
enhanced by clustering using the [2,3]FKBP-system in cell culture. Moreover, this increase in 
kinase activity came along with a remaining ability to induce cell collapse upon dimerizer 
application. These results suggest that eeEph receptors are only partially constitutively-active 
and are corroborated by findings of the Sicheri lab. A Tyr750Ala EphA4 mutant also showed 
an increased kinase activity again pointing to the fact that kinase activity may be further 
increased for eeEphA4 by abrogation of further structural constraints [107,112]. However, 
adaptiveness of eeEph receptor kinase activation was lost in response to differences between 
2FKBP and 3FKBP cluster size distributions. This loss in adaptiveness was also observed in 
knock-in mice for eeEphA4, which only displayed a defect in thalamocortical mapping, where 
adaptive, gradual signaling was perhaps necessary to establish proper innervation [113]. 
In summary, the constitutively kinase-active eeEph receptor provides a deeper insight into 
kinase activation. Apparently, abrogation of JM structural constraints does not lead to a fully 
constitutively kinase-active Eph receptor. Additional structural constraints and an underlying 
thermodynamic equilibrium are additional regulators, representing Eph-intrinsic screws for a 
graded control of Eph kinase activity.  
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Fig. 4.3 Clustering serves as mechanistic relay for kinase activation by causing a 
macromolecular crowding effect. 
(A) Eph kinase activation comprises phosphorylation of key residues in the JM segment and an 
underlying thermodynamic equilibrium between an open and closed kinase conformation. Clustering 
limits spatial freedom of receptors engaged in different cluster species of different quality. The thereby 
exerted molecular crowding effect may govern the conformational equilibrium to enhance kinase 
activity. This process may be interpreted as a digital-to-analog conversion to account for graded 
kinase signaling responses. (B) Receptors engaged in cluster species from monomers to tetramers 
experience different degrees of spatial freedom (indicated by grey areas).  
 
 
Clustering produces a macromolecular crowding effect governing kinase activity (Fig. 
4.3 & 4.4). In review of my results and present literature, I propose that clustering causes a 
shift in the thermodynamic equilibrium between an open, kinase-active and a closed, kinase-
inactive conformational state, which is provoked by a macromolecular crowding effect caused 
by clustering (Fig 4.3A).  In this sense, bigger or more stable clusters, digitized as discrete 
clustered states, simply cause the Eph intracellular domain to spend more time in the 
catalytically competent conformation.  
For other RTKs, which display full signal amplification upon dimerization, the mechanistic 
component of action is more likely to function in an ON-OFF mode, e.g. through reorientation 
of inter-structural relationships between neighboring receptors snapping into a static 
conformation (e.g. EGFR). For Ephs, I propose a rather gradual transition to an active state 
governed by a thermodynamic equilibrium between an open and closed kinase conformation.  
The underlying phenomenon of this shift of the thermodynamic equilibrium to the competent 
catalytic conformation may be a macromolecular crowding effect that limits the spatial 
freedom of each receptor molecule (Fig. 4.3B). Thermodynamic equilibria may be governed 
by crowding conditions in living systems, like the cell cytoplasm or membranes, which 
contain high concentrations of high-molecular-weight components that occupy a substantial 
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part of the volume of the medium [349]. Biochemical processes therefore proceed in a 
medium containing high concentrations of macromolecules (50-400 mg/ml) with 
concentrations of single macrosolute species being not so high. In fact, macromolecular 
crowding is more accurately termed “the excluded volume effect” because its most basic 
characteristic is the mutual impenetrability of all solute molecules. While macromolecular 
crowding is a well-established concept in enzyme kinetics changing the thermodynamic 
reaction equilibria and reaction rates, effects on conformational transitions have also been 
described lately [350,351]. Crowding affects the equilibria and transition rates between open 
and closed conformations of enzymes including kinases like adenylate kinase [350].  
 
  
Fig. 4.4 Eph/RTK enzyme kinetics. 
The activation process may be divided 
into two receptor transitions based on 
the known underlying mechanisms for 
Ephs, which undergo multimerization, 
and other RTKs, which undergo 
dimerization for full activation. The first 
transition represents a conformational 
change to a kinase-active con-
formation. For RTKs this transition is 
thought to occur in a rather ON-OFF 
switchlike mode, while for Ephs this 
transition may occur gradually. The 
change to an active kinase con-
formation may be governed by a rather 
ligand-independent thermodynamic 
equilibrium between two states 
(entirely receptor-mediated activation) 
or by a specific ligand-dependent 
conform-ational re-configuration (e.g. 
as for EGFR). While for RTKs 
dimerization or conformational re-
configuration will already result in 
complete transition to the kinase-active 
state, Eph activation is initially only 
governed by the thermodynamic 
equilibrium, which may be affected by 
a macromolecular crowding effect. The crowding effect may be taken into account by the non-ideality 
factor ψ [351]. For eeEph receptors, the conformational equilibrium (Kconf) is shifted to a more open 
kinase conformation. The second transition typifies as autophosphorylation reaction of RTKs and 
Ephs. This reaction is determined by the intrinsic kinase activity of the receptor  (kcat) and the cell’s 
phosphatase activity (kdephos) and results in the autocatalytic loop of RTK/Eph activation. For all RTKs 
a leakage in the activation mechanism is observed which is constantly opposed by phosphatase 
activity resulting in a low activation steady-state. kact (forward) and kdeact (reverse) are conformational 
transition rates for dimerizing RTKs, kopen (forward) and kclose are conformational transition rates for 
multimerizing Eph receptors. 
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Results from eeEph constitutively kinase-active receptor studies also support the rationale for 
a molecular crowding effect governing a thermodynamic equilibrium between an open and 
closed kinase-active state. The residual ability of the eeEph receptor to adapt an increased 
kinase-active state upon clustering could in parts rely on the fact that the constitutive activity 
did not reach 100% prior clustering and that clustering, i.e. molecular crowding, provoked a 
further shift in the equilibrium to a more open conformation. 
 
4.4 Eph clustering serves as the central integrator to elicit appropriate 
kinase‐dependent signaling responses 
 
This study reports that kinase-dependent cellular responses strictly correlate to Eph receptor 
clustering over several steps in the Eph signaling cascade, highlighting Eph clustering as 
higher-order control entity to elicit appropriate cellular responses. Clustering of Eph receptors 
is suggested to function as an ADC generating a uniform digital output, which after 
reconversion is “dumped” into the cell and produces a respective kinase-dependent signaling 
response. Interestingly, clustering, i.e. the ADC, may be able to integrate analog signals of 
different origin and quality, e.g. high-affinity extracellular ligand binding and low-affinity 
intracellular adaptor protein binding. The clustering ADC would then also serve as a central 
integrator of all receptor activation determining analog inputs. Thus, I reasoned that 
simultaneously to analog-to-digital conversion, clustering may serve as a central integrator to 
elicit appropriate kinase-dependent signaling responses through integration of various 
clustering determinants. 
The FKBP/dimerizer system made it possible to test for this integrative feature of analog 
signals for Eph clustering. The Eph oligomerization state was manipulated from the 
intracellular side of the receptor and probed for integration with extracellularly applied 
clustering stimuli and subsequent cellular responses. Indeed, I provide direct evidence that 
manipulation of Eph oligomerization by intracellular forces alters the sensitivity of the cell 
towards extracellular ephrins. EphB2 dimerization and sub-threshold ephrinB2-Fc stimulation 
synergized to induce EphB2 autophosphorylation and cell collapse. Conversely, EphB2 
monomerization (by steric hindrance) blocked ephrinB2-Fc-induced kinase signaling and cell 
collapse. Intrinsic and extrinsic clustering forces are thus interconnected, resulting in an 
overall clustered state, which represents the digitized output of a multichannel analog input 
(Fig. 4.5 & 4.6).  
 
 
Fig. 4.5 Possible scenarios of analog signal integration based on the model approach using the 
FKBP/FRB-clustering system. 
(A) Positive integration of clustering determinants. Extracellular and intracellular analog signals may 
act simultaneously on Eph receptors and synergize to produce a uniform output, i.e. in a respective 
phosphorylation (P) activation state of the receptor. (B) Negative integration of clustering 
determinants. Eph interaction partners may also negatively integrate to produce an alleviated 
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clustered state (arrows) with a lower phosphorylation activation state (as indicated by SAM domain 
adaptor protein binding). Moreover, steric interference may also result in total impairment of the kinase 
activation mechanism thereby silencing the digital-to-analog conversion (as e.g. in the case of Eph 
kinase-null variant co-clustering).  
 
 
Can adaptor proteins represent an analog signaling component (Fig 4.5A)? Regulation of 
intrinsic Eph clustering may be carried out by multi-domain proteins that both bind the 
cytoplasmic region of the Eph and have the propensity to scaffold the receptors. Interaction of 
EphB2 with the multi-PDZ-domain adapter protein GRIP has previously been shown to 
regulate reverse signaling of ephrinB3 at specific hippocampal synapses [352]. Although the 
composition of EphB2 clusters was not analyzed in that study, it is conceivable that the 
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interaction with GRIP-preclustered EphB2 sensitizes the cells for the trans-interaction with 
ephrinB3. An earlier study identified other PDZ-adaptor proteins, among those are GRIP and 
PICK1, for direct interaction with EphB2 [151]. While PICK1 was clearly shown to be 
phosphorylated upon binding to EphB2, the activation status of EphB2 was not addressed. 
Here I was working to bridge this gap by testing GRIPs and PICK for their propensity to 
activate EphB2 when co-expressed. In fact, co-expression leads to autophosphorylation of 
EphB2 indicating receptor activation and possibly priming, i.e. preclustering of the EphB2 
receptors similar to the experimental situation using the 1FKBP receptor isoform preclustered 
with AP20187. This re-examination of PDZ-adaptor protein binding with regard to the 
activation state of the EphB2 receptor accentuates the physiological relevance of such an 
integrative signaling mechanism computed into the clustered state. Cytosolic adaptor protein 
concentration may therefore, in addition to an external ephrin stimulus, represent an 
underlying analog input to the clustering ADC, which eventually alters the digital signaling 
output and downstream signaling responses. 
 
Negative integration of clustering determinants (Fig. 4.5B). The clustering ADC may also 
serve as integrator in a negative sense meaning that adequate analog signals also deliver a 
negative component to the cumulative signaling response. More precisely, they might act 
through graded attenuation of clustering thereby reducing the crowding condition within the 
cluster they affect. Even more, physical Eph receptor interaction and steric interference 
through intimate co-clustering with e.g. Eph kinase-null receptors may totally impair the 
kinase activation mechanism and act in a rather ON-OFF kind of manner as dominant-
negative effectors to shut down the DAC for kinase activation completely.  
To also investigate these negative modes of regulation by surrounding determinants, I set up a 
model approach based on the inhibition by steric hindrance using an artificial intracellular 
inhibitor construct. Kinase activity and cellular collapse were abrogated in the presence of 
heterodimerizer AP21967. On the mechanistic level, ephrinB2 binding to the Eph LBD is not 
affected, presumably causing the constitution of an intact extracellular clustering platform 
irrespective of the intracellular steric interference (data not shown). Intracellularly, the 
inhibitory construct is assumed to keep Eph receptors at a distance from each other through 
FRB-FKBP domain coupling to the inhibitory construct. The intracellular cluster platform 
must therefore be impaired resembling an apparent “monomerized status” of Eph receptors. 
The model approach can only be validated as a proof of principle of the postulated concept. 
However, literature delivers various implications for validation of this model approach, 
elaborated as follows.  
Adaptor proteins may indeed reduce signaling from Eph clusters by acting as spacers between 
single Eph monomers to produce the same mode of inhibition as for myr-FRB-mCherry. A 
hot candidate region, which might serve for interaction with adaptor proteins is the SAM 
domain. SAM domains of Eph receptors revealed a mechanism for modular dimerization 
[99,101]. This finding led to the speculation that Eph receptors may recruit signaling partners 
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through heteromeric SAM-SAM interactions. In fact, SHIP2 and ILK were shown to bind to 
Eph receptor and interestingly enough act on it in a rather inhibitory mode by opposing cluster 
internalization or promoting cell spreading rather than collapse [155,156]. Whereas active 
signaling links were established to pathways involving integrin- and Rac-signaling, now in 
reflection of the here presented results, passive Eph receptor silencing through steric 
interference might also play a significant role in inducing those specific signaling responses.  
A more evident form of cis-inhibition based on steric hindrance or “apparent intracellular Eph 
monomerization” is the formation of mixed clusters of full-length EphA7 or EphA2 and the 
C-terminally truncated or soluble EphA7 splice form, respectively, which act as dominant-
negative constructs on downstream signaling events [171,353]. A similar mode of interaction 
is seen for kinase-null EphB6 receptors which are proposed to heterodimerize with EphB4 or 
EphB1 and thereby become trans-phosphorylated [169,354,355]. Interestingly, this 
heterodimerization or formation of mixed clusters upon ephrin engagement is accompanied by 
a switch to rather adhesive signaling. It can thereby be speculated that the formation of mixed 
clusters incorporating kinase-dead receptors presumably produces a lower signaling potency 
of the paired EphB1 or EphB4 receptors. Again, steric interference or alleviation of the 
crowded clustered state could play a significant role and be an underlying mechanistic 
component for the functional consequences observed. Whereas these kinase-signaling 
deficient Eph receptors quite consistently antagonize their signaling potent interacting partner 
in cis, heterotypic and physical interactions between Eph receptors and other receptor families 
do not draw a clear antagonistic picture of signaling action [192]. However, for many other 
receptor cross-talk scenarios physical protein interactions are still unknown and signaling 
might only intersect on downstream mediators. Furthermore, the origin of signaling is often 
not assigned to either receptor species exclusively. The Eph receptor might function as a 
modulator for the other receptor and not be antagonized upon its own signaling potency.  
Cis-interactions of  Ephs and ephrins are also known to reduce Eph signaling [103,199-201]. 
However, how cis-interacting ephrins reduce Eph signaling was to date unknown and was 
only speculated upon to rely on steric interference [32]. This study now provides direct 
evidence for a possible steric interference mode of signaling inhibition for Eph receptors, 
thereby deactivating the analog-to-digital convering properties of Eph clustering.  
 
Adhesive versus repulsive Eph signaling responses (Fig. 4.6). In retrospective of the 
discussed results, Eph kinase-dependent signaling responses seem to be strictly controlled by 
receptor clustering.  
Furthermore, clustering serves as integrator for various analog signals, computed into one 
digital output, which is then reconverted into graded kinase-signaling. Kinase-dependent 
signaling responses almost always result in cell repulsion or contraction of the cell periphery. 
However, adhesive cellular responses have also been observed for Eph/ephrin signaling in 
vivo [30]. They are either mediated by specific kinase-dependent signaling through the 
integrin pathway or kinase-independent “cell surface” signaling through high binding 
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affinities between Ephs and their cognate ephrins [161,162,164-167,290]. Whereas kinase-
dependent adhesion may only apply to a subset of Eph signaling scenarios, kinase-
independent adhesion is intrinsically present in all Eph/ephrin signaling scenarios. I have 
addressed the mechanistic aspects underlying the switch from repulsive to kinase-independent 
adhesive signaling responses by the use of the inhibitory FKBP/FRB-system performing a co-
culture assay with HeLa cells. In fact, steric interference disabled the digital-to-analog 
conversion to kinase activity resulting in a switch to adhesive signaling responses marked by 
e.g. filopodia sticking to the adjacent ephrin-expressing cell. 
In consequence, adhesive versus repulsive cellular responses may be gradually balanced 
through the integrative computation of analog signals by the clustering ADC. In very severe 
cases, steric interference may also lead to total impairment of the DAC for kinase activity and 
result in a complete switch to cell adhesion.  
 
4.5 Eph steady‐state signaling network 
 
Eph receptor signaling induced cellular responses are not the mere isolated response to 
receptor activation by clustering but the cumulative outcome of an in vivo network 
configuration, which underlies the Eph signaling system and is specific to the cellular 
background. In all cells, Eph kinase modules are tightly controlled by positive and negative 
feedback loops, in addition to an intrinsic self-enforcing autocatalytic feed-forward loop. 
Moreover, independent of Eph activation, a constant negative phospho-signaling regulation 
by phosphatases is a feature of inherent cell homeostasis, which might differ in activity levels 
in different cell types. For instance, PTP1B was shown to constitutively regulate EphA3 
activity [176]. In my study, the autocatalytic feed-forward loop became visible in biochemical 
autophosphorylation assays using weak clustering stimuli like the low-affinity homodimerizer 
AP1887 or ligand ephrinA5 for EphB2. In contrast to the high-affinity homodimerizer 
AP20187, AP1887 produced a delay in the autocatalytic feed-forward loop of receptor 
activation (cp. Fig. 4.4). Absolute substrate phosphorylation levels were significantly higher 
for the constitutively kinase-active eeEph receptors as compared to wildtype receptors but 
eeEph-expressing cells were not affected by constitutive kinase-active signaling. This 
indicates a negative feedback loop on downstream kinase signaling targets, which desensitizes 
the cell to the constant higher level of kinase signaling. A clustering stimulus would then 
indeed cause a further enhancement of kinase activity but the cell would only be capable to 
respond towards the relative change in kinase activity - and not to the absolute state of 
receptor kinase activity. This effect may be seen in the reduced cell collapse response upon 
clustering of eeEph receptors. 
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Fig. 4.6 Clustering as the central integrative device for Eph signaling. 
Model depicting the computation of clustering determining multichannel analog signals which are 
transmitted into kinase activity by an analog-to-digital-to-analog conversion process through clustering. 
In the case of steric interference, which results in full impairment of the kinase activation mechanism, 
kinase-dependent repulsive signaling will convert into kinase-independent passive adhesion. A 
possible selection of analog signals is presented without claim to be complete. Eph-ephrin trans-
interactions: color code of line indicates binding affinities (red: Kd > 5 nM; orange 1 nM < Kd < 5 nM ; 
green Kd < 1 nM according to [70,356]; Eph-ephrin cis-interactions: red lines indicate cis-inhibition of 
Eph receptors between ephrinAs and EphAs and ephrinBs and EphBs respectively; Eph-Eph cis-
interactions: red lines indicated cis-inhibition between Eph receptors. A7splice = truncated splice form 
of EphA7 co-expressed with full-length EphA7. EphB6 is kinase-null. Adaptor proteins: heterotypic 
SAM-SAM domain interactions to adaptor proteins may be implicated in negatively regulating Eph 
receptor signaling. PDZ-adaptors are implicated in preclustering of Eph receptors and thereby priming 
them; cell-specific clustering determinants like lipid composition may also have an impact on 
clustering. 
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It is conceivable that integration of all negative and positive feedback loops together with 
receptor kinase activation upon clustering may result in a cumulative Eph signaling network 
response (Fig. 4.7). Prior to ephrin engagement, the Eph signaling network is kept on a low 
activation level in steady-state. This is accomplished through a permanent negative regulation 
of Eph receptor kinase activity leakiness by phosphatases. By contrast, the eeEph signaling 
network settles down on a much higher activity level in steady-state due to the constitutively 
kinase-active state of the receptor mutant. Clustering enhances Eph kinase activity 
instantaneously leading to a temporary distortion of the Eph signaling network steady-state of 
activation. Simultaneously, clustering may even have the ability to suppress a negative 
regulation of phosphatases by spatial exclusion from clusters. The Eph signaling network 
immediately tries to re-establish the initial pre-stimulation state and swings into a new steady-
state of activity. This phase became obvious in cell collapse assays, when a cellular re-
spreading process jumped in after reaching a maximal amplitude of collapse. Moreover, 
quenching of clustering in phase I of the cell response pattern (Fig. 4.7) resulted in a weaker 
collapse and faster adaption to a new steady-state. Negative feedback loops are most likely 
enhanced upon Eph receptor activation to accomplish this process.  
 
 
 
Fig. 4.7 Steady-state of activation of 
the Eph receptor signaling network. 
Curve graph delineates the cellular 
response pattern of Eph receptor-
expressing cells over time. Arrows 
indicate underlying configurations of 
the signaling network (PTP- 
phosphatase activity; receptor inter-
nalization; negative feedback loops of 
downstream signaling cascade; Eph 
autocatalytic feed-forward loop; 
clustering; possibly more), which  are 
constitutively active or are induced 
upon Eph clustering. The Eph receptor 
signaling network may be specifically 
configured (indicated by tachometer) 
according to cellular background 
and/or Eph intrinsic/extrinsic de-
terminants such as constitutive kinase 
activity (eeEphB2) or a weak 
(AP1887/efnA5) or strong (AP20187/ 
efnB2) clustering stimulus. (?) indicates 
a possible enhanced (*) PTP-activity 
upon receptor clustering. 
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Moreover, Eph receptor internalization, which is specific to receptor activation, likely 
represents an opposing force to receptor signaling and thereby supports negative feedback 
loops. Inhibition of Eph internalization was indeed shown to abrogate the re-spreading 
response [133]. Theoretically, additional phosphatases may also be activated upon Eph 
activation, which would also counteract Eph signaling and help in re-establishing the initial 
pre-stimulation state. 
 
4.6 Eph clustering produces diffusion‐limited spatial signaling entities 
redistributed to the lateral cell edge 
 
RTK signaling in general, but also Eph signaling in particular is influenced by trafficking and 
processing prior and posterior to receptor activation [10,235]. Irrespective of its effect on Eph 
receptor signaling, I studied the effect of clustering on the distribution, movement and 
processing of Eph receptors. Prior to ligand engagement, Eph receptors are transported to the 
cell surface plasma membrane by guided vesicle transport, most likely along microtubules 
(this thesis and [251]). Indeed, the discovery that the microtubule motor protein KIF5 (also 
known as kinesin 1) interacts with a region of GRIP1, also established as scaffolding protein 
for Eph receptors, indicates an anterograde microtubule transport mechanism for Eph 
receptors [151,251,357]. Eph receptors, finely distributed in the membrane prior to ligand 
engagement, display surprisingly high density fluctuation rates as visualized by TIRF 
microscopic analysis. A more profound analysis using fluorescence correlation spectroscopy 
and/or FRAP (fluorescence recovery after photobleaching) may help to determine actual 
diffusion rates in future studies and confirm these preliminary implications. Immediately after 
clustering, spatially static Eph receptor accumulations emerged at sites where the stimulus 
could access the cell surface plasma membrane. Cluster accumulations were stable for an 
extended amount of time but then degraded in a process, which is most likely due to specific 
Eph receptor internalization.  Interestingly, signaling entities also rapidly re-distributed to the 
lateral cell edge in a strict cluster size-dependent manner. Based on cell geometry concepts, 
the strong membrane curvature at the lateral cell edge may produce a membrane division of 
limited diffusion, which leads to Eph receptor cluster accumulations. 
Strikingly, redistribution of Eph receptor signaling entities to the lateral side of the cell may 
serve an important role for Eph receptor spatial signaling properties. In contrast to many other 
signaling systems which have not implemented clustering mechanics for themselves, the 
Eph/ephrin signaling system requires a high sub-cellular spatial resolution for signaling in 
order to meet the needs for guided repulsive responses such as axon growth cone guidance or 
cell sorting into different domains. Triggers for contractions of cell protrusions, such as Eph 
signaling entities, must specifically act at the lateral cell side to be able to directly and locally 
affect actin cytoskeleton dynamics. In this respect, clustering may then indirectly serve as a 
means to re-distribute activated Eph receptor signaling entities to sub-cellular sites where 
local signaling is required to mediate contractive cell responses.  
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4.7 Outlook 
 
Eph receptor clustering. This study has provided a deeper insight into the RTK-unique 
feature of Eph receptor clustering and its functional importance for signaling. Addressing 
oligomerization processes of proteins in living cells is by no means an easy and 
straightforward task. Thus, this work can only build the fundamental basis for further and 
more detailed studies - solidifying the here offered analog-to-digital converter model for 
clustering and bringing trafficking aspects of Eph receptor clustering into sharper focus. In 
ongoing, preliminary work I deal with a computational modeling approach to simulate the 
clustering ADC thereby corroborating experimental results.  
Only little is also known about the intracellular vesicular pathways upon Eph internalization. 
Fractions of smaller clusters might be differentially trafficked and recycled in Rab11-positive 
compartments, whereas fractions of bigger clusters would follow the degradative sorting 
pathway to lysosomes.  
Mechanistically, I propose clustering to be a relay for kinase activation by causing a 
macromolecular crowding effect, which may shift an underlying dynamic equilibrium 
between a closed and open kinase conformation. Based on the here presented results and 
implications from other studies, this model seems plausible. However, direct proof is missing. 
To obtain more definitive insights into the mechanism of Eph activation, structures of full-
length Eph receptors or Eph kinase sensors would be necessary. The system of dimerizer-
inducible cluster formation has proven to be a powerful tool. It is therefore conceivable to 
implement this system in further ex vivo and in vivo studies, in model organisms like zebrafish 
or mouse.  
 
Role of Eph receptor clustering. Clustering of bacterial chemotaxis receptors has been 
studied over decades suggesting a whole list of advantages for the signaling system [267,286]. 
While some may be intuitively mapped onto the Eph signaling system, others remain 
questionable if they also apply for Eph receptor clustering. Furthermore, bi-directional 
signaling and co-clustering of the cognate ephrin ligand in the opposing cell complicates the 
signaling scenario and may prevent a one-to-one analogy to other signaling systems.  It is 
therefore difficult to identify the specific, counter-intuitive advantages of the Eph signaling 
system. Three of them were proposed in this study: high fidelity, robustness and the 
possibility to integrate multiple analog signals. Others, like a heightened sensitivity of the 
signaling receiver are rather intuitive. Future studies will most likely contribute further pieces 
to the big puzzle about the role of Eph receptor clustering for signaling processes.  
 
Therapeutic implications of receptor clustering. Mechanistic to functional studies of 
RTKs, involved in cancerogenesis, are generally of broad interest in pursuing new therapeutic 
strategies for signaling inhibition [358]. Therapeutic antibodies belong to the most promising 
new-age therapeutics of cancer biology. Their mechanisms of action range from induction of 
 
131 
 
DISCUSSION 
apoptosis (e.g. Rituximab, Genentech/Roche) to competing for binding with ligand molecules 
(e.g. Trastuzumab, Genentech/Roche). It is therefore absolutely necessary to understand the 
target on a mechanistic to functional basis. This study delivers important insights into receptor 
mechanics and underlying signaling function. As an example of a way to suppress signaling, 
Eph receptors must be targeted in a way, which would keep them in their monomeric 
configuration, as it is the case for receptor inhibition via the myr-FRB-mCherry inhibitory 
construct used in this study. 
 
Ephrin ligand clustering. Although the FKBP/FRB-system was also implemented for 
ephrins, Eph clustering has been the main focus of this study. Preliminary results point to the 
same benefits of the FKBP/FRB-system for studying ephrin clustering. Initial experiments 
demonstrated similar outputs for the dimerizer-induced and Eph-induced ephrin signaling 
responses and clustering seems to tightly correlate with internalization responses. The ephrin 
signaling pathway has not been studied in this context, which remains for further studies. 
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5. EXPERIMENTAL PROCEDURES 
 
5.1 Molecular biology techniques 
 
Expression constructs used in this thesis were either obtained from elsewhere as indicated in 
table 5.2, or cloned using standard molecular biology techniques [359].  
 
Plasmid DNA Preparation. Plasmid DNA was purified from small-scale (4 ml, 
minipreparation), medium-scale (100 ml, midipreparation) or large-scale (250 ml, 
maxipreparation) bacterial cultures. Respective LB0 medium (lysogeny broth medium, 10 g 
Bacto-Tryptone, 5 g Bacto-Yeast extract, 5 g NaCl, autoclaved) volumes were inoculated with 
single colonies picked from agarose plates (1 l LB media, 15 g Bacto-Agar, antibiotic, 
autoclaved) containing 100 µg/ml ampicillin or 50 µg/ml kanamycin and grown overnight at 
37 °C shaking. After centrifugation of the cell suspensions, pellets were resuspended in buffer 
P1 (Qiagen, Hilden, Germany) and stored at -20 °C until DNA preparation. DNA preparations 
were carried out according to the Qiagen protocol using the respective scale-sized kits (27104, 
QIAprep Spin Miniprep Kit; 12163, QIAGEN Plasmid Maxi Kit; 12843, CompactPrep 
Plasmid Midi Kit). 
After preparation, DNA pellets were re-dissolved in a suitable amount of TE buffer (10 mM 
Tris-HCL, 1 mM EDTA, pH 8.0) and plasmid DNA concentration (λ= 260nm) and quality of 
purity (260/280 nm ratio) was determined using the UV spectrometer NanoDrop 2000 
(PeqLab, Erlangen, Germany).  
 
Enzymatic treatment of DNA. Cleavage of plasmid DNA or DNA-fragments for insertion 
was done using digestion with restriction enzymes (NewEngland BioLabs, Ipswich, MA). 
Approximately 2-10 µg of DNA was cut in 20-100 µl of the appropriate restriction enzyme 
buffer and 2-10 units of restriction enzymes for 1 to 2 hrs, or overnight, at the enzyme-
specific temperature. De-phosphorylation of cleaved plasmids with sticky ends was performed 
with calf intestine alkaline phosphatase (713023, Roche Diagnostics, Indianapolis, IN) 
according to the manufacturer’s protocol. Ligations of plasmid backbones and target DNA-
fragments were carried out in an incubation of a 1:1, 1:2 and 1:5 and molar ratio (total 400 ng 
DNA per 20 µl reaction volume) of plasmid and insert with 1 unit of T4 DNA Ligase 
(M0202L, NewEngland BioLabs) in ligase buffer at 4 °C overnight. The next morning, 
ligation samples were either frozen and stored for further use, or 2-5 µl of the mix was 
transformed via electroporation (settings: 25 µF, 2.5 kV, 200 Ω, GenePulser, BioRad, 
Hercules, CA) into 30 µl electrocompetent E. Coli cell suspension (OneShot Top10, C4040-
52, Invitrogen) and plated on selective agarose plates.  
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Separation of DNA. For separation of DNA on agarose gels, 6x loading buffer (50 % 
glycerol v/v, 1x TAE buffer, 0.2 % w/v Laemmli buffer) was added to appropriate volumes of 
DNA and loaded on a 0.8-2 % agarose gel in TAE buffer (50x TAE: 242 g Tris base, 57.1 ml 
glacial acetic acid, 100 ml 0.5 M EDTA pH 8.0, add H2O 1 l) containing ethidium bromide 
(2218.2, Roth, Karlsruhe, Germany, 6 µl per 100 ml agarose suspension), and run at 120-200 
V for 30 min to 2 hrs. After electrophoresis, the gel was scanned in the transilluminator on a 
UV light box and printed. For preparative agarose gel, electrophoresis bands of interest were 
excised with a clean, sharp scalpel and purified using the QIAquick Gel Extraction Kit 
(28704, Qiagen) according to the manufacturer’s protocol. The resulting extracted DNA was 
redissolved in sterile, distilled water.  
 
DNA Purification. Small-scale DNA purification steps were carried out following restriction 
digests or de-phosphorylation using the QIAQuick PCR Purification Kit (28104, Qiagen) 
according to the manufacturer’s protocol. For purifications followed by restriction digests, 
columns were rinsed with 70 % ethanol (v/v) in water, in addition to the washing steps, to 
remove any residual salt, which could interfere with restriction enzyme reaction conditions. 
DNA was eluted from columns in pure water.  
 
Mutagenesis. For site-directed mutagenesis, the QuikChange II XL Site-Directed 
Mutagenesis Kit (200521, Stratagene, La Jolla, CA) was used. Mutagenesis primers were 
designed using an online tool (http://labtools.stratagene.com/QC) provided by the 
manufacturer. All steps were carried out exactly as outlined in the manufacturer’s protocol. 
 
Polymerase chain reactions. For production of inserts used for cloning, polymerase chain 
reactions (PCRs) were performed using respective templates and primers as indicated in 
tables 5.1 and 5.2. Template (100 ng), primers (0.2 µM each), nucleotides (1 mM of NTP 
mix), 1x polymerase reaction buffer, and sterile, distilled water to give a final volume of 50µl 
were mixed on ice in PCR tubes. PfuUltra High-Fidelity DNA Polymerase (2.5 units, 1 µl; 
600385, Stratagene) was added last and the reaction mixture was kept on ice until the start of 
the cycle. PCR parameters comprised an initial hot start denaturing step of 95 °C for 2 min, 
followed by 30 cycles of double strand DNA denaturation, primer annealing and chain 
extension. Denaturation was performed for 1 min at 95 °C. Annealing temperatures were 
chosen to be between 3- 5 °C below calculated annealing temperatures for respective primer 
pairs (53- 68 °C) and kept for 30 s. Depending on the target-size of the amplified DNA-
fragment, chain extension was performed for 1 min/kb DNA at 72 °C. After finishing the 30 
cycles, the PCR-program entered a final 10 min chain extension period of 72 °C before 
cooling the reaction to 10 °C. For identification of possible positive clones from ligations, 
either restriction digests with subsequent analytical agarose gel electrophoresis from 
minipreparations were performed, or a bacterial colony-PCR was used. For colony-PCR, T4-
Taq Polymerase (M0267L, NewEngland BioLabs) was added to a mix of the respective PCR 
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reaction buffer, primers and NTPs to give a master-mix without template DNA. Single 
colonies were then picked from agarose plates with a tip and replicated onto another agarose 
plate for later use. In parallel, the same tip was used to inoculate the aliquoted master-mix 
samples with template DNA. After PCR, possible positive clones were then identified by 
assessing correct band patterns using agarose gel electrophoresis. Finally, true positive clones 
were identified by sequencing [360]. 
 
In vitro RNA transcription was carried out using the SP6 mMessage mMachine 
Transcription Kit (Ambion, Austin, TX) according to the manufacturer’s protocol. Briefly, 
DNA (pSFVwtEphB2-xFKBP-YFP and pSFVhelper) was linearized using the restriction 
enzyme SpeI. The plasmids were then purified using a standard phenol/chloroform extraction 
[361,362] and 100-200 ng were then used as template for transcription under standard 
conditions. RNA was precipitated using the LiCl solution provided in the kit. It was then 
resuspended in nuclease-free water and analyzed for correct size and integrity by agarose gel 
electrophoresis.  
 
5.2 Plasmids and cloning strategies 
 
Table 5.1 List of oligonucleotides. 
Key for use of oligonucleotides: C, Cloning; M, mutagenesis; S, sequencing; L= linker oligonucleotide; 
SG, synthetic gene. For PCR-primers, annealing temperatures were calculated using an online tool 
(http://www6.appliedbiosystems.com/support/techtools/calc/). 
 
Name Oligonucleotide Sequence (5’  3’) Use 
EphB2-1Fv-fwdG TATAGCTAGCGTCTAGTGGAGTGCAGGTGGAGAC    C 
EphB2-1Fv-revCG TATAGGATCCCGACTAGTTTCCAGTTTTAGAAGCTCCAC   C 
t3565g_t3567g GACCCCAGGCATGAAGATCGAGATAGATCCTTTCACCTATG M 
t3565g_t3567g_antisense CATAGGTGAAAGGATCTATCTCGATCTTCATGCCTGGGGTC M 
t3583g_t3585g CGAGATAGATCCTTTCACCGAGGAAGATCCTAATGAGGCAG M 
t3583g_t3585g_antisense CTGCCTCAATTAGGATCTTCCTCGGTGAAAGGATCATCTCG M 
a3566t CCCCAGGCATGAAGATCTTTATAGATCCTTTCACCTA M 
a3566t_antisense TAGGTGAAAGGATCTATAAAGATCTTCATGCCTGGGG M 
a3584t GATCTTTATAGATCCTTTCACCTTTGAAGATCCTAATGAGGCAG M 
a3584t_antisense CTGCCTCATTAGGATCTTCAAAGGTGAAAGATCTATAAAGATC M 
2-5-mchFRB TATAACTAGTTCAGGCATGGTGAGCAAGGGCGAGGAG C 
2-3-mchFRB TATAGGATCCTTAAAGCTTCTTGTACACCTCGTCCATGCCG C 
NT-MemFRB-fwd AATTCATGCTGTGCTGTATGAGAAGAACCAAACAGGTTGAA 
AAGAATGATGAGGACCAAAAGATCGGCTCAAGTGGCATGGCTT 
L 
Nt-MemFRB-rev GAATTCATGCTGTGCTGTATGAGAAGAACCAAACAGGTTGAAAA
GAATGATGAGGACCAAAAGATCGGCTCAAGTGGCATGGCTTCT
AGA 
L 
B2-1Fv-FWD TATATCTAGAACTAGAGGAGTGCAGGTGGAGACTATC C 
B2-1FV-Rev TATA GCGGCCGC CAGTGTGATGGATATC C 
linkSpeI/NotIfwd CTAGTTGAGATATCGC L 
linkSpeI/NotIrev GGCCGCGATATCTCAA L 
1-5-mcherry TATAGGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGA
G 
C 
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1-3-mcherry TATAAAGCTTGTACACCTCGTCCATGCCG C 
EphAfwdNheI TATAGCTAGCGGCAGCGGCGTCCAAGTCGAAACCATTAG C 
EphArevNheI GCTAGCGCCGCTGCTGCCCTTGTACAGCTCGTCCATGCCG C 
pSFVEphB2ectofwd TATAGGATCC ATGAACTTTATCCCAGTCGACATTC     C 
pSFVEphB2ectoFKBPrev TATAGGATCCCGACTAGTTTCCAGTTTTAG C 
pSFVEphB2ectorev TATAGGATCCCGGGCCCGCG      C 
FLAG-FNIIIb-TM-Cyt TATAGATATCGAGGTGTGGCAGGCTTGAGATCTGGCCATACACT
TGAGTGACAATGACATCCACTTTGCCTTTCTCTCCACAGGTGTC
CACTCCCAGGTCCAACTGCAGGCGAGCCTGAATTCTTTCGGGA
CTGTCAGTGAATCCAGAGAAGCTAACATCTATGAACTCTGATTT
GAATACAGGATTCAAGCGTGTACTGGCCTGTTTGGCAGAAAAAT
ATCATTTCTGATCGACGATCATCATGAACTTTATCCCAGTCGACA
TTCCACTCTTGATGATCTTCCTTGTGACAACTGGGGGCTCAGCG
GACTACAAAGACGATGACGACAAGGGGCCCGGCTCAGGGGTG
AACATCACCACCAACCAAGCAGCACCATCGGCCGTGTCCATCAT
GCACCAGGTGAGCCGCACTGTGGACAGCATCACCCTGTCGTGG
TCCCAGCCAGACCAGCCCAACGGTGTGATCCTGGACTACGAGC
TGCAGTACTATGAGAAGGAGCTCAGTGAGTACAACGCCACGGC
CATAAAAAGCCCCACCAACACAGTCACTGTGCAGGGCCTCAAA
GCCGGCGCCATCTATGTCTTCCAGGTGCGGGCACGCACCGTTG
CAGGCTATGGGCGCTACAGTGGCAAGATGTACTTCCAAACCAT
GACAGAAGCCGAGTACCAGACCAGCATCAAGGAAAAGCTACCC
CTCATCGTTGGCTCCTCCGCCGCCGGCTTAGTCTTCCTCATCGC
TGTGGTCGTCATTGCCATCGTATGTAACAGACGGGGGTTTGAG
CGTGCCGACTCAGAGCTAGCTATA 
SG 
CMVfor CGCAAATGGGCGGTAGGCGTG S 
Seq-rev-ephrb2 TTTATGTTTCAGGTTCAGGG S 
Seq-fwd-ephrinb2TM CTAGCACCGATGGCAACAG S 
Seq-fwd-EphB2TM GGAAAAGCTACCCCTCATC S 
Seq-rev-pFRB CCCTGAAAACTTTGCCCCCT S 
CT-ExFP-AS220 fwd GAAGCGCGATCACATGGTCC S 
pSFV fwd CTACGGCGGTCCTAGATTGG S 
pSFV rev CCGTAAAACGTTTGCGTAGG S 
pSFVfwdup GGCGAGGGACATTAAGGCG S 
pSFV revdown CGGCGCTGATGAGTTGCTG S 
EphB2globrev CGCTGGGAATGCTGCTGCAG S 
NTExFPrev GTCCAGCTCGACCAGGATG S 
RevKinaseATP GGTCGAACTGGCCCATGATG S 
 
Newly cloned plasmids were sequenced, at least over cloning sites, for sequence verification 
[360].  
5.2.1 EphB2 mammalian expression constructs 
 
All EphB2 mammalian expression constructs were under the control of the CMV-Promoter, 
with pcDNA3.1 as the backbone vector.  
 
EphB2-xFP :  
Expression constructs encoding either full-length wildtype (pJK10/12; pAS01), c-terminally 
truncated (pJK18; pAS02) and kinase-dead (K660R mutation) (pJK27; pAS03) murine 
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EphB2 with incorporated xFP variants were generated by Jenny Lauterbach [238,313] and 
used as wildtype controls and templates for cloning of FKBP constructs.  
 
wt/∆CEphB2-[1-3]FKBP-xFP (pAS04-08; pTM25,26; pTM40,41):  
Wildtype and C-terminally truncated EphB2-EYFP (pJK12/pJK18) constructs served as  
templates for generating expression constructs encoding xFP-tagged murine EphB2 with the 
insertion of one to three FKBP clustering domains. For insertion of two and three FKBP 
domains at the 5’ end of the JM domain, a NheISpeI-BamHI linker was introduced into the 
NheI/BamHI sites of pJK12 (5’ of the EYFP in JM domain). For generation of the 3FKBP 
insert, one FKBP domain from pC4-FV1E was introduced into pC4M-FV2E, via the XbaI/SpeI 
restriction sites, to give the plasmid pC4-FV3E. Following these preparative steps, an 
EcoRV/NotI fragment of EphB2-EYFP (pJK12) containing the region of interest for insertion 
was subcloned into pBS plasmid. Then, ligated 2FKBP (from pC4M-FV2E) or 3FKBP 
domains (from pC4M-FV3E), respectively, were subcloned as XbaI/SpeI fragment into the 
SpeI site. Finally the new FKBP domain containing the EcoRV/NotI fragment in pBS was 
moved back via the same restriction sites into the original EphB2-EYFP (pJK12/pJK18) 
backbone to yield wt/∆CEphB2-[2-3]FKBP-EYFP (pTM25 & pTM26). The wtEphB2-
1FKBP-EYFP plasmid (pAS-1) was obtained with excision replacement of the 3FKBP 
domains by the 1FKBP domain insert via the NheI/BamHI restriction sites. The 1FKBP 
domain insert was amplified by PCR using the primer pair EphB2-1Fv-fwdG/ -revCG and 
template pC4-FV1E.  
In wildtype constructs, the flanking amino acid sequence for insertions in the juxtamembrane 
region is …GFERADSE- LATRYTDKLQ-[1-3FKBP]-SRDPPVAT-[xFP]-YTDKLQHY….  
For the C-terminally truncated EphB2-[2,3]FKBP constructs, the remaining EphB2 
cytoplasmic domain is …GFERADSE, followed by three FKBP repeats and EYFP. 
 
kdEphB2-[1-3]FKBP-xFP (pAS14-16) :  
Kinase-dead variants of the clustering constructs pAS04/pTM25/pTM26 were produced via a 
subcloning strategy with excision exchange of the wildtype kinase-domain using enzymes 
BsrGI/XbaI. The kinase-dead fragment containing the K660R mutation was obtained from 
construct pJK27. 
 
ee/eyEphB2-[2,3]FKBP-EYFP (pAS09-13):  
Constitutively kinase-active eeEphB2-[2,3]FKBP-EYFP constructs were generated in two 
steps by site-directed mutagenesis using the Stratagene-QuikChange-II XL® Kit. Firstly, aa 
residue Y604 was mutated using primers t3565g_t3567g/-antisense and templates pTM25 & 
pTM26, to produce constructs eyEphB2-[0,2,3]FKBP-EYFP. Secondly, aa residue Y610 was 
mutated using primers t3583g_t3585g/-antisense to yield eeEphB2-[2,3]FKBP-EYFP. 
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ff/fyEphB2-[2,3]FKBP-EYFP (pAS17-20):  
Plasmids ff/fyEphB2-[2,3]FKBP-EYFP were cloned in two steps by site-directed mutagenesis 
using the Stratagene-QuikChange-II XL® Kit. Firstly, aa residue Y604 was mutated using the 
primer pair a3566t/-antisense and templates pTM25 & pTM26, to produce constructs 
fyEphB2-[0,2,3]FKBP-EYFP. Secondly, aa residue Y610 was mutated using the primer pair 
a3584t/-antisense to yield ffEphB2-[2,3]FKBP-EYFP. 
 
∆NEphB2-[0,3]FKBP-EYFP (pAS21,22):  
For cloning of the N-terminally truncated ∆NEphB2-[0,3]FKBP expression constructs, a 
synthetic gene segment was designed comprising the FNIII, TM and part of the JM domains. 
The gene was synthesized by MWG BIOTECH (Ebersberg, Germany) and provided in a 
backbone ready for excision via the EcoRV/NheI restriction sites. The DNA-fragment was 
then ligated into EcoRV/NheI-digested wtEphB2-[0,3]FKBP-EYFP to produce ∆NEphB2-
[0,3]FKBP-EYFP. 
 
xFP variants of EphB2 expression constructs. Simultaneous visualization of different 
combinations of isoforms required the cloning of various xFP-variants. In general, xFP was 
exchanged from the parent plasmid of interest via subcloning the AgeI/BsrGI excision 
product from xFP template plasmids pEYFP-N1, pECFP-C1, pmGFP-N1 or pmCitrine (Ola 
Sabet MPI Dortmund), pRSET-B-mcherry (from Tsien lab). 
 
pSFVwtEphB2-[0,3]FKBP-YFP (plasmids for Semliki Forest Virus constitution; pAS23-26):  
The JM-YFP-kinase-SAM-PDZ fragment was subcloned into pSFV using the BamHI/NotI 
restriction sites to give pSFVEphB2intra. Subsequently, PCR-amplification of full-length 
wtEphB2-[0-3]FKBP-YFP using the primer pairs pSFVEphB2ecto-fwd/ pSFVEphB2ectoFKBP-
rev (pSFVEphB2ectorev for 0FKBP) yielded the remaining EphB2ecto-TM-xFKBP insert for 
subcloning into pSFVEphB2intra. 
 
5.2.2 EphA4 mammalian expression constructs 
 
wtEphA4-EYFP-[2,3]FKBP (pAS27,28):  
Wildtype EphA4-aa574-NheI with an in-frame NheI restriction site introduced at aa residue 
position 574 served as a template backbone for insertion of two and three FKBP domains with 
EYFP. The insert was PCR-amplified from wtEphB2-[2,3]FKBP-EYFP using the primer pair 
EphAfwdNheI/EphArevNheI and inserted at the NheI restriction site. The site of insertion 
was similar to that of the EphB2 expression constructs containing FKBP and xFP.  
 
eeEphA4-EYFP-[2,3]FKBP pAS29,30):  
Constitutively kinase-active eeEphA4-aa573-NheI served as a template and cloning was 
carried out as described for wtEphA4-EYFP-[2,3]FKBP. 
 
139 
 
EXP. PROC. 
5.2.3 EphrinB2 mammalian expression constructs 
 
Expression constructs encoding for full-length wildtype murine EphB2 with incorporated xFP 
variants (pJK38; pAS33) were generated by Jenny Lauterbach  [239,313] and used as 
wildtype controls and templates for cloning of FKBP constructs.  
 
xFP-wtefnB2-[1-3]FKBP (pAS34-36; pTM13,14):  
The wildtype xFP-wtefnB2 (pJK38) construct served as a template to generate expression 
constructs encoding for xFP-tagged murine ephrinB2, with the subsequent insertion of one to 
three FKBP clustering domains. For insertion of two and three FKBP domains downstream of 
the TM domain, the extracellular and transmembrane domains were PCR amplified and 
inserted into pBS using the EcoRI/SpeI restriction sites. After that, the intracellular domain, 
which was also PCR-amplified from pJK38, was cloned into the same pBS plasmid 
containing the EC and TM domains, using the restriction sites SpeI/NotI. Following these 
preparative steps, already ligated 2FKBP (from pC4M-FV2E) or 3FKBP domains (from pC4-
FV3E) were subcloned as XbaI/SpeI fragments into the SpeI site. Finally, the new FKBP 
domain containing the cloned fragment in pBS was moved back to pJK38 using the XbaI/NotI 
restriction sites to yield xFP-wtefnB2-[2,3]FKBP.  
For cloning the xFP-wtefnB2-1FKBP plasmid, xFP-wtefnB2-2FKBP (pTM13) was used as a 
template for PCR-amplification of a fragment comprising the 1FKBP domain and the efnB2 
IC domain. For this, the b2-1FV-fwd/rev primer pair was used. The resulting fragment, with 
flanking XbaI/NotI restriction sites, was then ligated into the SpeI/NotI site of pTM30 to give 
xFP-wtefnB2-1FKBP. 
 
xFP-∆CefnB2-[2,3]FKBP (pAS37,38): 
Full-length wildtype xFP-wtefnB2-[2,3]-FKBP served as a cloning template for the deletion 
of the cytoplasmic tail downstream of the FKBP domains. The cytoplasmic tail of ephrinB2 
was excised using SpeI/NotI and vector was then re-ligated in the presence of annealed linker 
oligonucleotides linkSpeI/NotIfwd & linkSpeI/NotIrev (annealing conditions as outlined 
above), to give xFP-∆CefnB2-[2,3]FKBP. 
 
xFP variants of efnB2 expression constructs. Simultaneous visualization of different 
combinations of constructs required the cloning of various xFP-variants. For mCherry-
wtefnB2-xFP constructs, EYFP was excised from EYFP-wtefnB2-xFKBP using the 
restriction enzymes BamHI/HindIII. mCherry PCR-amplified from pRSET-B-mCherry or 
ECFP from pECFP-C1, using the primer pair 1-5-mcherry/1-3-mcherry, was ligated into the 
remaining backbone.  
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5.2.4 Other expression constructs 
 
myr-FRB-mCherry (pAS32): 
pC4-RHE, containing the FRB fragment as an insert, was used as a backbone for generating 
myr-FRB-mCherry. The FP mCherry was PCR-amplified from vector pRSET-B-mCherry 
using the primer pair 2-5-mchFRB/2-3-mchFRB and inserted via the restriction sites 
SpeI/BamHI, to produce construct FRB-mCherry. For myristoylation of FRB-mCherry, 
myristoylation sequence encoding oligonucleotides NT-MemFRB-fwd/-rev were diluted in 
H2O bidest. and annealed by heating to 95 °C and subsequent gradual cooling to 10 °C at a 
rate of 2 °C/min. Annealed oligonucleotides were then used for insertion into EcoRI/XbaI 
restriction sites to yield myr-FRB-mCherry. 
 
An overview of all constructs cloned and used in this thesis is given in table 5.2. All 
constructs were sequence verified and tested for correct expression and ephrin-Fc induced 
signal induction, if applicable.  
 
 
Table 5.2 List of expression constructs. 
 
Plasmid Description Modification Tags Reference 
Plasmids for cloning/co-expression  
pC4-FV1E 1FKBP - - ARIAD 
Pharmaceuticals® 
pC4M-FV2E 2FKBP - - ARIAD 
Pharmaceuticals® 
pC4M-FV3E 3FKBP - - thesis; Taija 
Makinen 
pC4-RHE 1FRB - - ARIAD 
Pharmaceuticals® 
pBS cloning vehicle - - Taija Makinen 
pECFP-C1 ECFP - - Clontech® 
pEYFP-N1 EYFP - - Clontech® 
pRSET-B-
mCherry 
mCherry - - Tsien lab [363] 
pmyr-mCherry mCherry - GPI Tsien lab [363] 
pmGFP-N1 based on  
pEGFP-N1 
EGFP mutations 
+ Ala206Lys
- Ola Sabet, 
Clontech® 
pSFV viral target vector - - [364] 
pSFVhelper viral structural 
genes 
- - [364] 
pcDNA3_EphA4w
t_NheI 
EphA4-aa574-
NheI 
aa574 - Katrin Deininger 
pcDNA3_EphA42
E_NheI 
eeEphA4-aa574-
NheI 
aa574 
Tyr604Glu 
Tyr610Glu 
- Katrin Deininger 
     
EphB2 expression plasmids 
pJK1 wtEphB2 - FLAG [313] 
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pJK2 kdEphB2 kinase-dead 
(Lys660Arg) 
FLAG [313] 
pJK10/12 
pAS01 
wtEphB2-xFP - FLAG 
ECFP/EYFP 
mCherry/ 
mGFP 
thesis; 
[313] 
pJK18 
pAS02 
∆CEphB2-xFP 
 
cytoplasmic 
domain deletion 
FLAG 
EYFP/ECFP 
thesis; 
[313] 
pJK27 
pAS03 
 
kdEphB2-xFP kinase-dead FLAG 
EYFP/ECFP 
mCherry/ 
mGFP 
thesis; 
[313] 
pAS04 wtEphB2-1FKBP-
xFP 
- FLAG 
EYFP/ECFP 
mGFP 
thesis 
pTM25 
pAS05 
wtEphB2-2FKBP-
xFP 
- FLAG 
EYFP/ECFP 
mGFP 
thesis; 
Taija Makinen 
pTM26 
pAS06 
wtEphB2-3FKBP-
xFP 
- FLAG 
EYFP/ECFP 
mGFP 
thesis; 
Taija Makinen 
pTM40 
pAS07 
∆CEphB2-
2FKBP-xFP 
cytoplasmic 
domain deletion 
FLAG 
EYFP/ECFP 
mGFP 
thesis; 
Taija Makinen 
pTM41 
pAS08 
∆CEphB2-
3FKBP-xFP 
cytoplasmic 
domain deletion 
FLAG 
EYFP/ECFP 
thesis; 
Taija Makinen 
pAS09 eeEphB2-YFP Tyr604Glu 
Tyr610Glu 
FLAG 
EYFP 
thesis 
pAS10 eeEphB2-2FKBP-
YFP 
Tyr604Glu 
Tyr610Glu 
FLAG 
EYFP 
thesis 
pAS11 eeEphB2-3FKBP-
YFP 
Tyr604Glu 
Tyr610Glu 
FLAG 
EYFP 
thesis 
pAS12 eyEphB2-2FKBP-
YFP 
Tyr604Glu 
 
FLAG 
EYFP 
thesis 
pAS13 eyEphB2-3FKBP-
YFP 
Tyr604Glu 
 
FLAG 
EYFP 
thesis 
pAS14 kdEphB2-1FKBP-
xFP 
kinase-dead 
 
FLAG 
EYFP/ECFP 
thesis 
pAS15 kdEphB2-2FKBP-
xFP 
kinase-dead 
 
FLAG 
EYFP/ECFP 
thesis 
pAS16 kdEphB2-3FKBP-
xFP 
kinase-dead 
 
FLAG 
EYFP/ECFP 
thesis 
pAS17 ffEphB2-2FKBP-
YFP 
Tyr604Phe 
Tyr610Phe 
FLAG 
EYFP 
thesis 
pAS18 ffEphB2-3FKBP-
YFP 
Tyr604Glu 
Tyr610Glu 
FLAG 
EYFP 
thesis 
pAS19 fyEphB2-2FKBP-
YFP 
Tyr604Phe 
 
FLAG 
EYFP 
thesis 
pAS20 fyEphB2-3FKBP-
YFP 
Tyr604Phe 
 
FLAG 
EYFP 
thesis 
pAS21 ∆NEphB2-
0FKBP-YFP 
- FLAG 
EYFP 
thesis 
pAS22 ∆NEphB2-
3FKBP-YFP 
- FLAG 
EYFP 
thesis 
pAS23 pSFVwtEphB2-
0FKBP-YFP 
- FLAG 
EYFP 
thesis 
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pAS24 pSFVwtEphB2-
1FKBP-YFP 
- FLAG 
EYFP 
thesis 
pAS25 pSFVwtEphB2-
2FKBP-YFP 
- FLAG 
EYFP 
thesis 
pAS26 pSFVwtEphB2-
3FKBP-YFP 
- FLAG 
EYFP 
thesis 
     
EphA4 expression plasmids 
pID EphA4 - mCherry Irina Dudanova 
pAS27 wtEphA4-2FKBP-
YFP 
 EYFP thesis 
pAS28 wtEphA4-3FKBP-
YFP 
- EYFP thesis 
pAS29 eeEphA4-2FKBP-
YFP 
Tyr604Glu 
Tyr610Glu 
EYFP thesis 
pAS30 eeEphA4-3FKBP-
YFP 
Tyr604Glu 
Tyr610Glu 
EYFP thesis 
pAS31 FRB-mCherry - mCherry thesis 
pAS32 myr-FRB-
mCherry 
- GPI 
mCherry 
thesis 
     
EphrinB2 expression plasmids 
pJK38 
pAS33 
 
xFP-wtefnB2 - HA-tag 
EYFP 
ECFP 
mCherry 
thesis 
[313] 
pAS34 xFP-wtefnB2-
1FKBP 
- HA-tag 
EYFP/ 
ECFP/ 
mCherry 
thesis 
pTM13 
pAS35 
xFP-wtefnB2-
2FKBP 
- HA-tag 
EYFP/ECFP 
mCherry 
thesis; 
Taija Makinen 
pTM14 
pAS36 
xFP-wtefnB2-
3FKBP 
- HA-tag 
EYFP/ECFP 
mCherry 
thesis; 
Taija Makinen 
pAS37 xFP-∆CefnB2-
2FKBP 
cytoplasmic 
domain deletion 
HA-tag 
EYFP/ECFP 
mcherry 
thesis 
pAS38 xFP-∆CefnB2-
3FKBP 
cytoplasmic 
domain deletion 
HA-tag 
EYFP/ECFP 
mcherry 
thesis 
     
Other expression plasmids 
pJEN121 JMA4- GST 
EphA4 substrate  
- GST [113] 
pSW12 GRIP1 - - [208,365] 
pKB33 GRIP2 - myc Katja Brückner 
pCMVSport6-
PICK1 
pAS39 
murine PICK1 - - Imagenes 
cDNA clone 
MGC:54727 
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5.3 Cell culture techniques 
 
5.3.1 Cell lines 
 
Cell lines from table 5.3 were cultured and maintained according to standard protocols using 
appropriate culture growth media (Gibco, Invitrogen, Carlsbad, CA) and conditions [366]. 
 
Table 5.3 Cell lines. 
 
Cell line organism 
ATCC 
number 
origin Reference 
Human embryonic 
kidney (HEK)293T 
Homo sapiens 
(human) 
CRL-1573 ATCC www.atcc.org 
HeLa Homo sapiens 
(human) 
CCL-2 ATCC www.atcc.org 
COS-7 (kidney 
fibroblast-like cell 
line) 
Cercopithecus 
aethiops 
(African green 
monkey) 
CRL-1651 Bastiaens Lab, MPI 
Dortmund, 
Germany 
www.atcc.org 
BHK-21 Mesocricetus auratus 
(baby hamster Syrian 
kidney) 
CCL-10 Stein Lab, MPI 
Neurobiology 
www.atcc.org 
 
 
5.3.2 Primary culture of hippocampal neurons  
 
Hippocampal neurons were taken from the embryos of pregnant Wistar rats (MpiChbb:Thom, 
animal house, Max-Planck-Institute of Neurobiology) at embryonic day 18.5. The pregnant 
rat was deeply anesthetized using diethyl ether, and then sacrificed by decapitation. After 
decapitation, embryos were obtained and kept in ice-cold dissection medium (HBSS, #2402, 
Gibco, supplemented with sterile filtered 10% penicillin/streptomycin, 10 mM MgSO4, 10 
mM HEPES). Working under an open sterile hood, embryo heads were removed and the skull 
opened to take out the brain. Embryonic brains were placed in fresh dissection medium and 
dissected under a stereomicroscope. Brain cortices were removed from the midbrain and 
brainstem and the meniges were detached. The striatum was then removed, and the 
hippocampus was separated from the cortex and placed in fresh 15 ml dissection medium on 
ice. After removing the medium, up to 3 hippocampi were incubated in dissection medium 
supplemented with papain (1 mg/ml, Sigma Aldrich) for 20 min in a water bath, heated to 37 
°C. The digestion reaction was stopped first by carefully removing the papain solution and 
then by washing hippocampi three times with 3 ml prewarmed Neurobasal-B27 (Neurobasal: 
#21103, Gibco; B27:  #17504-049, Gibco) . The tissue was then triturated approximately 20 
times with the help of fire polished Pasteur pipets, and the cell suspension was centrifuged for 
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5 min at 80 x g to remove the debris. The pellet was resuspended in an appropriate volume of 
Neurobasal-B27 medium. Cells were counted using a hemacytometer and plated on coated 
glass coverslips (1 mg/ml poly-D-lysine, Sigma-Aldrich; 5 µg/ml laminin, Invitrogen) in a 24-
well plate at a density of 25,000 cells per well, or on coated glass botton live-cell dishes 
(LabTek, Nunc) for subsequent lipofectamine transfection the next day. AMAXA® 
transfection was immediately carried out after dissociation of neurons. Conditioned 
Neurobasal-B27 (~10 days) was added up to 50 % (v/v) to fresh Neurobasal-B27 and used for 
culturing of neurons after dissociation/transfection. 
5.3.3 Preparation of Semliki Forest virus 
 
For production of viral particles, two expression vectors were transfected simultaneously into 
BHK-21 cells using electroporation (twice, with interval 10-15 sec, settings: voltage 1.5 kV, 
capacity 25 µF, infinity resistance; time constant 0.7-0.8) (GenePulserII, BioRad). The first 
expression vector contained the cDNA of interest, as well as the nonstructural genes (nsP1-4) 
and the subgenomic 26S promoter. The second expression vector, pSFVhelper, contained 
coding regions for structural proteins. 36 hours after electroporation and seeding of BHK-21 
cells, the medium containing released viral particles was collected (10 ml) and centrifuged to 
pellet cell debris at 2500 x g for 10 min at 4 °C. The supernatant was then collected and stored 
at 4 °C until concentration of viral particles via ultracentrifugation was performed the same 
day. The supernatant was spun for 2 hrs at 76800 x g and 4 °C using an SW41 rotor 
(Beckman, Brea, CA). The supernatant was aspirated and the viral pellet resuspended in ~250 
µl of sterile filtered neurobasal medium overnight at 4 °C. It was then aliquoted and stored at -
80 °C. For activation of the virus, structural proteins forming the spikes, necessary for 
infection of host cells but insensitive to endogenous proteases, had to be converted by an 
exogenous protease. 50 µl of viral solution was first digested with α-chymotrypsin at RT for 
45 min (1:20 v/v), then inactivated at RT for 10 min with aprotinin (1:15 v/v). Activated virus 
was then aliquoted and stored at -80 °C until required further for infection of hippocampal 
cultures. For more details of SFV production please refer to [364]. 
After testing the virus in Hek293T cell culture, infection of hippocampal slices was performed 
overnight by adding ~5-10 % (v/v) of the virus suspension to neurons cultured in neurobasal 
growth medium for 1 day in vitro. Cultures were imaged the morning following infection.  
 
5.3.4 Mammalian cell transfection 
 
Cell culture transfections. COS-7 cells used for homo-FRET experiments, immunostainings 
and blue-native PAGE were grown to 70 % confluency and transfected overnight with various 
EphB2-xFKBP constructs using FUGENE6 reagent (Roche Diagnostics, Mannheim, 
Germany). HeLa cells were grown to 70 % confluency and transfected in growth medium 
overnight with 0.5 to 5 µg of DNA using a Calcium-Phosphate transfection kit (Invitrogen, 
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Carlsbad, CA). The next morning, COS-7 cells were washed with D-PBS (Sigma Aldrich), 
and HeLa cells were washed with wash buffer (135 mM NaCl, 4 mM KCl, 1 mM Na2HPO4, 2 
mM CaCl2, 1 mM MgCl2, 20mM HEPES, 20mM d-Glucose, pH 7.3), before the addition of 
fresh growth medium. 12-16 hrs before stimulation, cells were starved in growth medium 
containing dialyzed 0.5 % fetal bovine serum (HyClone, Logan, Utah). For FKBP domain 
containing constructs, FK506 (300 nM) was added to the growth medium after transfection to 
reduce Eph clustering.  
 
Transfection of primary hippocampal neuron cultures. Depending on the assay 
performed, but usually the next day (DIV 1), cultures plated on coverslips or in live-cell 
chambers were transfected with lipofectamine ltx® or lipofectamine 2000® (Invitrogen) 
according to the manufacturer’s protocol. Prior transfection, growth medium was exchanged 
for Neurobasal without B27 serum and kept in incubator. For transfection of 1.8 cm² wells in 
a volume of 0.5 ml, 0.7-1 µg of DNA was diluted in 50 µl of Opti-Mem (GlutaMAX, 
#51985,Gibco). In parallel, 2 µl of lipofectamine was added to 50 µl of Opti-Mem and 
incubated for 5 min at RT. Subsequently, the DNA mix was added to the lipofectamine mix to 
yield a final volume of ~100 µl, which was further incubated for 20 min at RT before adding 
to the well. Transfection was stopped after 1.5-2.5 hrs by washing twice with 7 mM HEPES 
in HBSS. Culturing of transfected neurons on cover slips or in live-cell chambers was 
continued on in growth medium from prior transfection supplemented with up to 1/3 (v/v) 
fresh Neurobasal-B27. Cultures were maintained in a humidified incubator with an 
atmosphere of 5 % CO2 at all times. 
For transfection of N-terminally truncated ∆NEphB2-0FKBP or ∆NEphB2-3FKBP constructs 
(1 µg/transfection), AMAXA® nucleofection for rat neurons (Lonza, Basel, Switzerland) was 
used according to the manufacturer’s protocol. After dissociation of the neurons, 600-800,000 
cells were electroporated in AMAXA transfection buffer with 1 µg DNA using program O-
003 for rat hippocampal neurons and seeded at a density of ~60,000 cells/cm². To reduce 
receptor clustering, 300 nM FK506 was added to the cultures 1 hr after plating.  
 
5.4 Clustering reagents and stimulations 
 
FKBP/FRB-system of non-covalent crosslinking. For non-covalent, homotypic crosslinking 
of EphB2/A4 receptors or ephrinB2 ligands the ARGENT® Regulated 
Homo(Hetero)dimerization kit from ARIAD Pharmaceuticals (ver. 2.0 - for reference see 
www.ariad.com) was implemented. The kit allows complex cellular events to be brought 
together under small molecule control via a homo/heterodimerizer. The reagents of the 
homodimerizer kit are based on the abundant cytoplasmic human FKBP12 (FK506 Binding 
Protein 12) and its small molecule ligands FK506 and rapamycin. The first generation 
homodimerizer system was invented by the Schreiber and Crabtree laboratories [367]. They 
chemically linked two FK506 molecules together, which produced two binding entities for 
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FKBP12 on one small molecule ligand, thereby creating a non-covalent crosslinker. Affinity 
and specificity was subsequently improved by Clackson and colleagues [368,369], resulting in 
the newest generation homodimerizer AP20187 with a high sub-nanomolar affinity to a 
Phe36Val mutated FKBP12 (FKBP-FV) and a weaker homodimerizer AP1887 with lower 
binding affinity to FKBP [369,370].  
AP21967, included in the heterodimerizer kit, is a chemical derivate of rapamycin (rapalog) 
that circumvents the cell cycle inhibitory effects of rapamycin. It functions by binding with 
high-affinity to FKBP and to FRB, a 93 amino acid portion of the large PI3K homolog FRAP 
(FK506-rapamycin complex associated protein; RAFT, mTOR), thereby joining the two 
proteins together [312,322].  
Homo and hetero-dimerizing agents AP20187 (same EC50 as AP1903, personal 
communication with Tim Clackson, ARIAD Pharmaceuticals) [369], AP1887 [316], and 
AP21967 were obtained from ARIAD Pharmaceuticals, dissolved in ethanol and stored at -20 
°C. The affinities of the homodimerizers AP20187 (IC50= 1.8 nM)  and AP1887 (IC50= 40 
nM) to a single FKBP-FV domain were determined using FL polarization competition assays 
[316]. Prior to stimulation, dimerizers were diluted in starving medium used for stimulation to 
the concentration indicated in figures.  
 
Soluble ligand stimulation. Human IgG Fc fragment (Jackson ImmunoResearch, West 
Grove, PA), mouse ephrinB2-Fc (AF496-EB), human ephrinB3-Fc (AF395) and human 
ephrinA5-Fc (AF374) fusion proteins (R&D Systems, Minneapolis, MN) were used for 
stimulations. Pre-clustered Fc fragment and ephrin-Fc fusion proteins were incubated with 
goat anti-human Fc at a ratio of 5:1 for 30 min at room temperature. Stimulations were carried 
out in a CO2-controlled incubator at 37 °C for the indicated time. Following stimulation, the 
cells were placed on ice.  
For stimulation with FL labeled ephrinB2-Fc, recombinant protein (AF496-EB, R&D 
Systems) was treated with Alexa-dye 594 according to the kit protocol (Alexa Fluor 594 
Microscale protein labeling kit, A30008, Invitrogen). The conjugate was cleared of excess dye 
by subjecting it to a purification resin and eluting in PBS. Concentration of Alexa-conjugated 
ephrinB2-Fc was estimated by absorbance spectroscopy before and after conjugation at 280 
nm and 590 nm wavelength. 
 
Inhibitor compounds. For inhibition of acto-myosin-dependent cell contraction, the myosin-
II inhibitor (S)-(-)-blebbistatin (#1852, Tocris Bioscience, Bristol, UK) was added to the 
culture medium at least 10 min before manipulation of the cells.  
Dynasore (D7693, Sigma Aldrich) was used as dynamin-1/2 specific GTPase inhibitor to 
block dynamin-dependent endocytosis [371]. It was prepared in DMSO (dimethyl-sulfoxide) 
and added to the growth medium 15 min prior start of the experiment at a final concentration 
of 80 µm.  
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For inhibition of receptor clustering of FKBP-domain containing Eph/ephrin isoforms, 300 
nM FK506 (F4679; Sigma Aldrich) was added after transfection. FK506 powder was 
reconstituted in ethanol.  
 
5.5 Protein chemistry techniques 
 
5.5.1 Antibodies 
 
Primary antibodies used in experiments are as follows: rabbit anti-phospho EphB1/2 
Y594/Y604 (ab61791, Abcam, Cambridge, UK); mouse anti-phospho tyrosine (clone 4G10, 
homemade), mouse anti-FLAG M2 (F-3165, Sigma Aldrich, St. Louis, MO); rabbit SAM-
domain specific anti-EphB2 [172]; rabbit anti-GST (sc-33613, Santa Cruz Biotechnologies, 
Santa Cruz, CA); rabbit anti-FKBP12 (PA1-026A, Affinity BioReagents, Golden, CO); 
mouse monoclonal anti-α-Tubulin (Sigma Aldrich); mouse monoclonal anti-GRIP (#611318, 
BD Biosciences, Franklin Lakes, NJ); rabbit anti-PICK1 (ab3420, Abcam); ectodomains-
specific goat anti-EphB2Ecto (AF467, R&D Systems); rabbit anti-phospho-EphA2/3/4 
Y588/Y596 (ab62256, Abcam); mouse monoclonal anti-c-myc (MA1-980, Sigma Aldrich); 
mouse monoclonal anti-EphA4/Sek (610471, BD Biosciences); mouse monoclonal anti-GFP 
JL-8 (632380, Clontech, Mountain View, CA);  rabbit anti-GFP (Invitrogen, Carlsbad, CA), 
1:2000; rabbit anti-mouse monoclonal anti-Tau1 (Chemicon, Temecula, CA), 1:500, and goat 
anti-human IgG Fcγ fragment specific for clustering of Fc-fusion proteins (Jackson 
ImmunoResearch).  
 
Secondary antibodies used were: donkey anti-mouse Cy3- or Cy5-conjugated, anti-rabbit 
Cy2-conjugated, and anti-rabbit/anti-mouse horse radish peroxidase (hrp) conjugated (Jackson 
ImmunoResearch). Streptavidin-hrp (GE Healthcare, Chalfont St. Giles, UK) was used to 
probe for biotinylated protein.  
 
5.5.2 Immunoprecipitations and Western blotting  
 
HeLa cells were harvested in lysis buffer (50 mM Tris pH 7.5, 120 mM NaCl, 1 mM EDTA, 
1 % TritonX-100, 10 % glycerol) supplemented with protease and phosphatase inhibitor 
cocktail tablets (Roche, Mannheim, Germany). For phosphorylation blotting, lysates were 
cleared by centrifugation and equal amounts were then incubated with 40 µl of anti-FLAG 
M2-agarose resin (A2220, Sigma Aldrich) overnight at 4 °C rotating, then washed 4 times 
with lysis buffer. Proteins were eluted by the addition of loading buffer and analyzed by 
Western blot. After SDS-PAGE separation of immunoprecipitations, semi-dry transfer of 
proteins to PVDF membranes and blocking with 5 % BSA (Sigma Aldrich) in PBS with 0.1 
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% Tween-20 (Bio-RAD, Hercules, CA), membranes were incubated overnight with the 
respective primary antibody. They were then incubated with the species-specific secondary 
hrp-coupled antibody, and proteins were detected with an enhanced chemiluminescence kit 
(GE Healthcare, Uppsala, Sweden). For re-blotting, membranes were stripped for 15 min with 
stripping buffer (Thermo Scientific, Rockford, IL) at room temperature, blocked again with 
BSA and re-probed using a primary antibody for total protein detection.  
In the biochemical kinase activity assay, co-expressed kinase substrate GST-JMA4 was pulled 
down with a 50 % slurry of glutathione sepharose 4B (GE Healthcare, Uppsala, Sweden), then 
eluted with loading buffer and subjected to SDS-PAGE for Western blotting as described 
above. Quantifications of unsaturated Western blots were done using Gel-Pro Analyzer 
software (Media Cybernetics, Bethesda, MN), normalizing to positive ephrinB2-Fc 
stimulation controls. 
 
5.5.3 Blue‐native PAGE  
 
COS-7 cells were lysed in NativePAGE sample buffer (Invitrogen, Carlsbad, CA) 
supplemented with 1 % n-dodecyl-b-D-maltoside and complete protease and phosphatase 
inhibitor cocktail (Roche, Mannheim, Germany). After centrifugation for 30 min at 13,000 x 
g, equal amounts of cell lysates and a NativeMark unstained protein standard (Invitrogen) 
were separated on a 3-12 % NativePAGE gradient gel (Invitrogen) in NativePAGE G-250 
sample buffer (Invitrogen) (final concentration 0.25 %). Proteins were then transferred to 
PVDF membrane and autophosphorylation was detected. For re-blotting, membranes were 
stripped, blocked again with BSA and re-probed using a primary antibody for total protein 
detection. For analysis of cluster sizes and phosphorylation states using kd/wtEphB2-xFKBP-
mGFP isoforms, developed blots were scanned lane by lane using an average optical density 
line scan with equal scan width (software MetaMorph, Molecular Devices). Values were 
normalized to each total lane input resulting from the sum of incremented optical densities 
and plotted against line-increments from lane scans.  
 
5.5.4 Surface biotinylation 
 
For surface biotinylation of plasma membrane proteins, HeLa cells were washed once with 
ice cold D-PBS (pH 8.0) after stimulation of the cells using ephrinB2-Fc/dimerizer. Cells 
were then incubated for 30 min with 1 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fisher 
Scientific, Waltham, MA) diluted in ice-cold D-PBS (pH 8.0). To quench the biotinylation 
reaction, cells were then rinsed for 5 min with ice cold D-PBS supplemented with 1 % BSA 
(w/v). Before cell lysis, cell were washed once more with ice cold D-PBS. 
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5.5.5 Immunocytochemistry 
 
Cells were fixed with pre-warmed 2 % paraformaldehyde, 4 % sucrose in D-PBS for 5 min at 
RT, rinsed twice with ice cold D-PBS, incubated with ice cold 50 mM ammonium chloride in 
D-PBS for 10 min, and then rinsed again. For phosphorylation labeling of Eph receptors, cells 
were permeabilized for 5 min with ice cold 0.1 % Triton X-100 in D-PBS at 4 °C. For surface 
labeling of Eph receptors, cells were not permeabilized. Blocking was performed for 30 min 
at RT, or overnight at 4 °C, with 5 % donkey serum (Jackson ImmunoResearch), 3 % BSA in 
PBS. Cells were then incubated with primary antibodies for 60 min at RT. After washing, 
cover slips were mounted using the ProLong antifade kit (Molecular Probes, Eugene, OR) or 
Aqua-Poly/Mount (Polysciences, Warrington, PA). 
Neuronal cultures were fixed using warm (37 °C) 4 % paraformaldehyde/ 8 % sucrose, 
permeabilized with 0.1 % Triton X-100 for 5 min and incubated with blocking solution (4 % 
goat serum, 4 % donkey serum, 2 % BSA in PBS) for 1 hr at room temperature, followed by 
incubation with primary antibody in blocking solution for 2 hrs at RT. After washing with 
PBS, secondary antibodies diluted 1:250 in blocking solution were added for 1 hr at RT. 
Texas-Red-conjugated phalloidin (1:100) was applied together with the secondary antibodies. 
Coverslips were mounted with fluorescent mounting medium (Dako, Hamburg, Germany) 
and imaged for epiFL using the Axioplan epifluorescent microscope (Zeiss, Göttingen, 
Germany). Images were acquired with MetaMorph software (Molecular Devices). Only 
axonal growth cones were quantified (an axon being defined as the longest neurite positive for 
Tau1). 
 
5.6 Cell microscopy assays and image analysis 
 
5.6.1 Cell collapse and co‐culture assays  
 
For cell collapse assays, 12-16 hrs prior to the start of the assay, transfected HeLa were 
detached from the flask using D-PBS lacking Ca2+ and Mg2+ (Sigma Aldrich) supplemented 
with 3 mM EDTA. After washing twice in D-PBS containing Ca2+ and Mg2+, cells were 
seeded in Lab-Tek glass bottom live-cell chambers (Nunc, Rochester, NY) or MatTek glass 
bottom dishes (MatTek, Ashland, MA) coated with 1 mg/ml poly-D-lysine (Sigma Aldrich) 
and 5 µg/ml mouse laminin (Invitrogen, Carlsbad, CA). For cells expressing FKBP receptor 
isoforms, DMEM starving medium was supplemented with FK506 (300 nM, Sigma Aldrich). 
One hour before the start of the experiment, cells on dishes were washed with D-PBS, and 
imaging medium DMEM without phenol red, supplemented with 25 mM HEPES 
(Invitrogen), was added. Time-lapse imaging was performed as described in section 5.6.2. 
Before stimulation, reference images were acquired. Sequential images were acquired every 3 
to 4 min following addition of the stimulus. Cell edges of montaged stacks were drawn using 
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a graphpad pen (Intous 4, Wacom, Otone, Saitama, Japan) and MetaMorph software 
(Molecular Devices, Silicon Valley, CA). Area of cell growth surfaces at all time points were 
normalized to the pre-stimulation image cell growth surface (set to 100 %).  
For cell co-culture assays, the donor cell population was seeded ~30 min prior to the start of 
the assay on top of the recipient cell population, after the detachment procedure using D-
PBS/EDTA as described above.  
 
5.6.2 Epifluorescent and confocal imaging 
 
Time-lapse epiFL imaging. EpiFL time-lapse imaging was performed using a Zeiss Axiovert 
200M or a Zeiss Axioobserver Z1 microscope equipped with a temperature-controlled carbon 
dioxide-incubation chamber set to 37 °C, 65 % humidity, and 5 % CO2. Single focal planes, 
intermittently refocused manually, were acquired every 2 to 5 min in brightfield and FL 
illumination over a time period of 2 hrs with a 40x phase contrast objective (Zeiss, Göttingen, 
Germany).  Illumination was provided by a X-Cite lamp (series 120, Lumen Dynamics 
Group, Mississauga, Canada) and images recorded with a Coolsnap HQ camera 
(Photometrics, Tucson, AZ).  
 
High-resolution imaging and processing. For high-resolution epifluorescent live-cell 
recordings, a 100x phase contrast objective (Zeiss) was used with z-stack resolution of 0.267 
µm in fast acquisition mode. Z-stacks of images were corrected for optical density and 
subjected to adaptive-blind psf deconvolution (AutoQuantX, Media Cybernetics, Bethesda, 
MN), followed by sum or maximum intensity projection as indicated in figures. For confocal 
time-lapse recordings (supplementary video 1), an Olympus Fluoview® FV1000 confocal 
microscope (Olympus Life Science Europe, Hamburg, Germany) equipped with an Argon ion 
laser (Melles Griot, Albuquerque, NM) and a temperature controlled CO2 incubation chamber 
(EMBL, Heidelberg, Germany) at 37 °C was employed. For all live cell experiments, either a 
60x/1.2 W UPlanSApo or 60x/1.35 Oil UPlasSApo objective (Olympus) was used.  Fixed 
samples were imaged with either a Leica Confocal SP2 (Leica Microsystems, Wetzlar, 
Germany), an Axioobserver Z1 (Zeiss) equipped with a CSU-X1 spinning-disc confocal unit 
(Yokogawa, Tokyo, Japan) or the epifluorescent microscopes Axiovert 200M or 
Axioobserver Z1 (Zeiss), with subsequent deconvolution processing of acquired z-stacks as 
described above. For FL background correction, the average FL signal from an area with no 
cells was linearly subtracted from the whole image. 
 
Standard image processing. During image acquisition with constant exposure times using 
MetaMorph software, or the acquisition software provided by the microscope manufacturer, 
12 or 16-bit TIFF images were obtained with non-saturating pixel intensities. Post acquisition, 
images were processed using MetaMorph (Molecular Devices) or ImageJ software [372], as 
indicated in figure legends. For FL background correction, the low-level background average 
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intensity was measured and subtracted from the whole image (Gaussian background 
distribution was assumed). For image display, images were dynamically scaled to 0.1% of 
lowest and 0.01% of the highest FL pixel intensity and subsequently converted into 8-bit 
images. Fixed image scaling was also used for image sequences, when appropriate.  The same 
scaling mode was always applied for both sample and control.   
 
FL quantification. Quantification of FL signals was done after image processing comprising 
deconvolution, background correction and maximum projection, if performed. Integrated FL 
intensities from surface or phosphorylation staining were measured from regions or whole cell 
bodies and normalized to the total protein FL signals. Very high or very low expressing cells 
were excluded from the analysis as indicated in figure legends. Average intensity linescans 
over areas of cells were performed for better visualization, or quantification of peak 
intensities of FL signals in the cell edge as indicated in figures. FL thresholds were set for 
quantifications, if applicable.  
 
5.6.3 Homo‐FRET imaging  
 
Theoretical background. Homo-FRET (Förster resonance energy transfer) between identical 
fluorophores can be conveniently measured by observing its effect on fluorescence anisotropy 
[373]. This can be implemented in fluorescence microscopes by the addition of polarizing 
optics. Homo-FRET can be observed by exploiting the difference in polarization of the 
emission of the fluorophores. Such differences are quantified by the fluorescence anisotropy r: 
2
 
with the emission intensities (I) parallel (par) and perpendicular (per) to the excitation 
polarization direction (Fig. 5.1) [310]. 
Excitation with polarized light results in photoselection of fluorophores, with their absorption 
transition dipole moments oriented parallel to the polarization direction of the excitation light. 
When the emission transition dipole moment is parallel to the absorption transition dipole 
moment, the anisotropy of this directly excited fluorophore is at its maximum. However, the 
observed anisotropy is often lower. Rotation leads to a broadening of the orientation 
distribution of the fluorophores, and consequently, a lower anisotropy. Importantly, energy 
transfer to neighbouring identical fluorophores will also decrease the anisotropy of the 
emission. The measured anisotropy is the average of the individual anisotropies of “directly 
excited fluorophores” and “fluorophores indirectly excited after energy transfer”. The latter 
fluorophores have not been photoselected by the excitation light, and therefore exhibit a lower 
anisotropy. This reduced anisotropy depends on the fraction of the emission that originates 
from these indirectly excited fluorophores. Thus, homo-FRET imaging has the ability to 
determine distances between fluorophores. It can be used to quantify cluster sizes, as well as 
cluster size distributions. The interpretation of homo-FRET signals is complicated by the fact 
 
152 
 
EXP. PROC. 
that both the mutual orientations of the fluorophores and the number of fluorophores per 
cluster affect the fluorescence anisotropy in a similar way [310].  
 
 
Fig. 5.1 Cartoon depicting homo-
FRET in a mGFP-dimer. 
Adapted from [310]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental procedure. Homo-FRET imaging was carried out at room temperature in 
imaging medium as described by Squire et al. [309] in transiently transfected COS-7 cells. 
Images were acquired 15-24 hrs post-transfection, using an Olympus IX81 inverted 
microscope (Olympus, Hamburg, Germany) equipped with an MT20 illumination system. A 
linear dichroic polarizer (Meadowlark optics, Frederick, CO) was placed in the illumination 
path of the microscope, and two identical polarizers were placed in an external filter wheel at 
orientations parallel and perpendicular to the polarization of the excitation light. The 
fluorescence was collected using a 20x 0.7 NA air objective, and parallel and polarized 
emission images were acquired sequentially on an Orca CCD camera (Hamamatsu Photonics, 
Hamamatsu City, Japan). Data acquisition was controlled by the CellR software supplied by 
the microscope manufacturer. AP20187/AP1887 or soluble ephrinB2-Fc was added 1 min 
after the start of time-lapse imaging. In addition to the recording of single cells, images of the 
same cells were taken prior to the addition of the stimulant and after 20 min - at the end of the 
time-lapse recording. Image and anisotropy analysis was done by Ola Sabet (MPI Dortmund, 
Germany) with image and anisotropy analysis programs as described by Squire et al. [309]. 
Steady-state anisotropy was calculated in each pixel of the image. For displaying calculated 
anisotropy images, ImageJ was used to set the threshold between 0.17 and 0.30 with an 
appropriate color coded look-up table for visualization. 
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5.6.4 Total Internal Reflection Fluorescence (TIRF) microscopy  
 
Theoretical background. TIRF (total internal reflection fluorescence) microscopy makes use 
of the evanescent wave to selectively illuminate and excite fluorophores in a restricted region 
of the specimen immediately adjacent to the glass-water interface. The evanescent 
electromagnetic field decays exponentially from the interface and thus penetrates to a depth of 
only approximately 100 nm into the specimen. This allows the visualization of the basal 
plasma membrane (~7.5 nm thick) of cells and the adjacent cytoplasmic zone beneath [374].  
 
Experimental procedure. TIRF microscopy was performed on an Olympus IX81 microscope 
equipped with an 60x NA= 1.8 TIRFM APOCHROMAT oil objective at room temperature in 
HEPES buffered (25 mM) imaging medium. The microscope is coupled to Argon lasers, 
which pass through condensers allowing manipulation of the incident angle of light onto the 
specimen. For FL background correction, the average FL signal from an area with no cells 
was linearly subtracted from the whole image. TIRF images were analyzed and/or quantified 
as described in figure legends. 
In order to determine if Eph receptors are differentially distributed upon induction of 
clustering, the ratio of TIRF intensity maps of the Eph receptor isoforms with that of a 
myristoylated mCherry was calculated. The contrast or disparity in the resulting ratio map 
provided an estimate of differences arising from Eph distribution upon clustering. 
 
5.7 Statistical analysis  
 
Results are expressed as the means ± SEM. To analyze statistical significance, either the 
Mann-Whitney nonparametric t-test, one-way ANOVA with posthoc Bonferroni/Tukey-
Kramer test or Student’s t-test was used appropriately, as indicated in figure legends. All 
datasets passed the Kolmogorov and Smirnov test for Gaussian distribution. Significance 
level of p= 0.05 was used to evaluate significance of differences of means (* p< 0.05; ** p< 
0.01; *** p< 0.001). For biochemical experiments, representative blots are shown.  
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